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ABSTRACT 
The recognised risk of antibiotic-resistant bacteria is a global concern that has put 
increased pressure on non-EU countries to decrease their use of antibiotic growth 
promoters and EU countries to reduce their therapeutic antibiotic usage in poultry. 
Therefore, viable non-antibiotic feed supplements are needed to improve bird gut health, 
immunity and performance, whilst reducing the proposed risk to human health. Many 
supplements are being produced with this aim, but limited understanding of how they 
work hampers improvements to efficacy. A natural carbohydrate fraction (NCF) refined 
from the cell wall of Saccharomyces cerevisiae yeast has been recently developed and 
proposed to improve gut health, immunity and bird performance. The aim of this 
research project was to examine possible modes of action behind this feed supplement 
on gut health, immunity and performance in broiler chickens. A total of 3 bird trials 
were performed to achieve this aim. 
Chapter 3 reports on a 6 week trial (Trial 1), designed to examine the performance and 
gut health of birds fed NCF with a commercial stocking density. The effects of NCF on 
gut development were examined only at 6 weeks in order to not alter stocking density. 
The results of this trial demonstrated a positive effect of NCF on performance and 
limited effects on gut health at 6 weeks. Performance improvements were also age-
dependent with younger birds showing greatest response to supplementation. Following 
the conclusion drawn from Trial 1, Trial 2 (Chapter 4) was conducted using weekly 
sampling from each bird pen to examine the effects of NCF on development of the gut 
and intestinal morphology in broilers prior to 6 weeks. Trial 2 investigated the effects of 
NCF on microscopic changes in the gastrointestinal tract (GI tract) from hatch to 
slaughter and relate effects to performance. In contrast to Trial 1, data from Trial 2 did 
not show any pronounced effect of NCF on gut health or bird performance. This may be 
due to the lack of pathogenic challenge or physiological stress on the birds resulting 
from the decrease in stocking density over the trial. In addition, activity of NCF in the 
manufactured diets could not be dependably verified to show the intended incremental 
increases between treatments, which may be due to an issue with the assay or 
supplement batch itself.  
Trial 3 (Chapter 5) was performed to investigate the effects in young (0-3 week) broilers 
of two commercial forms of butyrate salts on gut health, performance, immunity and 
digestive enzyme activity, both singly and in combination with NCF. Butyrate salts are 
reported to have similar effects to NCF on gut health and performance but thought to 
engage different response mechanisms. Again, it was seen that NCF with or without the 
inclusion of butyrate did not show a pronounced effect on the gut health parameters 
measured or bird performance in this trial.  
This project aimed to clarify mechanisms behind the observed effects of gut health 
supplements in broilers by investigating parameters spanning from the overall 
performance down to individual gene expression. Chapter 6 reports on upstream factors 
with the potential to subsequently influence gut health and performance. While NCF 
had no effect on the digestive enzyme activity or serum immunoglobulin measured, a 
substantial effect on the gene expression of pathway involving immune response and 
metabolic processes was observed. Furthermore the project provides evidence that some 
of the immune adaptations are borne out through alteration to mucin production by 
goblet cells. It was also indicated in this chapter that the mechanism underlying the 
effects of NCF depend on the inclusion level: 200g/t NCF altered immune and 
metabolism genes, 400g/t NCF altered mostly immune genes, whereas 800g/t altered 
mostly metabolism genes. From the alterations seen in the gene expression and mucin 
capacity when feeding NCF, it appears that NCF is increasing immune defences to 
prevent growth impedance, rather than any metabolic, growth promoting effect. From 
this it may be concluded that performance improvements are more likely to be observed 
when some level of challenge is placed on the bird. 
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CHAPTER 1: REVIEW OF THE LITERATURE 
 
1.1 INTRODUCTION 
Intensive broiler production began in the United States and came to the United 
Kingdom in the 1950s (Sainsbury, 1999), resulting in the UK poultry production 
industry rapidly increasing. In 2010, the UK broiler production population had 
increased to over 105 million (DEFRA, 2010). However in-between 2011 and 2012, 
broiler numbers declined to 74 million (DEFRA, 2012), thought to be due to increasing 
feed costs. If this reduction in numbers of broilers is due to feed cost, it is economically 
important for the poultry industry that the broiler can maximally absorb and utilise feed 
provided to efficiently reach its target weight. The poultry industry has, over the past 
few decades, made notable developments in management, genetic engineering, nutrition 
and disease control, thus improving the efficiency of growth performance and total yield 
output. However, the intensive systems used in the poultry industry together with 
genetic selection for growth have led to a number of negative effects on broiler health. 
Negative effects caused by genetic selection for growth include; compromised immune 
system; pulmonary hypertension syndrome resulting in ascites (accumulation of 
oedematous fluid with in the abdominal cavity); lameness due to bone, tendon and 
ligament defects; tibial dyschondroplasia; and sudden death syndrome (flipover) (Julian 
1998; Rauw et al., 1998).  
 
Alongside genetic selection for rapid growth, the use of antibiotics was recognised in 
1946 as a tool to help maintain and support growth of the birds (Moore et al., 1946; 
Bozkurt et al., 2009). This led to reliance on antibiotics to maintain efficient production 
methods (Nasir and Grashorn 2010). Antibiotics have been shown to reduce the burden 
of pathogens (Leitner et al., 2001) and increase feed conversion efficiency (Dibner and 
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Richards, 2005) in birds that often have compromised immune function due to intensive 
farming methods (Heckert et al., 2002) and aggressive genetic selection (Emmerson, 
1997; Rauw et al., 1998).  On the 1st January 2006 a ban on using antibiotics as growth 
promoters was put in place throughout Europe (Regulation (EC) No 1831/2003), due to 
the increasing awareness of the appearance of antibiotic resistance in certain pathogenic 
bacteria (Diarra et al., 2007). Therefore in-feed antibiotics cannot now be introduced to 
an animal’s feed in order to improve their growth performance (Baurhoo et al., 2007b). 
Despite the decrease in the uses of antibiotic growth promoters (APGs) in recent years 
the use of therapeutic antibiotics is believed to have increased. The over-use of 
antibiotics is postulated to potentially lead to an increase in antibiotic-resistant 
infections among humans (Bates et al., 1994; Van den Bogaard and Stobberingh, 2000; 
Roe and Pillai, 2003). This poses a significant threat to human health, as antibiotic-
resistant bacteria infections are harder to overcome (Baurhoo et al., 2007). This is 
recognised as a global priority and has put increasing pressure on non-EU countries to 
decrease their use of antibiotic growth promoters, and EU countries to reduce their 
therapeutic antibiotic usage in poultry. 
  
The EU-wide ban on AGP has resulted in increased incidence of endemic diseases in 
poultry (Chee, 2008) as well as performance problems such as decreased body weight 
(BW), increased feed conversion ratio (FCR), and higher disease challenges (Thomke 
and Elwinger, 1998; Engster et al., 2002; Huyghebaert et al., 2011). This has resulted in 
either, substantial economic losses and severe negative welfare implications for broilers, 
or increased use of therapeutic antibiotics. There is now a drive for a viable feed 
supplement, which will improve gut health, immunity and bird performance, whilst 
reducing the proposed risk to human health.  
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There are a number of naturally derived feed supplements that have been reported to 
have beneficial effects on bird health, such as immunomodulators, organic acids and 
prebiotics. These supplements are thought to have similar beneficial effects to each 
other and AGP on performance, however they have different modes of actions. Organic 
acids, such as sodium butyrate, are bacterial growth inhibitors. Prebiotics, such as 
mannan oligosaccharides (MOS) are indigestible feed supplements that encourage the 
growth or activity of non-pathogenic bacteria species in the digestive tract (Bozkurt et 
al., 2009). MOS have been suggested to have a similar, positive effect on gut heath to 
AGP, through a different action of binding to pathogens and modulating immune 
function (Ewing, 2008).  
 
MOS have been shown to improve gut health by changing the population of bacteria in 
the gastrointestinal tract (GI tract) and decreasing levels of pathogenic bacteria, as well 
as increasing performance parameters (Apajalahti et al., 2006). MOS have also been 
indicated to modulate the immune response and inhibit pathogenic bacterial 
proliferation, thus leading to an improvement in the birds gut health and growth 
performance (Iji et al., 2001; Bozkurt et al., 2009). The beneficial effects of MOS on 
the growth performance of broiler chickens have been investigated by both meta- and 
holo-analysis, suggesting that MOS has an overall positive effect. However this does 
not take into consideration private research where the data has been withheld from 
being published (Hooge, 2004; Rosen, 2007). Additionally, reports of the effects of 
MOS are variable, with some reports showing that MOS have no effect on bird 
performance or gut health (Iji, et al., 2001). Due to the limited knowledge about their 
modes of action, there is no clear understanding why the results are variable. Possible 
contributing factors are differences in the composition of the MOS products 
investigated, alterations in rearing environment and the level of pathogenic challenge to 
4 
 
which the birds are subjected. 
 
Recently a refined prebiotic, Actigen™ (Alltech Inc.) has been derived by isolating the 
active component of an existing MOS product. This means that it may have greater 
ability to bind pathogens and modulate the immune function than MOS. As Actigen™, 
a natural carbohydrate fraction (NCF), is derived by isolating the active part of an 
existing MOS supplement, it is possible the inclusion level may be lowered due to 
possible higher efficiency. The aim of this research is to quantify the efficacy of feed 
supplements, concentrating on NCF in promoting gut health. 
  
1.2 GUT STRUCTURE AND FUNCTION IN POULTRY 
Poultry are classified as monogastric animals (Ewing, 2008). The major function of the 
gastro-intestinal tract is the absorption of nutrients from the feed to support health and 
growth. The development of the GI tract is associated with the early gastric experience 
of an animal (Ewing, 2008). After the birds have hatched, in order to survive they must 
make the transition from using the energy obtained from the yolk (endogenous) to the 
utilisation of carbohydrate-rich feed (exogenous) via the GI tract (Sklan, 2001). The 
degree of access to food in the immediate post-hatch period affects the level of 
development of the GI tract.  
 
1.2.1 Gross morphology of the poultry gut 
The digestive tract in poultry comprises of the oesophagus, crop, proventriculus, 
gizzard, small intestine, caeca, and large intestine (figure 1.1). The development of the 
GI tract in the post-hatch period in terms of gross morphology is measured in growth; 
i.e. weight and length.  
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Figure 1.1: Anatomy of the gastro-intestinal tract in galliforms (Larbier and Leclercq, 
1992) 
 
1.2.1.1 Oesophagus and crop   
Food enters the oesophagus, through the buccal cavity, which is the area within the  
beak of the chicken, containing a narrow triangular tongue. The numbers of taste buds a 
chicken has (312) is relatively few in number when compared to a mammals, however 
the number of taste buds to their bite size is higher than in mammals (Roura et al, 2008). 
Therefore, taste appears to play a role in consumption. Food is taken in and mixed with 
saliva, produced by salivary glands  throughout the buccal cavity, a bolus is formed 
which moves down the oesophagus. In a mature chicken the oesophagus is about 20-
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21cm long and enters the crop (Sturkie, 1976; Hill, 1976).  The food bolus moves in to 
the crop, which is well developed in the chicken. The bolus may then be stored in the 
crop if the proventriculus is full/ The crop enables the bird to consume large quantities 
of food at one time. It also serves as a reservoir which regulates the transit time of 
digesta. There are three muscle types in the crop allowing for it to contract, mix and 
pass the food on to the proventriculus. In addition a small amount of softening and 
fermentation will occur in the crop.  
 
1.2.1.2 Proventriculus and gizzard   
The proventriculus and gizzard have complementary roles and make up the stomach of 
the chicken. The cells that line the proventriculus, the chief cells, secrete hydrochloric 
acid and pepsinogen, therefore it has a secretory role, whereas the gizzard has a 
mechanical role. The proventriculus starts the process of breaking down protein into 
amino acids (Grist, 2006). However due to the fast transit of the food from the 
proventriculus most of this occurs in the gizzard. The food in then held in the gizzard, 
which is covered by a hard yellow, ridged lining called the cutica gastrica. The cutica 
gastrica grinds food which is assisted by the extensive muscle development and grit that 
the bird has ingested. Under normal ad libitum feeding conditions the content of the 
proventriculus and gizzard are acid, due to the gastric secretions from the proventriculus. 
After the mixing and pepsin digestion the food/digesta is in the form of a paste, known 
as chyme, which passes on to the small intestine. 
 
1.2.1.3 Small intestine   
The small intestine is the principal site of digestion and absorption of soluble nutrients. 
Digestion in the small intestine involves enzymes from both intestinal and pancreatic 
origins. Intestinal juices are secreted by the brush border of the small intestine and 
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contain enzymes, although most of the digestion occurs here through the action of bile 
and pancreatic juices. The small intestine wall consists of an inner lining (the mucosa), 
a secondary layer (the submucosa), an inner circular layer of muscles and an outer layer 
of longitudinal muscles. The small intestine of the chicken is approximately 120-140cm 
long in adult birds and is divided into four regions, the duodenum, jejunum and ileum 
(Grist, 2006).  
 
The duodenum follows the gizzard in the digestive tract, it a horseshoe-shaped loop 
surrounding the pancreas (Larbier and Leclercq, 1992). The pancreas secretes 
substantial concentrations of bicarbonate ions, peptidases, amylases, saccharidases and 
lipases. The bicarbonate ions neutralise the chyme so that the enzymes can digest 
protein, carbohydrates and lipids. The production of pancreatic juices is stimulated by 
secretin, which is produced by the intestinal wall when food reaches the duodenum 
(Duke, 1986b). Bile also enters the small intestine in the duodenum though two ducts 
from the liver. Bile aids the pancreatic lipase and the absorption of lipids by emulsifying 
the lipids (Sturkie, 1976). The duodenum is continuous with the jejunum, the jejunum 
starts where the bile and pancreatic ducts enters the small intestine. The jejunum is also 
continuous with the ileum which looks very similar, although the two segments are 
clearly distinguished by the presence of the Meckel’s diverticulum (Chee, 2008),  which 
is the remnants of the yolk sac.  The jejunum and ileum constitute the major absorptive 
region of the digestive tract. The ileum runs to the ileo-caecal junction where the two 
caeca branch off. 
 
1.2.1.4 Large intestine   
The large intestine consists of the caeca and colon. The caeca are two 20cm long sacs at 
the junction between the small and large intestine. They are involved in the reabsorption 
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of water from the digesta (Grist, 2006), and contain micro-organisms which breakdown 
undigested nutrients.  The microflora of the intestinal tract is very important to the 
health of the bird, through their effects on gut structure, nutrition, intestinal disease, and 
immunity (Lu et al., 2003). Therefore it is very important for the beneficial population 
of micro-organisms in the caeca to establishment early, which will assist in the 
competitive exclusion of pathogenic bacteria.  
 
1.2.2 Microscopic morphology of the gut 
The gastrointestinal tract is made up of five distinct layers, mocosa, muscularis 
mucosae, submucosa, muscularis externa and serosa (figure 1.2). The mucosa is made 
up of the epithelium and the underlying lamina propria, which is a structural network 
containing nerve fibres, lymph and capillaries (Larbier and Leclercq, 1992; Grist, 2006; 
Koutsos and Arias, 2006). The muscularis mucosae is involved in the motion of the villi 
through a layer of circular and longitudinal muscle. The submucosa and the lamina 
propria, contain blood vessels, nerves and lymph tissue. The muscularis externa is a 
muscle layer containing circular muscle involved in motility and longitudinal muscle 
involved in maintaining integrity, and the serosa is the outer most layer containing a 
layer of squamous epithelium cells.  
 
The epithelial luminal surface of the gastrointestinal tract in chickens has finger-like 
projections called villi, predominantly made up of enterocytes. The villi increase the 
surface area of the luminal surface and enterocytes have microvilli on the luminal 
surface, further increasing the surface area. The microvilli become less numerous and 
shorter toward the distal end of the small intestine. Goblet cells are also present in the 
epithelial layer, which secrete mucin. Mucin is the principle component of the mucus 
that lines the intestinal tract and acts as a lumenal lubrication. The villi are lined with 
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epithelial cells and are continuously being regenerated, which occurs near the bottom of 
the crypt. The crypts of Leiberkuhn and the cells produce epithelial cells that move up 
the villus and are eventually sloughed off the tip. Villi length are affected in response to 
a number of factors, such as diet and enteric micro-organisms. consequently,  the 
turnover rate of the villus epithelial layer varies and is related to crypt mitotic activity. 
 
 
 
Figure 1.2: Diagram of the cross section of the gastrointestinal tract of a chicken.  
 
1.3 DIGESTIVE ENZYMES 
The main site of digestion in the bird is the small intestine, because most enzyme 
secretion occurs into the proventriculus or duodenum, Table 1.1 shows the location of 
digestive enzyme production and their substrates in the chicken. Figure 1.3 shows 
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location of digestive enzyme excretion in the digestive tract. Amylase, trypsin and 
chymotrypsin are secreted into the duodenum from the pancreas. The pancreatic ducts 
enter the latter portion of the ascending branch of the duodenum (Larbier and Leclercq, 
1992). Amylase is secreted in the saliva as well as the duodenum, however most 
carbohydrate digestion occurs in the jejunum (Osman 1982). Alpha-amylase hydrolyses 
1,4 α-linkages on both sides of the 1,6 branching points of starch, producing small 
branched oligosaccharides which are further broken down into glucose molecules 
(Leeson and Summers 2001). 
 
 
Figure 1.3: Digestive enzyme location in the chicken 
 
 
Protein is broken down in the bird by a number of specific enzymes, which are 
produced by the pancreas in inactive forms, such as trypsinogen, which is activated to 
trypsin in the duodenum by enterokinase. Once trypsin is activated, it activates a 
cascade of other proteolytic enzymes meaning it is central to protein digestion.  
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Proteolysis is initiated by pepsin producing polypeptides that are broken down further 
by trypsin and chymotrypsin releasing terminal peptide bonds. In the intestinal content 
of chickens the trypsin activity increases from hatch to 15 days of age by a factor of 10 
(Leeson and Summers 2001). Lipase produced in the pancreas breaks down fat that has 
been emulsified by bile salts into fatty acids, monoglycerides and glycerol.  
 
Table 1.1: Digestive enzyme location and substrate in the chicken (Leeson and 
Summers 2001) 
Location Enzyme Substrate 
Mouth Amylase Starch 
Gizzard and proventriculus Pepsin Protein 
 Lipase Triglyceride 
Duodenum Amylase Starch 
 Trypsin Protein/peptides 
 Chymotrypsin Protein/peptides 
 Elastases Protein/peptides 
 Carboxypeptidase Peptides 
 Collagenase Collagen 
 Lipase Fat 
 Cholesterol esterase Cholesterol esters 
Jejunum  Maltase Maltose 
 Sucrose Sucrose 
 Lactase Lactose 
 Peptidase Peptides 
 
1.4 INTESTINAL MICROFLORA AND GUT DEVELOPMENT 
The GI tract of the newly hatched chick is sterile and chicks are relatively immuno-
incompetent (Dibner et al., 2008). This means that a chick when hatched is highly 
susceptible to having pathogen colonisation of their GI tract (Nurmi and Rantala, 1973). 
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It is vital that a chick develops a normal intestinal microbial population and resistance 
against enteric pathogens, as the gut microflora plays a significant role in maintaining 
optimal animal health (Lee et al., 2010). It has been found that when an animal is germ 
free, it is highly susceptible to intestinal infection (O’Hara and Shanahan, 2006) and not 
able to establish an effective antibody response until their gut microflora has developed 
(Rhee et al., 2004; Lee et al., 2010). The development of the enteric microflora in a 
chick helps prevent a sudden growth of potentially lethal pathogens that are inevitably 
introduced at some point during the life of a bird. The mechanism of protection from the 
development of enteric microflora is thought to be through competition for binding site, 
competition for nutrients, production of antibacterial substances and immuno-
stimulation (Perry, 2006). 
 
Colonization by microbial populations proceeds immediately after hatch; normally the 
GI tract becomes populated quickly by bacteria from the hatchery. Therefore 
commercial birds are already populated by microorganisms before arriving at the farm 
(Dibner et al., 2008). Development occurs through a series of colonisation steps that are 
similar across species (Dibner et al., 2008). First of all, aerobic and facultative 
organisms colonise the GI tract; these organisms change the condition of the GI tract, 
making colonization for anaerobes easier. This is thought to be through lowering the 
oxidation reduction potential in the intestine (Dibner et al., 2008). The small intestine 
microflora of a bird is developed within the first two weeks of its life. However the 
cecal flora, mainly composed of obligate anaerobes, require up to 30 days to become 
established (Amit-Romach et al., 2004). The GI tract of poultry is composed of 
generally 107 to 10 11 bacteria per gram of gut contents, but can be up to 1013 
(Apajalahti et al., 2004; Perry, 2006; Lee et al., 2010). The healthy GI tract microbiota 
consists of approximately 400 known species. However as there is a large proportion 
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that cannot be cultured the total amount is unclear (Dibner et al., 2008).  
 
The commensal bacterial populations in a healthy bird can vary greatly depending on its 
age, environment, region of intestine, feed particle size and feed composition (Rehman 
et al., 2007). Also, as not all bacteria can be cultured or detected, it is difficult to define 
an ideal population for gut health, as current knowledge of the intestinal bacteria is 
inadequate to support a definition (Rehman et al., 2007). However Rehman et al., (2007) 
reviewed literature of indigenous bacteria in the gastrointestinal tract of broiler chickens 
and reported the following; the crop had mainly gram-positive facultative anaerobic 
bacteria particularly Lactobacillus spp.; Lactobacilli, enterococci, lactose-negative 
enterobacteria and coliform bacteria were the principal organisms in the gizzard; in the 
duodenum, jejunum and ileum, lactobacilli streptococci and E. coli were the primary 
organisms; and the caecal bacteria contained anaerobes comprised of mainly anaerobic 
cocci, Eubacterium spp., Lactobacillus spp., Clostridium spp., gemmiger, 
Fusobacterium spp. and Bacteroides spp.  
 
Not only is the colonisation of the microflora population important in the development 
of the young birds GI tract but also the timing of the first feed after hatch. The timing of 
the first feed and the makeup of that feed can change the level of development of the 
small intestine (Perry, 2006). The GI tract is developmentally very active in the period 
just after hatching in birds (Uni et al., 2000). Delayed access to feed may result in the 
late development of the small intestine mucosal layer (Uni et al., 1998; Geyra et al., 
2001). Crypts form on the day of hatch, become defined in the first 48 to 96 h and 
continue growing quickly during the first 7 days after hatching (Uni et al., 2000). The 
intestinal villi increase significantly in diameter and length during the first 7 to 10 d 
after hatching (Sklan, 2001; Solis de los Santos et al., 2007) 
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As the GI tract is the main area for nutrient absorption and infection in the bird, gut 
health is very important to the bird’s overall wellbeing. When considering gut health, 
many aspects can be assessed from gross morphology of the intestine down to digestive 
enzyme production and subsequently integrity of cellular tight junctions.  In addition to 
these aspects of gut health, the micro-organism population of the intestinal tract must 
also be taken into account, as they affect gut structure, nutrition, intestinal disease, and 
the immune status of the bird (Yegani and Korver 2008). Preferably, a bird would have 
ideal gut health by optimising the following factors; gut length, mucin production 
(mucosa thickness), commensal bacteria population, villus height, villus width, crypt 
depth, turnover rate of the epithelial layer, digestive enzyme production, gut wall 
thickness and  ph. Factors that affect these parameters include; feed composition, 
particle size, feed conditioning, processing and presentation, and environmental bacteria 
population and conditions (Yegani and Korver 2008). 
 
1.5 GASTROINTESTINAL TRACT AND IMMUNE SYSTEM OF THE BIRD 
The GI tract lumen can be considered as being part of the external environment. One of 
the most important roles of the gut is providing a barrier between the internal and 
external environment, as the GI tract is the site of colonisation and invasion of many 
pathogenic bacteria. Through this and several other functions, the GI tract has an 
important role in the immune function of a bird (Patterson and Burkeholder, 2003; Beal 
et al., 2006). Post hatching is a vital time for the development of the gut immune system 
of the bird. The immune system has to differentiate between food, beneficial bacteria 
and harmful pathogens (Perry, 2006), so there is a fine balance between tolerance and 
response to antigens. This is fundamental to gut health as a prolonged immune response 
can cause problems such as villus atrophy (Perry, 2006). 
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Newly hatched chickens have some degree of immune resistance via the innate immune 
mechanisms, which involve macrophages, dendritic cells, heterophils and natural killer 
cells, which recognise and control pathogens (Powell, 1987; Kogut, 2009). The innate 
immune system is non-specific or broadly specific and has no memory. Conversely, the 
adaptive immune system is specific and has memory, and is mediated by both B and T 
lymphocytes. Macrophages are part of the innate and adaptive immune system of the 
broiler and can destroy pathogens directly (Qureshi, 2003;). Macrophages also can 
secrete cytokines that act in the inflammatory process. Lymphoid cells, such as natural 
killer cells, T cells and B cells, can be found in key immune tissues in the GI tract called 
the gut-associated lymphoid tissue (GALT). GALT is crucial in developing the immune 
system of the GI tract and is the largest component of the birds entire immune system 
(Casteleyn et al 2010). 
 
The Bursa of Fabricius, Peyer’s Patches and cecal tonsils are all parts of the GALT 
(figure 1.4). The Bursa of Fabricius is a sac like structure located between the cloaca 
and sacrum. The Bursa of Fabricius is the key lymphoid organ of the bird, and 
responsible for the development and maintenance of the B-cell (Alitheen et al 2012; Wu 
et al., 2013). Its removal during embryonic life can prevent the development of B cells 
and the production of antibodies (Ratcliffe 2006). Peyer’s Patches are made up of 
lymphoid tissues situated at numerous sites along the small intestine (Makala et al., 
2002). One Peyer’s Patch is always situated in the ileum, 5 to 10 cm from the ileum-
caecal junction (Casteleyn et al., 2010). Peyer’s Patches have been reported to be vital 
in local protection in the GI tract as regulators of the gut immune response in mammals 
against intestinal pathogens. little is known about the role of Peyer’s Patches in gut 
immunity of the chicken. However they do contain T and B cells and are the main 
source of precursors of IgA-producing cells (Muir et al., 2002; Davison et al., 2008; 
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Holt et al., 2011). Caecal tonsils are similar to Peyer’s patches, containing T and B 
lymphocytes and are located in each caeca where they join the ilium. It has been shown 
that under a pathogenic infection caecal tonsils have increased B lymphocyte and 
macrophages numbers (Setta et al., 2012) and therefore are assumed to be important in 
the bird’s immune response to pathogens.  
 
Newly hatched chickens also have a lot of maternal antibodies, which are transmitted 
from hen yolk (Lee et al., 2010) Following hatching, the adaptive immunity of a 
chicken will take at least three weeks to mature and development (Beal et al., 2006). 
Therefore, it is crucial that a bird is assisted through management and dietary 
supplements intervention in the early stages of life to give some protection against the 
microbial pathogens, when a bird is exposed to pathogens when it first eats, to minimise 
the negative effects of pathogenic bacteria on bird health, welfare and performance.  
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Figure 1.4: Diagram showing the locations of Peyer’s Patches, Caecal tonsils and Bursa of Fabricius in a chicken. 
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1.6 DIFFERENCES BETWEEN COMMERCIAL AND RESEARCH BROILER 
PRODUCTION ENVIRONMENTS  
In a new commercial poultry house it is possible to sensitively control the birds’ 
environment. This is due to good heating, ventilation systems, water and wind tight 
roofing and walls. However, many commercial poultry houses were built decades ago, 
meaning that some houses have roofs that are not watertight, have cracked concrete, 
poor heating and ventilation systems. Consequently, birds are put under varying levels 
of environmental stress due to fluctuation in temperature, and cracked concrete can 
harbour pathogenic bacteria. Generally, poultry research facilities are kept to a high 
standard of repair, meaning that the likelihood of leaks, draughts and cracked concrete 
are low. Also, as research facilities are smaller and purpose built to maintain tightly 
controlled temperatures, fluctuations in temperature are small. 
 
The maximum stocking density in the Nottingham Trent University poultry research 
facility is 24kg/m2, whereas in a commercial farm it is 34kg/m2 (DEFRA 2013). This 
means that birds that are in a commercial farm have a different amount of physiological 
stress from birds in a research facility, as there is more competition for space at the feed 
and drinker lines. Another factor that decreases the stress of birds in research facilities is 
the use of pen systems. Figure 1.5 shows the avian research facility of Scotland's Rural 
College and Nottingham Trent University’s poultry research facility. Use of larger pens 
of 40 birds at the avian research facility of Scotland's Rural College provides an 
environment closer to a commercial condition than Nottingham Trent University. In 
commercial farms it is also common practice to over stock at the beginning of a crop, so 
that they ‘thin’ (remove a number of the birds) before the final harvesting of birds. This 
distresses the birds, as well as increasing the chance of pathogenic bacteria being 
brought in to the poultry house. Biosecurity on commercial farms can vary greatly, and 
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is generally dictated by the competence of the manager making sure correct protocols 
are followed for footwear and vehicles coming on to the farm. 
 
The quality of floor litter can have a substantial effect on the birds, as they are 
constantly in contact with it. In a research facility it is very unlikely to have a capped 
litter (solid crust of excreta and litter stopping the mixing of the litter) due to the good 
environmental controls and the ability to top up litter easily. However in commercial 
situations the litter is more likely to cap due to stocking density, environmental 
conditions, management and condition of the building. Quality of feed can also vary 
substantially between batches, in regards to nutrient availability, presence of anti-
nutrient factors and contaminants. This is due to the variability in crops nutrient 
composition and the price of crops, as formulation are made to balance cost with 
nutrition. Pellet quality can also vary and cause stress on birds’ digestive systems. 
 
Another area in which commercial situation varies from research is that the range of 
flock age of the parent flock that research will accept is normally tighter than the 
commercial range. This means that the evenness of commercial flocks may be worse 
that research flocks, and they are more likely to get ‘problem’ flocks. Therefore in 
commercial broiler production it is more likely that one or more of these conditions; 
presence of unfavourable organisms, extremes in ambient temperature, diseases, 
crowding and poor management will be present (Midilli et al., 2008). All of these 
factors above which interfere with the birds normal growth development and wellbeing 
are commonly referred to as challenges. 
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Figure 1.5: Pen sizes of poultry research facilities, Left Scotland's Rural College avian 
research facility, right Nottingham Trent University’s poultry research facility.   
 
1.7 BROILER FEED COMPOSITION AND SPECIFICATION 
It is important that a broiler diet contains the correct concentration and ratios of 
nutrients, particularly energy, protein, minerals and vitamins. In most poultry diets, 
starch from maize or wheat forms the major source of energy. The energy needs of the 
bird depends on the strain and type breed of broiler. For example, a Ross 308 strain 
broiler needs 12.65MJ of metabolisable energy between 0-10d, whereas a Cobb 500 
strain needs 12.70MJ. Between 11-24d Ross 308 needs 13.20MJ/kg diet and Cobb500 
needs 13.00MJ/kg diet; and between 25 and slaughter Ross 308 needs 13.40MJ/kg diet 
and Cobb 500 needs 13.30MJ/kg diet of metabolisable energy (Aviagen, 2007; Cobb, 
2013). If a diet is low in energy, then the bird will increase its feed consumption to meet 
its energy need. However in the case of the maintenance energy needs not being met, 
the bird will lose weight. If a diet has a large excess of metabolisable energy relative to 
protein content required for normal growth, activity and maintenance, the bird will 
reduce its intake. This will result in the bird not taking in enough protein and vitamins 
to meet its needs and will show signs of  protein and vitamin malnutrition.  
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Vegetable proteins are used as the main protein source in poultry diets. These include 
soybean meal, canola, field beans, peas and lupins. A Ross 308 broiler diet needs to 
contain 22-25% crude protein between 0-10d, 21-23% crude protein between 11-24d 
and 19-23% crude protein between 25d and slaughter (Aviagen 2007). The broiler 
requirement for crude protein actually describes the requirements for amino acids, the 
building blocks of protein. In order for a bird to reach its genetic potential it must be 
provided with the right balance of amino acids, avoiding excess or deficiencies. The 
amino acid requirement for a broiler chicken is made up by the maintenance 
requirement and the growth requirements of the chicken, Table 1.2 shows the amino 
acid specifications for Ross 308. The requirements for amino acids for both 
maintenance and growth change depend upon the age, genetic growth rate, carcass 
composition, and body weight of the chicken. In poultry diets the main limiting amino 
acids are lysine, methionine and threonine. Therefore, supplementation of these amino 
acids into poultry diets may allow for an increase in the efficiency of protein utilisation, 
and a decrease in nitrogen excretion. The requirements for amino acids are affected by 
the supply of others, so increasing the supply of one amino acid (AA) may improve 
performance only if other amino acids are not limiting. This can be overcome by 
expressing the amino acid requirements as ideal ratio to lysine because, although the 
AA requirements change due to the factors above, the ideal ratio of essential AAs to 
lysine will be only slightly affected within a specific age range. (Mack et al, 1999; 
Schutte and De Jong, 1999). 
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Table 1.2 Amino acid specifications for Ross308 as hatched (Aviagen 2007) 
AMINO ACIDS 0-10 days 11-24 days 25- slaughter 
Lysine % 1.43 1.24 1.09 
Methionine and Cystine % 1.07 0.95 0.86 
Methionine % 0.51 0.45 0.41 
Threonine % 0.94 0.83 0.74 
Valine % 1.09 0.96 0.86 
iso-Leucine % 0.97 0.85 0.76 
Arginine % 1.45 1.27 1.13 
Tryptophan % 0.24 0.20 0.18 
 
Minerals are inorganic nutrients and are classified as major or trace elements. The major 
minerals in broiler diets include calcium, phosphorus, potassium, sodium, chlorine, 
sulphur and magnesium. Calcium (Ca) and available phosphorus (P) are closely related 
in metabolism and bone formation. Most calcium in broilers is used for bone formation. 
The ratio of calcium to phosphorus is important, with a ratio of around 2:1, Ca:P 
typically being needed. It has been seen that a ratio of 3.3:1 Ca:P will result in rickets 
and leg problems. For optimum bone integrity in young chicks they may need a ratio 
greater than 2.2:1 (Leeson and Summers 2001). Both Ross 308 and Cobb 500 nutrition 
specifications have ratios of Ca:P between 2:1 and 2.1:1. A diet deficient in calcium 
will reduce growth, cause leg weakness, decrease feed intake, activity and produce 
increased urine volume. The signs of phosphorous deficiency and calcium toxicity is 
similar to calcium deficiency due to the ratio between calcium and phosphorus. 
Potassium, sodium and chlorine have primarily roles in electrochemical functions, to 
maintain acid-base balance and osmotic regulation. Trace minerals added to broiler diets 
include iron, iodine, copper, manganese, zinc and selenium. Vitamins are routinely 
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supplemented in most poultry feeds and can be classified into either water-soluble or 
fat-soluble. Water-soluble vitamins include the B-complex vitamins and vitamin C. 
Vitamins classified as fat-soluble include A, D, E and K. The fat-soluble vitamins can 
be stored in the liver and other parts of the body. Vitamins are naturally occurring in 
plant based feed ingredients, although content can vary due to crop location, soil type, 
fertiliser use, variety, stage of growth at harvest, and drying and storage conditions. in 
addition, the fat soluble vitamin content can be affected by mould. As levels of naturally 
occurring vitamins are variable birds diets are supplemented with synthetic vitamins. 
Vitamin D3 is important in broiler diets as its involved in calcium and phosphorus 
balance. Vitamin D3 stimulates the active transport of calcium and phosphorous across 
the GI tract of broilers, its uptake and release from bones and its recirculation via the 
kidneys. If a diet is deficient in vitamin D the signs are similar to deficiencies in 
calcium; reduced growth and leg weakness.  
 
Fibre is also present in broiler diets, and represents a group of carbohydrates that are 
resistant to digestion and absorption in the birds small intestine, with complete or partial 
fermentation in the large intestine. This is due to the bird lacking the enzymes capable 
of digesting fibre. Fibre can either be soluble or insoluble and includes lignin, non-
starch polysaccharides, resistant starch, inulin and non-digestible oligosaccharides. 
Soluble fibre has been seen to increase luminal viscosity, the solubility of non-starch 
polysaccharides (NSP) is a major anti-nutrient factor as increased viscosity means that it 
is less likely for the enzymes to have contact with the nutrients in the digesta.  
 
1.8 ANTIBIOTIC USE IN POULTRY DIETS 
Antibiotic growth promoters (AGP), avoparcin, virginiamycin, bacitracin zinc, tylosin 
phosphate, spiromycin, avilamycin and flavomycin, have been used since the mid-1940s 
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in agricultural animal production (Dibner and Richards, 2005; Yegani and Korver, 
2008). Their use in animal feed grew as it was reported that AGP improved animal 
performance and health status (Miles et al., 2006; Yegani and Korver, 2008). The 
routine inclusion of AGP in feed negated the requirement to select genetic strains of 
broiler with disease resistance. This combined with the physiological stress induced by 
their immense potential for fast growth has led to compromised immune systems in 
modern strains of broilers used in intensive poultry production (Emmerson, 1997; 
Heckert et al., 2002). Antibiotics have their effect through reducing the birds pathogenic 
burden (Leitner et al., 2001). However pathogens can become resistant to antibiotics in 
specific situations. Therefore there has been an increased awareness of the link between 
the use of antibiotics in animal production to antibiotic resistant pathogens in humans, 
as a number of AGP used in animal production systems belong to classes of drugs used 
in human medicine (Emborg et al., 2002).  
 
The use of antibiotics gave rise to the possible problem of antibiotic resistant pathogenic 
bacterial strains (Budino et al., 2005) and residual components entering the food chain 
(Chen et al., 2005). It has been shown in many reports that there is an increase in the 
prevalence of resistance to antibiotics in pig and poultry enterococci, Escherichia coli 
and Campylobacter spp. when feeding antibiotics (Linton et al., 1985; Mathew et al., 
1998; Taylor et al., 2008). Ramos et al. (2012) found that in E. coli in faecal samples of 
73 sheep, 71 pigs and 54 beef cattle, 76.6% were resistant to one or more antimicrobial 
agents. Antibiotic-resistant pathogens can be spread from animals to humans in several 
ways. Firstly through foodborne infection via humans having contact with 
meatcontaminated with the resistant bacteria, secondly, through direct contact with the 
infected animals, and thirdly through contact with bacteria in the animal manure (van 
den Bogaard and Stobberingh, 2000). Due to the possible undesirable negative effects of 
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AGP on human health, the agriculture industry has been under increasing pressure to 
reduce and eliminate their use of AGP. This led to the steady voluntary withdrawal of 
AGP from animal feed in many EU countries. On 1st January 2006, the use of 
antibiotics as growth promoters was prohibited in the EU (Regulation (EC) No 
1831/2003). 
 
It has been reported that AGP exerts growth promoting effects through several 
mechanisms. Antibiotics can influence the harmful effects of micro-organisms by 
stabilising the intestinal microbial flora and decreasing gram negative bacteria (Gunal et 
al., 2006), and decreasing competition for nutrients, such as simple sugars and amino 
acids ideally utilised by the host, but also available for utilisation by the bacteria 
population of the GI tract (Dibner, and Richards, 2005; Apajalahti, 2005; Brisbin et al., 
2008). Antibiotics also have been observed to increase nutrient digestibility (Dibner and 
Richards, 2005; Miles et al., 2006); Knarreborg et al. (2004) found that ileal absorption 
of fatty acids were greatly improved by salinomycin and avilamycin in broilers; whereas 
Sayrafi et al., (2011) found improvements in villus height when feeding bacitracin 
methylene disalicyate. In addition in-feed antibiotics can result in a reduction of 
microbial metabolites that depress growth (Feighner and Dashkevicz, 1987; Knarreborg 
et al., 2004; Dibner, and Richards, 2005), the quantity of opportunistic pathogens and 
levels of subclinical infection (George et al., 1982; Brennan et al., 2003; Butaye et al., 
2003; Dibner and Richards, 2005).  
 
Common types of antibiotics used in broiler production are effective against Gram-
positive bacteria. However, these antibiotics also inhibit the gram-positive commensal 
bacteria, thought to be beneficial to the bird (Apajalahti and Kettunen, 2013). It has 
been shown that antibiotics can decrease the number of bacteria in the GI tract, however 
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with this change the percentage of beneficial bacteria in the population decreases and 
the percentage of harmful bacteria in the bacterial population of a chicken increases. 
Therefore, it is thought that antibiotics have their beneficial effect on bird GI tract and 
growth performance by decreasing the total number of bacteria, not by selectively 
altering and shifting the microbial populations to reduce pathogenic load (Apajalahti 
and Kettunen 2006). This has led to the view that the gut of the bird fed antibiotic is not 
in fact a healthy gut, although it is an efficient gut (Apajalahti and Kettunen, 2013). 
 
The ban of AGP in poultry diets in the EU is thought to have led to reduced efficiency 
in feed conversion and a rise in the incidence of certain animal diseases, such as 
(subclinical) necrotic enteritis (Wierup, 2001; Dibner and Richards, 2005). These issues 
have been cited as causing substantial economic losses, and may have been due to 
changes in the gut microbial composition (Yegani and Korver, 2008), which may have 
increased the pathogenic burden on the bird and therefore decreased performance due to 
poor gut health. In Demark, the FCR of 6,179 flocks were calculated and it was reported 
that they found that the average FCR was significantly higher (0.016 kg/kg (P<0.001)) 
in the period after the voluntary removal of AGPs that before (Emborg et al., 2002). 
Additionally, there are conflicting reports that suggest that the beneficial effects of AGP 
on weight gains are not adequate to offset the cost of the AGP (Graham et al., 2007; 
Yegani and Korver, 2008). Despite the conflicting views around the economic impact of 
removing AGPs, there is consensus that bird gut health has deteriorated since their 
removal. Following the ban on the use of AGP in animal feeds, many believe that the 
use of therapeutic antibiotics have increased in livestock. The total poultry only 
veterinary antibiotics sold in the UK in 2006 was 17 tonnes, which increased to 50 
tonnes in 2010 (Veterinary Medicines Directorate, 2012). However this has decreased 
since, which may be due to a drive to decrease the use of therapeutic antimicrobials in 
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poultry. 
 
1.9 MANNAN OLIGOSACCHARIDES 
Due to the increased pressure from consumers to reduce the use of sub-therapeutic 
antibiotics in poultry diets, there is an increased interest in natural feed supplements in 
the animal feed industry (Benites et al., 2008). Prebiotics are non-digestible food 
ingredients that selectively stimulate the growth and/or activity of bacteria in the 
digestive system (Bozkurt et al., 2009). This is in contrast to antibiotics which decrease 
the total level of bacteria in the GI tract. One class of prebiotics are mannan 
oligosaccharides, which have been isolated by enzymatic hydrolysis or autolysis of the 
cell wall of the Saccharomyces cerevisiae yeast (figure 1.6), a common yeast in feed 
supplements (Vondruskova et al., 2010). MOS consist of a mannan and a glucan 
component. The structure of the mannan component resembles that of the surface 
glycoproteins containing mannose present on the mucosal surface of the intestine. The 
mannans act as high-affinity ligands for the mannose- specific type-1 fimbriae of 
pathogenic bacteria (Ofek,  et al., 1977; Spring et al., 2000; Miguel et al., 2004) thus 
rendering them inert. The glucans component is a polymer of glucose linked by β-
glycosidic bonds and is discussed later in this chapter (1.10).  
 
It has been reported that MOS may have a number of beneficial effects, similar to those 
of AGP, on growth, intestinal development and immunity (Fernandez et al., 2000; 
Spring et al., 2000; Iji et al., 2001). It has been indicated that MOS may modify the 
microbial gut ecosystem by adhering to the receptors on the intestinal epithelium, 
thereby blocking the binding of specific pathogens exhibiting mannose-sensitive 
glycoproteins and the colonization of the pathogens (Spring et al., 2000; Chee, 2008). 
MOS are also thought to contribute to the establishment of a stable gastrointestinal 
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microbial balance and have a favourable effect on the intestinal microflora (Lyons and 
Bourne, 1995; Gaggia et al., 2010). It has been reported that MOS can stimulate the 
local immune system by acting as a non-pathogenic antigen to increase the activities of 
macrophages and T-lymphocytes (Lyons and Bourne, 1995; Kelly, 2004; Ewing, 2008; 
Vondruskova et al., 2010) In addition, MOS have been reported to improve the 
functions and health of the GI tract by improvement in the intestine morphology (Iji et 
al., 2001; Chee, 2008) and therefore improving nutrient digestibility and level of 
apparent metabolisable energy (Biggs et al., 2007) 
 
However the effects of MOS on the bird are variable; Iji et al. (2001), Midilli et al. 
(2008) and Brummer et al. (2010), showed no significant effects of MOS on bird weight 
and feed intake. Yang et al. (2007) also reported broiler feed conversion ratio (FCR) to 
be unaffected by MOS supplementation. It is thought that MOS is most effective under 
conditions of physiological stress (Baurhoo et al., 2009), which are frequently present at 
some level in a commercial broiler production systems. However in a research 
environment the physiological challenge to the birds is typically lower (Midilli et al., 
2008). 
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Figure 1.6 Schematic outline of the preparation procedure and analysis of yeast cell walls and extraction and analysis of alkali-soluble and alkali-
insoluble fractions (Yiannikouris et al., 2004)    
30 
 
1.10 BETA-GLUCANS  
β-glucans are polymers of glucose linked by β-glycosidic bonds. There are many types 
of β-glucan with different structures (Bohn and BeMiller, 1995); β-1,3/1,6-glucan is 
from the cell wall of S. cerevisiae (figure 1.7). β-1,3/1,6-glucan is recognised by the 
immune systems of mammals, fish, and birds (Huff et al., 2007). It is thought that the ß-
glucans present in yeast cell wall stimulate macrophages through binding to 
macrophages via specific cell receptors, ß-1-3 or ß-1-6 links (Ferreira et al., 2011). 
Macrophages are considered the first line of immune defence in birds (Qureshi, 1998; 
Ferreira et al., 2011), as they form part of both the innate immune system and adaptive 
immune system (Qureshi, 2003; Ferreira et al., 2011). It has been reported that β-glucan 
can have a number of stimulatory effects on the immune systems in pigs, poultry and 
some marine animals (Reynolds et al., 1980; Bohn and BeMiller, 1995; Cleary et al., 
1999; Sohn et al., 2000; Tzianabos, 2000; Suphantharika et al., 2003; Mao et al., 2005; 
Huff et al., 2006; Leblanc et al., 2006; Morales-Lopez, 2009). Many authors suggest 
that β- glucans have their immunomodulating effects through increasing functional 
activity of macrophages and neutrophils (Reynolds et al., 1980; Cleary et al., 1999; 
Tzianabos, 2000; Guo et al., 2003; Yun et al., 2003; Cheng et al., 2004). Reynolds, 
(1980) reported a protective effect in a number of disease challenge studies. Lowry et al. 
(2005) indicated that β-glucan, present in the yeast walls, can decrease enteric 
Salmonella enteritidis in 7 day old chicken tissues and stimulate phagocytosis, bacterial 
killing, and oxidative burst in chickens after oral challenge. These improvements in 
defences against pathogens may result in the birds having better immunity and may 
contribute to the increased weight gain concurrently observed. More recently, Huff et al. 
(2006) demonstrated that β-glucans can maintain FCR of birds challenged with 
Escherichia coli respiratory disease, and numerically improved mortality. 
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It has been reported in a number of studies that supplementation with yeast β-1,3/1,6-
glucan improved performance in broilers (Chae et al., 2006; Zang et al., 2008) and 
nursery pigs (Dritz et al., 1995). This was also found by Huff et al. (2006) who 
observed an improvement in BW and FCR of broiler fed β glucans and challenged with 
Escherichia coli, compared to a negative control. However, Huff et al. (2006) also 
found that non-challenged (positive control) chickens fed β-glucans had a reduced body 
weight. This reduction in growth may be due to the energy expenditure associated with 
increased immune stimulation by the dietary yeast β-glucans and therefore increased 
energy used by the immune system, which is not needed in healthy birds and simply 
diverts energy away from growth. This may be the reason why Huff et al. (2006) found 
a negative effect on body weight effects when birds were not challenged.  
 
The endemic presence of β-glucan in the cells wall of S. cerevisiae, means that most 
yeast cell wall products will contain some level of β-glucan (Morales-Lopez et al., 
2009). Mannan oligosaccharides are also derived from the cell wall of S. cerevisiae, 
suggesting that most yeast cell wall supplements are likely a mixture of mannan 
oligosaccharides, β-glucan and other cell wall components despite being commonly 
referred to as a MOS supplement. From this it is key to note that when a yeast cell wall 
product is fed to an animal, any observed  effects could be  a result of either or both 
MOS and β-glucan. The typical composition of yeast wall is 30 to 60% polysaccharides 
(15 to 30% of β-1, 3/1, 6-glucan and 15 to 30% of mannan sugar polymers), 15 to 30% 
proteins, 5 to 20% lipids, and no more than 5% of chitin (Aguilar-Uscanga and 
Francois, 2003; Ferreira et al., 2011). This unmeasured and undeclared portion of β-
glucan within so called MOS supplements may explain some of the variability observed 
in bird response when such supplements are commercially applied.  
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Figure 1.7 Yeast β- glucan (Sigma 2013)  
 
1.11 SUPPLEMENTS BASED ON MANNAN RICH YEAST FRACTIONS 
Actigen™ (Alltech) is a commercial form of mannan rich yeast fraction, which has been 
isolated from a MOS product. It is a soluble extract of the yeast cell wall of S. 
cerevisiae whereby the mannoproteins are separated from the other cell wall 
components. Actigen is a mannan rich fraction, which is produced to contain a greater 
concentration of mannan reactive units (alpha 1,3 mannan units) than previously 
produced yeast derived prebiotics such as BioMOSTM (Alltech) (Mathis et al., 2012). 
Alpha 1,3 mannans are involved in agglutination and recognition of phagocytic cells. It 
is therefore hypothesised that a NCF is more concentrated than traditional MOS 
supplements and therefore could have a similar action at a lower level of inclusion. At 
present there has been little work into the effect of NCF on poultry gut health and 
production, or their mode of action.  
 
1.12 SUPPLEMENTS BASED ON BUTYRATE SALTS 
Whilst prebiotic supplements modify the microflora in the birds GI tract, short chain 
fatty acids are thought to reduce pathogenic microorganisms without affecting the 
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beneficial intestinal microflora (Fernandez rubio et al., 2009). Sodium or calcium 
butyrates are the sodium or calcium salts of butyric acid, which is a short chain fatty 
acid (SCFA) (figure 1.8). Butyrate is a natural substance that can be found in the 
intestinal tract of birds, mainly produced by the bacterial fermentation of dietary fibre 
(Hamer et al., 2008; Guilloteau et al., 2010). In broilers, SCFA levels increase from 
untraceable levels to a stable concentration between 1 and 15 days, after 15 days the 
levels then stabilise (Guilloteau et al., 2010).  There are a number of reported beneficial 
effects of increasing levels of butyrate in poultry; butyrate can be used as an energy 
source (Jozefiak et al., 2004), induce mucin synthesis, affect intestinal motility, 
regulates gene expression and inflammation (Hammer et al., 2008; Louis and flint 
2009), affects proliferation of intestinal cells (Kripke et al., 1989; Friedel and Levine, 
1992) and enhances disease resistance by inducing antimicrobial host defence peptide 
gene expression (Sunkara et al., 2011).  
 
 
Figure 1.8 Sodium butyrate and calcuim butyrate chemical composition  
 
Butyrates are fed as Na or Ca salt because they are easier to handle than the acid form in 
the feed manufacturing process (Guilloteau et al., 2010). The Na or Ca butyrates can be 
covered in a fat coating, called microencapsulation, which protects the butyrate, 
allowing the molecules to be released further down the intestinal tract (Van Immerseel 
et al., 2004; Fernandez Rubio et al., 2009). Un-protected butyrate added to poultry 
feeds are metabolised in the upper GI tract, while microencapsulation reduces 
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dissociation of butyrate in the proventriculus, meaning more butyrate reached the distal 
part of the GI tract (Hu and Guo 2007; Zhang et al., 2011). When butyrate is 
unprotected it is readily taken up by the GI tract epithelium, where it is metabolised for 
energy through the tricarboxylic acid (TCA) cycle (figure 1.9). This means that the host 
animal can get a significant source of energy from butyrate (Lawhon et al., 2002; 
Guilloteau et al., 2010), which may be one mechanism by which butyrate improves 
performance and gut integrity. 
 
It is thought that sodium or calcium butyrate may have growth promoting effects due to 
their possible effects described, especially though providing energy for the epithelium 
and their antimicrobial activity. However, studies investigating butyrate growth 
promoting effects are inconsistent, the varied findings may be due to the type of 
environment and management conditions of the trial, particularly the microbial 
population to which the broilers or pigs were exposed. This suggest that broilers that are 
reared in a low pathogen environment do not have promoted growth due to butyrate 
supplementation, because the animals already have a high health status. A number of 
studies have found improvements in growth parameters in piglets when being 
challenged though weaning (Piva et al., 2002; Manzanilla et al., 2006; Le Gall et al., 
2009) and broilers when being challenged with coccidial oocytes, corticosterone or E. 
coli (Leeson et al., 2005; Zhang et al., 2011; Zhang et al., 2011b) respectively, when 
feeding butyrate. However improvements in performance have also been seen in 
broilers when they have no recorded challenge (Smulikoska et al., 2009). In contrast, 
other studies have found no effect of feeding butyrate on performance parameters in 
chickens (Leeson et al., 2005; Zhang et al., 2011b) and piglets (Biagi et al., 2007; Tonel 
et al., 2010) which were not challenged. It was also seen by Hu and Gao (2007) that 
feeding butyrate to unchallenged broilers negatively affected FCR. 
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Figure 1.9 The tricarboxylic acid cycle (TCA cycle) is a series of enzyme-catalysed 
chemical reactions that form a key part of aerobic respiration in cells. (Donohoe et al., 
2011) 
 
Sodium butyrate has been reported to prevent salmonella colonisation of the GI tract in 
broilers (Fernandez rubio et al., 2009), layers (Van Immerseel et al., 2005) and cultured 
chicken cecal epithelial cells (Van Immerseel et al., 2004), by down regulating 
expression of bacterial genes involved in salmonella invasion of the GI tract (Gantois et 
al., 2006). Sodium and calcium butyrate may also have antimicrobial activity due to 
their ability to acidify bacteria cell cytoplasm. Sodium and calcium butyrate can cross a 
bacterial cell wall when un-dissociated and dissociate in the more alkaline cell to H+ 
and anions inside, therefore bacteria that are unable to decrease intracellular pH 
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accumulate organic acid anions, causes a lowering in the pH of cytoplasm (Fernandez 
Rubio et al., 2009).  
 
Similarly to mannan oligosaccharides and other feed supplements, the feeding of 
butyrate seems to have variable effects on gut health parameters. Positive effects of 
butyrate on gut health may be through butyrate decreasing pathogenic load and 
therefore their harmful toxins, and/or increasing energy available to the epithelial cells. 
A lack of butyrate in the GI tract, whether from the diet or bacterial fermentation, can 
lead to nutritional deficiencies of the epithelium and result in atrophy (Hamer et al., 
2008).  Manzanilla et al. (2006) found that pigs fed butyrate had a higher number of 
colonic goblet cells, whereas Le Gall et al. (2009) found no effect on intestinal goblet 
cell numbers. Manzanilla et al. (2006) also reported an increased jejunum crypt depth 
(CD) and Hu and Guo (2007) at 21 days found an improved VCR when feeding sodium 
butyrate. Leeson et al. (2005); Smulikowska et al. (2009) and Tonel et al. (2010) 
contradict these finding as they found no effect on gut morphology. As with 
supplements previously discussed, the variability reported in gut morphology when 
feeding butyrate may be due to differences in environmental and health statuses of the 
birds. Butyrate may only have an effect when the bird is not meeting its optimum 
performance due to some level of challenge.  
 
The molecular composition of butyrate suggests that when fed to poultry, it may act as 
an acidifier, however the extremely low concentration of butyrate fed to poultry is not 
thought to be enough to change GI tract pH. This is supported by Manzanilla et al. 
(2006), Smulikowska et al. (2009), Zhang et al. (2011) and Czerwinski et al. (2012) 
who reported that GI tract pH was not affected when feeding sodium butyrate. However 
Biagi et al. (2007) did see an increase in pH of the cecum when feeding sodium butyrate.  
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There is little published data on the effects of feeding sodium or calcium butyrate on the 
digestive enzymes activity in broilers. Sileikiene et al. (2005) found that intra-ileal 
infusion of short chain fatty acids in pigs increased trypsin production. However this is 
contradicted by Le Gall et al. (2009) that found feeding sodium butyrate to pigs 
decreased the activity of chymotrypsin and trypsin in the GI tract.  
 
In the poultry nutrition industry, there are numerous supplements that are marketed as 
having a regulatory effect on the immune status of the bird. The supplements are 
thought to provide a way to improve poultry health and production, sodium or calcium 
butyrate may mediate the immune system and result in performance improvements. 
Most studies looking into the effects of butyrate on intestinal inflammation are focused 
on humans, where it has been seen that SCFA can affect the recruitment of circulating 
leukocytes to the site of inflammation (Vinolo et al., 2011). It has also been reported 
that SCFA can activate specific G protein coupled receptors that are involved in 
neutrophil migration, and suggested that SCFa may have an inhibitory effect on 
neutrophil migration (Vinolo et al., 2011). Additionally, SCFA have been reported to 
affect human macrophage cytokine production and expression of Nitric oxide synthase 
(iNOS), Tumor necrosis factors (TNF)-α, and interleukin (IL)-6 induced by interferon 
(IFN)-γ, seeming to have an anti-inflammatory effect (Park et al., 2007; Hamer et al., 
2008; Vinolo et al., 2011). Similar to this, it has been noted in poultry that dietary 
sodium butyrate significantly inhibits the elevation of serum IL-6 and TNF- in chickens 
(Zhang et al., 2011b) 
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1.13 THE EFFECT OF SUPPLEMENTS ON GUT TISSUE MORPHOLOGY 
 
1.13.1 Length and weight 
The addition of AGP has been reported to reduce intestinal weight and size. This effect 
is thought to be mediated through thinner intestinal villi, total gut wall and villus lamina 
propria as well as shortening of the gut (Thomke and Elwinger, 1998; Dibner and 
Richards, 2005). The reduction in the gut wall thickness has been used to explain the 
enhanced nutrient digestibility observed with AGP (Dibner and Richards, 2005). AGPs 
are also thought to decrease the intestinal muscularis weight, which is likely associated 
with a reduced need for gut motility to control microbial activity (Chee, 2008). A lower 
relative intestinal weight due to the reduced need for gut motility and a slower rate of 
epithelial cell renewal may have a favourable effect on basal energy expenditure and 
efficiency of nutrient utilisation (Chee, 2008). The energy spared from gut maintenance 
can subsequently be made readily available for growth (Iji et al., 2001; Miles et al., 
2006; Chee, 2008). Increases in gut mass have been associated with inflammation 
following bacterial infection (Baurhoo et al., 2007), and this response mechanism is 
supported by a study reporting that germ-free birds have thinner muscularis mucosae 
than conventional birds (Gordon and Bruckner-Kardoss, 1961). 
 
The proposed theory that MOS influence the microbial population in the intestinal tract 
(Oyofo et al., 1989; Sim et al., 2004), suggests that MOS supplements may reduce 
intestinal weight by decreasing inflammation of the GI tract caused by pathogenic 
bacteria. A decrease in the weight of the intestine may be due to a decrease in the 
thickness on the muscularis. Ferket et al. (2002) reported that when turkeys were fed 
MOS, their muscularis thickness was significantly reduced. An increase in the intestinal 
weight has also been associated with inflammation following bacterial infection 
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(Baurhoo et al., 2007). Therefore a reduction in the weight of the intestine may indicate 
a reduction in the volume of pathogenic bacteria in the GI tract. Chee (2008) concluded 
that MOS-supplemented birds have a thinner gut and therefore have a lower gut mass to 
maintain. This therefore would decrease the energy needed to maintain the gut and leave 
more energy for growth. However previous research is conflicting; Iji et al., 2001 at 21 
days,  Yang et al., 2007 at 28 days and Baurhoo et al. (2007) at 14, 28, 42 days all 
found that there was no effect of MOS on the weight of the intestinal tract. Chee (2008) 
found that MOS reduced the duodenal length at 28 days, in contrast Trevifio (1990) 
reported that birds fed oligosaccharide dried extract to 28 days had a longer relative 
length of jejunum, ileum and caeca than those fed on the control diet (P< 0.05). These 
observations demonstrate the variability in the effects reported when feeding a yeast cell 
wall product, which may be due to differences in the products or environments that the 
trials were performed.  
 
1.13.2 Villus and crypt 
The morphological structure of the GI tract offers key information to assessing gut 
health. Villus height (VH), width and CD are thought to reflect the health status of the 
GI tract of the bird.  Longer, thinner villi are considered to indicate that the bird will 
have a better ability to absorb nutrients, due to the increased surface area (Gao et al., 
2008). Shorter villi and deeper CD have been associated with the presence of toxins 
(Yason et al., 1987), decreasing the digestibility of nutrients (Zhang et al., 2005). 
Increased CD is considered a negative indication of gut health because to compensate 
for villi atrophy the bird has to increase its tissue turn over and, as epithelial cells are 
produced in the crypts and migrate along the villi to the tip, it is thought that the higher 
turnover in the crypt cell cause it to become deeper (Gao et al., 2008). Therefore 
shallower CD are considered a good indicator of gut health. Atrophy of villi can be due 
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to inflammatory response to pathogens and their toxins (Gao et al., 2008). The higher 
turnover of epithelial cells during inflammatory response has an impact on the protein 
and energy requirement of the gut, leaving fewer nutrients for growth. VH and CD may 
be presented as a ratio of VH:CD as a single combined marker of overall intestinal 
health. However, an improved ratio can be achieved by solely the VH or CD changing; 
which may occur though different mechanisms.  
 
Several studies have reported that MOS improves the overall intestinal health, when 
considered in terms of VH and CD. Iji, (2001) Santin, (2001), Sun, (2005); Zhang et al., 
(2005) and Baurhoo et al., (2007) in broilers and  Mourao et al., (2006) in rabbits found 
that feeding yeast cell wall products increased VH over controls. The effect of MOS is 
not always shown throughout a study; Baurhoo et al. (2007) found that MOS improved 
VH at 28 days but not at 42 days and Baurhoo et al. (2009) again found that MOS 
increased duodenum VH only at 14 days. Conversely, Ferket et al. (2002), Yitbarek et 
al. (2012) and Sohail et al. (2012) in broilers and White et al. (2002) in pigs report no 
effect of feeding MOS on VH. There are also contradicting results over which region of 
the GI tract shows effects of MOS on VH. Santin et al. (2001) found that feeding yeast 
cell walls (likely to contain MOS type compounds) increased VH in the duodenum, 
jejunum, and ileum. However Baurhoo et al. (2009) found that feeding MOS increased 
VH on day 14 only in the duodenum and on day 24 VH was only increased in the 
jejunum.  
 
Feeding of MOS has also been shown in some studies to decrease CD in broilers (Santin 
et al. 2001; Ferket et al. 2002). Santin et al. (2001) also found that villus:crypt ratio was 
increased in a dose dependent manner by dietary yeast cell wall treatment, but only in 
the jejunum. As with VH, the effects of MOS on CD are varied in terms of whether 
41 
 
there is any observed effect, which part of intestine is affected and at what bird age they 
have an effect. Iji et al. (2001), Zhang et al. (2005) Yitbarek et al. (2012) and Sohail et 
al. (2012) observed that MOS had no effect on CD in broilers; this was also found by 
Mourao et al. (2006) in rabbits. Changes in  VCR may occur via a change in either or 
both VH and CD. Zang, (2005) found that birds fed yeast cell wall had increased VH 
and VCR but no change in CD; Ferket, (2002) found that MOS fed birds had decreased 
CD and increased VCR but no change in VH, whereas Santin, (2001) found that yeast 
cell wall fed birds had decreased CD and increased VH and VCR than that of the 
control. In contradiction, White (2002) found that the VH:CD ratios did not differ 
among dietary treatments when feeding MOS.  
 
The term mannan oligosaccharides is used for a range of commercial products that are 
refined from yeast cell walls and are a variable mixture of mainly mannans and β-
glucans. The terms yeast cell wall and MOS are used interchangeable in literature and 
the content of mannans and β-glucans depends on the extraction technique and yeast 
strain. The levels of mannans and β-glucans in a commercial product many be variable 
and might be contributing to the variability in the effects of MOS on VH and CD and 
therefore on the birds intestinal tract health. 
 
The mechanism of action of MOS on intestinal microstructure is not fully understood 
and is complicated by the fact that many studies show that MOS had no effect on VH, 
CD or their ratio (Castillo et al., 2008). However Bourhoo, (2009) suggested that the 
increase in villi length associated with MOS supplementation may be associated with 
increased lactobacilli and bifidobacteria colonization of broiler intestine. This is thought 
to be through the indigenous microbes stimulating vascularisation and villi development 
(Baurhoo et al., 2007), but the exact mechanism underlying this effect is still not clear. 
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A more accepted theory is that the beneficial effect of MOS on intestinal morphology 
may be due to a reduction in the enterobacteria population (Castillo et al., 2008), 
consequently reducing the presence of harmful toxins they produce. MOS is often 
attributed to reduce effects of pathogenic bacteria in the intestinal tract because it has 
been reported that MOS contains mannans that bind to pathogens with the mannose-
specific type-1 fimbriae (Spring et al., 2000). Therefore the pathogens cannot attach to 
the intestinal epithelial cells (Castillo et al., 2008), and are evacuated from the intestine 
with other non-digested feedstuffs. This may reduce sloughing of villi in birds fed MOS 
as the pathogenic bacteria cannot colonise the GI tract and release toxins. These bacteria 
and their toxins can cause inflammation that in turn cause atrophy of the epithelial cells 
of the villi (Gao et al., 2008), thus reducing the absorptive function of the gut through 
shorter VH and deeper CD (Yason et al., 1987).  
 
1.13.3 Goblet cells  
Goblet cells are found in the epithelial layer along the villi of the avian gastrointestinal 
tract. Goblet cells are produced in the crypt cells and migrate up the villi to the tip, 
which takes 2 to 3 days (Uni et al., 2003). Goblet cells produce and secrete mucin 
glycoproteins that make up part of the mucus layer, which protects the intestinal surface 
against damage by bacterial and environmental toxins, microorganisms and some coarse 
dietary components (Santos et al., 2007). The mucus layer is also thought to be a 
medium for lubrication and transportation of nutrients between the lumen and the brush 
border (Uni, el at., 2003; Smirnov et al., 2004). While mucin can either be neutral or 
acidic, it has been suggested that acidic mucins in early life may be beneficial to the 
developing innate and intestinal immune system (Koutsos and Arias, 2006), through 
protecting against bacterial translocation in immature birds (Santos et al., 2007).  
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There is no consensus on whether an increase in goblet cell numbers and area is 
considered an improvement in bird health. Increasing the number and area of goblet 
cells is thought to increase the volume of mucin stored in the GI tract and possibly its 
production (Brümmer et al., 2010). Mucin is essential for a number of brush border 
processes, including facilitating the absorption of nutrients, enzymes carriage, 
lubrication and decreasing the binding and colonisation of pathogenic bacteria to the 
intestine (Blomberg et al., 1993; Smirnov et al., 2004). Therefore an increase in the 
level of mucin could have a beneficial effect on the first line of defence of the immune 
system (Baurhoo et al., 2009) and the absorptive function of the gut. Conversely, 
overproduction of mucin may result in an negative effect, by increasing the mucus 
thickness on the GI tract wall to a level that might negatively affect the ability of 
nutrients to pass through to the gut epithelial to be absorbed (Smirnov et al., 2004; 
Brummer et al., 2010).  
 
Baurhoo et al. (2007; 2009), Chee et al. (2010), Morales-lopez et al. (2010), Brummer 
et al. (2010) and Muthusamy et al. (2012) all found goblet cell numbers were increased 
by yeast cell wall product supplementation. However, an absence of response in goblet 
cell number to MOS was reported by Castillo et al. (2008) and Yitbarek et al. (2012), 
As with the other gut morphology measures, the effects of MOS on goblet cell number 
are variable between the different sections of the small intestinal tract and birds of 
different ages (Santos et al., 2007; Baurhoo et al., 2007; Castillo et al., 2008; Baurhoo 
et al., 2009). Published data on goblet cell area is limited; Uni and Smirnov, (2006) and 
Brummer et al. (2010) found that the area of goblet cells increased with 
supplementation of MOS.  
 
An increase in goblet cell area is thought to show that the storage capacity of the goblet 
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cell for mucin has increased (Smirnov et al., 2005). The increase in mucin storage may 
suggest that the bird is more capable of forming a protective layer on the villi, thereby 
helping protect the intestine from damage caused by enteropathogens if there was a 
challenge from pathogenic bacteria (Smirnov et al., 2006; Brümmer et al., 2010). The 
mechanism by which MOS increases the goblet cell numbers or area is not clear, 
however one suggested mechanism of MOS on mucin production is through changing 
the gene expression of key genes through direct crosstalk between beneficial intestinal 
microbes and goblet cells, (Mack et al., 1999; Freitas et al., 2003; Smirnov et al., 2005 
Uni and Smirnov 2006; Chee, 2008).  
 
1.14 PATHOGENIC COLONISATION OF THE GASTROINTESTINAL TRACT 
AND INHIBITION OF PATHOGENS 
It is vital that a chick develops a normal intestinal microbial population and resistance 
against enteric pathogens, as the gut microflora plays a significant role in maintaining 
optimal immune defence (Lee et al., 2010). It has been found that when an animal is 
germ free it is highly susceptible to intestinal infection (O’Hara and Shanahan, 2006) 
and not able to establish an effective antibody response until its gut microflora has 
developed (Rhee et al., 2004; Lee et al., 2010). The development of the enteric 
microflora in a chick helps prevent a sudden growth of potentially lethal pathogens. The 
mechanism of protection from the development of enteric microflora is thought to be 
through competition for binding sites; competition for nutrients; production of 
antibacterial substances and immuno-stimulation (Perry, 2006). 
 
One of the most important roles of the gut is providing a barrier between the internal 
and external environment, as the GI tract is the site of colonisation and invasion of 
many pathogenic bacteria (Patterson and Burkeholder, 2003; Beal et al., 2006). The 
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mechanism by which a pathogen infects the GI tract and causes a disease can be 
through, the release of toxins and epithelial attachment, invasion, or local invasiveness 
and local toxicity. The way in which the host neutralises the organism depends on the 
type of mechanism of immunopathogenicity. When the mechanism is through toxins 
and epithelial attachment the host may only need to produce antibodies to neutralise 
them. However if the organism invaded the host cells, the host must destroy and 
degrade the organism by the cell-mediated immune response. When there is local 
toxicity, the host uses both antibodies and cell-mediated responses (Roitt et al., 1998).  
 
The first line of defence is the GI tract epithelial surface, which has a ciliary action, 
acidic pH and commensal bacteria as defences. The second line of defence is initially 
through the innate immune system, without B cells and T cells, and then through the 
adaptive immune system (Roitt et al., 1998). Phagocytic cells that are not specific to a 
particular microorganism are part of the innate immune system, these include 
macrophages monocytes and neutrophils, which can internalise microorganisms and kill 
them (Qureshi, 1998; Ferreira et al., 2011). Lymphocytes are part of the adaptive 
immune system and include B cells and T cells, B cell produce antibodies that are 
specific, whereas T cells can modulate B cell and antibiotic development, interact with 
phagocytic cells and recognise cells and destroy them.  Immunoglobulins (Igs) are 
antibodies that are expressed and secreted by B cells, as part of the immune system. Igs 
have two functions; one binding to antigens; and a second having an effector function 
by activating complement pathways or binding to receptors. Binding to antigens causes 
agglutination, facilitates removal of toxins and blocks entrance of viruses into cells 
(McKay and Perdue 1993; Arnold et al., 2006).  Through the complement pathway, 
immunoglobulins can affect the inflammatory reaction of bringing leucocytes and 
immune molecules to a site of infection to eliminate it (Roitt et al., 1998). 
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Pathogenic bacteria such as Salmonella spp., Escherichia coli, and Clostridium 
perfringens can bind to the GI tract, proliferate and cause an increased incidence of 
disease. Disease frequently only occurs at a sub-clinical level but this can lead to a 
decrease in the nutrients absorbed by the bird and therefore has economic consequences 
(Niewold, 2007; Jacob and Parsons 2009). Where the disease develops to a level that 
shows clinical signs in the bird, welfare is also severely affected. The development of a 
microflora population is very important to the bird as the presence of a balanced 
microflora helps to prevent pathogenic bacteria build up in the gut. Bifidobacteria and 
Lactobacilli are thought to be beneficial microorganisms for chickens, as they can 
create conditions unfavourable to the growth of pathogens, such as salmonella, 
enterobacteria and clostridia (Fernandez et al., 2002). This is achieved by Lactobacilli 
and Bifidobacteria competing against pathogenic bacteria for nutrients and binding 
sites, and secreting compounds that are noxious to pathogenic bacteria. Lactobacilli 
secrete bacteriocins and bifidobacteria produce organic acids, such as butyrate, which 
can suppress the colonization of the intestines by pathogenic bacteria, thereby reducing 
the intestinal population of pathogens (Rolfe, 2000).  
 
1.15 MOS AND THE INHIBITION OF PATHOGENIC COLONISATION 
MOS is thought to work though competitively excluding pathogenic bacteria from the 
intestine. MOS has been shown to bind gram-negative pathogenic bacteria which use 
mannose-binding lectins to attach to the intestinal wall for colonization (Sims et al., 
2004). The mannose-specific type-1 fimbriae that are found on some pathogenic 
bacteria such as E. coli can attach to MOS and then are excreted from the bird without 
being able to colonise the chicken gut (Oyofo et al., 1989; Sim et al., 2004). MOS are a 
non-digestible oligosaccharide and can therefore reach the lower intestinal area of the 
GI tract before fermentation and subsequent utilisation by only certain microbes such as 
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lactobacilli and bifidobacteria (Baurhoo et al., 2007; Jung et al., 2008; Jacob and 
Parsons, 2009). Bifidobacteria and lactobacilli are thought to be beneficial 
microorganisms for chickens, as they can create conditions unfavourable to the growth 
of pathogens, such as salmonella, enterobacteria and clostridia (Fernandez et al., 2002). 
Therefore it is thought that feeding MOS may decrease pathogenic bacteria and increase 
beneficial microbes in the GI tract. 
 
Spring et al. (2000) and Fernandez et al. (2002) found that birds challenged with 
Salmonella that were fed MOS had significantly reduced Salmonella colonisation. It has 
also been observed in broilers (Baurhoo, 2007) and turkeys (Zdunczyk et al., 2005) that 
MOS reduced the population and therefore the growth of E. coli. Sim et al. (2004) also 
found a similar effect of MOS on Clostridium perfringens in turkeys. MOS has also 
been reported to have decreased the number of enterobacteria in pigs (Castillo et al., 
2008). However, as with other measures, such as performance, in to the effects of MOS 
on poultry, studies are not consistent. Sims et al. (2004) reported that turkeys fed MOS 
did not differ from those fed a control when looking at the concentrations of E. coli and 
coliforms. White et al. (2002) reported that MOS had no effect on the numbers of 
coliforms, E. coli or Clostridium perfringens in pigs.  
 
MOS effects on bacteria populations deemed beneficial are also variable. MOS has been 
reported to increase levels of Bifidobacterium and Lactobacillus in turkeys (Zdunczyk 
et al., 2005) and broilers (Fernandez et al., 2002; Baurhoo et al., 2007). But this is 
contradicted by Jacob and Parsons, (2009) who found a significant decrease in caecal 
Lactobacilli populations in chicks fed yeast cell wall. Whereas Castillo et al. (2008) and 
Spring et al. (2000) found no difference when feeding MOS. When looking at these 
studies as a body of evidence no definitive conclusion can be made on how MOS affects 
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the bacterial colonisation of the GI tract. 
 
1.16 YEAST CELL PRODUCTS AND IMMUNITY  
Yeast cell products may contain several different components which affect immune 
response, including mannan oligosaccharides and β glucans. It has been shown that 
yeast cell products can modulate the immune system. However, it is presently not clear 
which component is causing the observed effect or the mechanisms behind it. Reynolds 
et al. (1980), Cleary et al. (1999) and Tzianabos, (2000) have all described the 
immunomodulating effects of β- glucan in mammals, reporting an increase in functional 
activity of macrophages and neutrophils.  
 
It is also thought that improving the balance of microflora in the GI tract can positively 
affect the immune system, as some microflora can produce antibacterial substances and 
stimulate the immune defence system (Muir et al., 2000). It has also been found that the 
right balance of microflora is vital for the development of acquired immune responses 
(Hooper and Gorden, 2001; Ewing, 2008) and that the bird may have a symbiotic 
relationship with some microorganisms through providing nutrients and defending 
against pathogenic bacteria (Gaskins et al., 2008). The ingestion of prebiotics increases 
the numbers of Lactobacillus and Bifidobacterium in the GI tract. Lactobacillus has 
been reported to be an immunomodulator through affecting the levels of T cells and 
cytokines, which can increase resistance to disease (Muir et al., 2002; Lee et al., 2010).  
Bifidobacterium has also been reported to affect cytokine levels; Chichlowski et al., 
(2007) found that feeding Bifidobacterium reduced intestinal mRNA of a pro-
inflammatory cytokine (IL-1β and IL-6) and increased an anti-inflammatory cytokine 
(IL-10). Therefore feeding MOS may have an effect though this mechanism on the 
immune system.  
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Igs are found in the serum at varying concentrations depending on the immune status of 
the bird. IgG is the most abundant serum Ig, whereas the most abundant mucosal Ig, in 
terms of production, is IgA (McKay and Perdue 1993). IgM can also be found in 
considerable amounts in the serum (Arnold et al., 2006). It has been seen that feeding 
MOS may affect circulating blood immunoglobulin level in poultry. However, as with 
other aspects of research investigating the effects of MOS on broilers, the effect of 
MOS on Ig levels in blood serum are variable. A number of studies have found no effect 
of feeding MOS on levels of IgG, IgM, and IgA in blood serum in broilers (Midilli et al., 
2008; Janardhana et al., 2009; Kim et al., 2011), horses (Gurbuz et al., 2010) and pigs 
(White et al., 2002; Castillo et al., 2008). These previous studies that showed no effect 
on Ig’s level placed no disease or enivromental challenge on the animal, except Castillo 
et al, (2008) in which temperature stressed the pigs. In conditadiction, Savage et al, 
(1996) found feeding 0.11% MOS increased plasma IgG in turkeys and White et al. 
(2002) fingings that IgG levels in pigs fed yeast tended to be higher than controls. 
Conversely, Gao et al 2008 found no effect on serum IgG, increased IgM and decreased 
IgA levels when feeding yeast culture to broilers, whilst Sauerwein et al, (2007) found 
higher IgA serum concentrations in pigs fed yeast cell wall extract at 0.03% but not at 
0.3%. Both Goa et al, (2008) and Sauerwein et al, (2007) found differences in 
immunoglobulins when feeding yeast cell wall or yeast culture, which will have 
different compositions and concentrations of mannans and β glucans to a more purified 
MOS as fed in the other studies. 
 
1.17 EFFECT OF MANNAN OLIGOSACCHARIDES ON GENE EXPRESSION 
Mannan oligosaccharides have been seen to have effects on broiler performance, gut 
morphology and the immune system, but the mechanisms by which these changes come 
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about are still unclear. The developing area of nutrigenomics may be used to increase 
understanding of how nutrients may affect gene expression and provide novel evidence 
on the molecular mechanisms behind the dietary modulation of immunity and 
metabolism. As many of the parameters measured in broiler studies are determined not 
only by genotype but environmental factors such as their nutrition, (Zhao et al., 2004), 
this may allow nutritionists to modulate the diet of a host to positively affect immunity, 
physiology, and metabolism (Weaver et al., 2011; Everard et al., 2011; Yitbarek et al., 
2012). However, published literature on the effects of yeast cell wall-derived mannan-
oligosaccharides on intestinal gene expression in broiler chickens is limited.  
Xiao et al., (2012) found that feeding MOS affected the gene expression of biological 
processes involving  protein synthesis of broilers. However, is difficult to define the 
potential impacts of this change, due to the wide range of changes that can result from 
this process, as protein synthesis is critical for many functions. Xiao et al., (2012) also 
reported effects of MOS on immune processes in broilers, such as Apolipoprotein 
(APO)-A1 (component of high-density lipoprotein) which may be involved in 
neutralising toxicity from gram-negative bacteria. In addition, it has been observed that 
MOS fed to broilers can up regulate the transcription of lysozyme, which is thought to 
be part of the first line of defence against bacteria (Xiao et al., 2012). Another effect 
seen by Xiao et al., (2012) in broilers when fed MOS is on oxidative phosphorylation, 
which is important in the energy released by nutrients to produce ATP.  
It has been reported that in ovo feeding of MOS to chickens can increase levels of 
mucin (MUC)-2 mRNA, which is involved in production of mucin in the GI tract, as 
well as effecting the expression of brush-border enzymes amino peptidase and sucrase 
isomaltase (Cheled-Shoval et al., 2011). This may mean that MOS improved the 
defence of the birds to bacterial population and improve digestive capacity but this link 
has yet to be demonstrated. Brennan et al., (2012) also reported that feeding MOS to 
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chickens resulted in changes in gene expression that correspond to slower gut cell 
turnover and therefore increased energy preservation for growth. In addition, it has been 
demonstrated that MOS can affect the gene regulation of toll-like receptors (TLR2 And 
TLR4)  (Cheled-Shoval et al., 2011; Yitbarek et al., 2012) and interleukin-12p35, and 
interferon-γ (Munyaka et al., 2012; Yitbarek et al., 2012) in broilers.  
 
In contrast, Munyaka et al., (2012) showed that expression of TLR2b and IL-6 was not 
affected by MOS in broilers, although Munyaka et al., (2012) did find that MOS down 
regulated expression of TLR4 and IL-10. Down regulation of IL-12p35 and IFN-γ 
cytokines may be explained by the reduced expression of TLR4 and result in an anti-
inflammatory effect. This could suggest that that birds fed MOS may have a reduced 
energy cost of their immune system, leaving more for growth performance (Huff et al., 
2006; Munyaka et al., 2012). 
 
1.18 DIGESTIVE ENZYMES AND MANNAN OLIGOSACCHARIDES 
There is very limited published data on the effects of prebiotics on broiler digestive 
enzymes. Iji et al. (2001) reported that broilers fed MOS has increased specific 
activities of maltase, leucine aminopeptidase and alkaline phosphatase in the jejunum, 
but not the ileum. Matur et al. (2010) found that feeding Saccharomyces cerevisiae 
extract increased amylase and chymotrypsin activity in the pancreas of layers but had no 
effect on activities in the duodenum or jejunum. Studies in fish have also found 
increased activities in a number of different digestive enzymes when feeding prebiotics 
in Atlantic salmon (Refstie et al., 2006), carp (Xu et al., 2009) and Caspian roach fry 
(Soleimani et al., 2012).  
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1.19 EFFECTS OF MANNAN OLIGOSACCHARIDES ON BIRD PERFORMANCE 
PARAMETERS 
Body weight has been frequently reported to be improved by supplementation of MOS 
(Santin et al., 2001; Benites et al., 2008). Chee, (2008) also found that MOS 
significantly improved body weight gain, but only in the starter phase of growth. 
However, research in poultry supplementation with MOS is contradictory: Midilli et al. 
(2008) and Brummer et al. (2010), found body weight in poultry was not affected by the 
supplementation of MOS. These conflicting findings have also been shown to be the 
case in other species (Dimitroglou et al., 2010). It has been reported previously that 
growth response in broilers to MOS is age-dependent with younger birds responding 
more than the older ones (Yang et al., 2007; Chee, 2008). This may be due to the fact 
that the gut microflora of younger birds is more transient in nature and thus less mature 
than that of older birds. This suggests feeding of MOS may increase the rate of 
maturation of the gut microflora, leading to improved growth performance (Yang et al., 
2007).  
 
A key measure of performance is the feed conversion ratio. MOS has been shown to 
improve FCR in numerous studies (Santin et al., 2001; Zhang et al., 2005; Chee, 2008). 
Any improvement observed in growth response after MOS supplementation may be 
linked with a series of improvements in intestinal mucosal integrity, gut microflora and 
local intestinal immunoresponse (Spring et al., 2000; Iji et al., 2001; Santin, 2001; Uni 
and Smirnov, 2006; Chee, 2008). It has been indicated in studies that there may be an 
optimum time for the supplementation of MOS to increase the efficiency of the birds. 
This may be due to the fact that the gut microflora of younger birds is more transient in 
nature and less established than in older birds and therefore more susceptible to 
colonisation by pathogenic bacteria. Therefore MOS may shorten the time required to 
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create a beneficial microflora population if it is offered early in life. MOS was reported 
to significantly increase body weight gain in birds between 1 and 21 days (Santin et al., 
2001) and Chee, (2008) found that the MOS significantly improved body weight gain in 
the starter phase (P<0.01). However, similar studies have found variable early 
performance effects (Zhang et al., 2005; Iji et al., 2001; Sun et al., 2005; Midilli et al., 
2008; Dimitroglou et al., 2010). 
 
1.20 PROJECT AIMS 
 
1.20.1 Overall Aims 
The aim of this project is to investigate the effect of a novel feed supplement 
(ActigenTM) on broilers by measuring a range of responses spanning whole bird 
performance to alteration in specific gene expression levels. By linking whole bird 
response to gross gut development, microscopic gut development, enzyme activity, 
immune function and gene expression, this project aims to clarify some of the 
mechanisms behind the observed effect of gut health supplements in broilers.   
 
The overarching hypothesis of this project is that Actigen will improve bird growth 
performance and efficiency through improving gut health. The first posed mechanism 
supporting this hypothesis encompasses increasing the gut surface area and increasing 
digestive enzyme production. The second posed mechanism of this project is that 
feeding Actigen will improve the immune defences against pathogens whilst decreasing 
damage from adverse inflammation.  
 
1.20.1.1 Specific objectives 
To assess the effect of adding a novel feed supplement to broiler diets on performance. 
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To assess the effect of adding a novel feed supplement to broiler diets on the gross 
development of the digestive system.  
 
To assess the effect of adding varying levels of a novel feed supplement to broiler diets 
on microscopic morphology of the gut. 
 
To determine the effect of feeding a novel feed supplement on the expression and 
activity of broilers’ digestive enzyme 
 
To determine the effect of feeding a novel feed supplement on the expression and 
activity of broilers’ immune cells 
 
To compare the effect of feeding a novel feed supplement with butyrate salts both fed 
alone and in combination. 
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CHAPTER 2: GENERAL METHODS 
 
2.1 INTRODUCTION 
Three trials were completed, the first trial investigated the efficacy of the ActigenTM 
(NCF) at 200g/t, 400g/t and 800g/t inclusion rates on the performance of the broiler in a 
research facility with a commercial stocking density over 6 weeks with measurements 
of gut development at 6 weeks. The second trial evaluated the effect of NCF at 200g/t, 
400g/t and 800g/t inclusion rates on the gut development and health of the broilers over 
the 6 weeks at 7, 14, 21, 28 and 42 days of age, whilst linking these to performance, and 
the third trial investigated the effect of NCF in combination with either of two organic 
acids, Ca butyrate or Na butyrate, on GI tract health parameters, digestive enzyme 
activity and immune parameters. Trial design and recorded parameters are given in table 
2.1 with chapter numbers. 
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Table 2.1 Trial design and recorded parameters. 
Trial details  Trial 1 Trial 2 Trial 3 
Design Trial duration  6 weeks 6 weeks 3 weeks 
 Supplements  NCF NCF  NCF, Ca and Na Butyrate 
 
Recorded Parameters Whole bird response - Performance Chapter 3 Chapter 4 Chapter 5 
 Gross gut development Chapter 3 Chapter 4 Chapter 5 
 Microscopic gut development Chapter 3 Chapter 4 Chapter 5 
 Digestive enzymes activity Chapter 6 N/A Chapter 6 
 Immune function Chapter 6 N/A Chapter 6 
 Gene expression Chapter 6 N/A N/A 
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2.2 DIET FORMULATION  
Birds were fed starter diets from 1 to 14 days, grower from 15 to 28 days and finisher 
from 29 to 42 days. In Trials 1 and 2, a basal diet was formulated and made by Target 
Feeds (Coton, Whitchurch, Shropshire, UK), the basal diet for Trial 3 was formulated 
by Target but made in house at Nottingham Trent University. The dietary treatments 
were then added to the basal diet, which was free of antibiotics, according to a mixing 
protocol at Nottingham Trent University, for Trials 1 and 2 the dietary treatments were: 
1) control diet (NCF free), 2) NCF at 200g per tonne, 3) NCF at 400g per tonne, and 4) 
NCF 800g per tonne. Dietary treatments for the Trial 3 were: 1) Control diet (NCF free), 
2) NCF at 200g per tonne, 3) Calcium Butyrate (300g/t Globamax performant), 4) 
Sodium Butyrate (Starter:1000g/t, Grower:750g/t Adimix 30 Coated) 5) Calcium 
Butyrate (300g/t) plus NCF (200g/t), and 6) Sodium Butyrate (st:1000g/t, gr:750g/t) 
plus NCF (200g/t).  
 
When adding the small amounts of supplements to the basal diet the following 
procedure was followed to ensure homogenous mixing. Firstly, three quarters of the 
basal diet was added to the ribbon mixer (Rigal Bennett, Goole, UK). Secondly, the 
supplement was then added to 2.5kg of basal diet, mixed in a bucket, then sprinkled 
over the top of the basal diet in the mixer. Thirdly, another 2.5kg of basal diet was then 
added to the bucket to rinse it and this with the last quarter of feed was added to the 
mixer and mixed for 5 minutes. Feed samples were taken for analysis of nutrient 
composition from the top and bottom of the mixer and then mixed together as a 
representative sample of the diet. 
 
2.3 ANIMALS, HOUSING AND MANAGEMENT 
All trials used Ross 308 male chicks aged 1 day supplied by P.D.Hook Hatcheries Ltd 
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(Cote, Bampton, Oxfordshire, UK). The birds were vaccinated at the hatchery with 
IB/H120 against infectious bronchitis.  The birds were placed in pens (area = 0.43m2), 
in a sanitary environment (biosecurity, disinfected facility on clean dry litter and good 
management). The room plan for each trial is given in figure 2.1. Birds were housed in 
an environmentally controlled room following a standard temperature regimen that 
gradually decreased from 31°C at bird height to 21°C by 21 days of the study. Heating 
was supplied as whole room heating using a mixture of fan heaters and heat lamps. 
Lighting was supplied by fluorescent strip lighting and on days 1 to 6 the birds had an 
increasing amount of darkness time during a 24 hour period. This started with 1 hour of 
darkness on day 1 and increasd consecutively until 6 hours of darkness on day 6. Then 
the lights were set to automatically give 6 hours of darkness from day 6 to end of trial, 
at the following times: 10pm-12am and 2am-6am. Ventilation was provided by a 
programmable fan and vent system. Ventilation was increased throughout the trial to 
meet the needs of the birds. Feed was provided on an ad libitum basis in a trough at the 
front of the pen and water was supplied by either bell drinkers or nipple drinkers. 
 
All procedures undertaken in this thesis have been approved by the Nottingham Trent 
University College of Arts and Science Ethics committee, and did not require a licence 
under the Animal Scientific Procedures Act (ASPA, 1986). 
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Figure 2.1 Room pen plan for each trial, D = door  
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2.4 TRIAL PERIOD 
 
2.4.1 Feed Intake 
Each pen of birds was fed from an individual pre weighed bag of diet. Feed intake 
was calculated weekly by weighing back uneaten feed. Troughs were positioned to 
minimize spillage and trays were placed under the troughs in the second trial to catch 
spilt feed in the first week. 
 
2.4.2 Bird Weights 
Birds were weighed by pen on day 1 and weekly, except on day 21 and 42 of Trial 1, 
when they were weighed individually. The birds were weighed using a top pan 
balance to one decimal place in grams (Mettler Toledo, Leicester, UK).  
 
2.4.3 Foot Pad Scores  
Foot pad scores were measured weekly using the method stated by Thomas, et al., 
(2004) to determine foot pad dermatitis. Briefly, this involved giving the birds a 
score of 1-3, where a score of 1 is when there are no burns, a score of 2 is mild burns 
and a score of 3 is severe burns, as shown in figure 2.2.  
 
Figure 2.2 Foot pad score (Poultry World, 2013)  
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2.4.4 Litter Quality  
Litter quality was quantified by collecting litter samples at 1, 13, 27 and 41 d to 
determine dry matter content via the method published by Thomas et al., (2004). 
Samples were taken from 5 areas in the pen and mixed to get a more accurate 
measurement, as shown in figure 2.3. 
 
 
Figure 2.3 Diagram of areas of litter collection. 
 
2.4.5 Histology 
Histological samples were taken to measure the gut morphology of the bird, 
including villus height, crypt depth and goblet cells. One bird per pen was culled via 
cervical dislocation. The gastrointestinal tract was excised and the last 2.5cm of the 
descending section of the duodenum loop was removed before the loop around the 
pancreas and a 2.5cm section of the jejunum just before the Meckel’s diverticulum 
were removed (figure 2.4). The sections of tissue were immediately flushed with 
cold phosphate buffered saline (PBS) with a 10ml syringe (pH 7.4).  After flushing, 
the sections were fixed in Bouins fixative solution for 6 hours, and then transferred 
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to 70% ethanol for storage until further processing.   
 
Figure 2.4. Diagram showing the sections of duodenum and jejunum removed for 
histology (Larbier and Leclercq, 1992) 
 
2.4.6 Blood Serum 
Blood was taken from the heart immediately after death with a 10ml syringe and 
transferred in a plain 15ml centrifuge tube. The blood was allowed to stand for 2-6 
hours before it was centrifuged at 2000g for 10 minutes and the supernatant (serum) 
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was subsequently transferred in to a 10ml blood tube and stored at -20oC. 
 
2.4.7 Tissue for RNA extraction  
A  0.2cm section of the duodenum was removed from the descending section of the 
duodenum loop before the loop around the pancreas and a 0.2cm section of the 
jejunum just before the Meckel’s diverticulum were taken from the same bird and 
placed in a micro centrifuge tube containing RNA stabilization reagent, RNAlater 
(Qiagen, Venlo, Netherlands). This was then stored at 4oC overnight and then stored 
in a -20oC freezer.  
 
2.4.8 Intestinal Weights 
The whole intestine was removed from a second bird from each pen, the intestine 
was exercised from the start of the duodenum (including the pancreas) to the ileal-
caecal junction. The combined and separate empty sections of the intestine, 
including duodenum, jejunum, ileum and pancreas, were weighed and their length 
measured 
 
2.4.9 Digestive Enzyme Samples 
The jejunum, duodenum and pancreas were removed from the bird, the digesta was 
squeezed into a single pot and frozen at -20oC. The mucosa was scraped using a 
glass slide into a pot and frozen at -20oC. The intestinal tissue left was placed into 
separate pots and frozen at -70oC.  
 
2.4.10 Viscosity 
Digesta samples were removed from the first bird from the ileum for determination 
64 
 
of digesta supernatant viscosity. Samples were collected in pots, mixed and 
transferred to Micro centrifuge tubes for centrifugation at 10,000g for 10 minutes in 
a microcentrifuge (SLS, Goole, UK) The viscosity of the supernatant collected was 
then measured using a Brookfield DV-II+ Pro spinning disc viscometer with a cone 
and plate attachment (Brookfield Engineering Laboratories Inc., Stoughton, MA, 
USA). Viscosity measurements were taken immediately after centrifugation of 
digesta at chicken body temperature (41oC).  
 
2.4.11 Intestinal tract pH 
Immediately post euthanasia the gizzard, duodenum, jejunum, ileum and caeca were 
removed intact and a digital pH meter (Mettler-Toledo, UK) with a spear tip piercing 
pH electrode (Sensorex, California, USA) was directly inserted into the digesta in the 
lumen of the GI tract, whilst ensuring the pH electrode did not touch the walls, and 
the pH was recorded in duplicate. The pH meter was calibrated with pH standards as 
stated in the operation manual of the pH meter. 
 
2.5 ANALYTICAL PROCEDURES 
 
2.5.1 Determination of Dry Matter 
The dry matter of the diets were determined as follows: 4-5g of finely ground sample 
were weighed accurately into pre-weighed crucibles and dried for 72 hours in an 
oven at 105oC. The samples were then removed from the oven, cooled in a desiccator 
and reweighed. 
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2.5.2 Determination of Nitrogen/Crude Protein 
Diets were analysed for nitrogen content using the kjeldhal method (AOAC official 
method 2001.11). Briefly, 1g of sample was digested in a tube with concentrated 
sulphuric acid, copper and selenium catalyst tablets at 450oC for 45 minutes in a 
Kjeltec digestion unit (Foss Tecator, Cheshire, UK). The tubes were then cooled 
before distillation in a 2100 Kjectec distillation unit (Foss Tecator, Cheshire, UK), 
with sodium hydroxide. The resulting ammonia was expelled into a conical flask 
containing boric acid solution with an indicator, changing the liquids colour (orange 
to blue). Post distillation, the boric acid solution was titrated with a weak 
hydrochloric acid solution until the colour changed back to orange. Crude protein 
was calculated from nitrogen content by multiplication by a conversion factor of 
6.25. 
 
2.5.3 Determination of Ether Extract 
Determination of percentage ether extractable oil content of the feed samples was 
performed by Soxhlet extraction, according to the method outlined by the 
Association of Official Analytical Chemists (2003.05). Briefly, 4.5g of the sample 
was refluxed with petroleum ether at 40-60oC through soxhlet thimbles for 18 hours, 
the resulting petroleum ether and extracted fats were then heated to evaporate the 
petroleum ether leaving the fat. The percentage of ether extractable oil content of the 
feed samples was calculated as the total fat extracted divided by total original sample 
weight. 
 
2.5.4 Determination of Ash 
Dry samples of feed were weighed (W2) in to a pre-weighed ceramic crucible (W1) 
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before placing in a muffle furnace at 650oC for 13 hours. Crucibles were allowed to 
cool in a desiccator and reweighed (W3), allowing percentage of ash to be calculated 
using the following equation ((W3-W1) / (W2-W1)) x 100 = % ash 
 
2.5.5 Determination of Energy  
Feed was analysed for gross energy content using a bomb calorimeter, as per the 
manufacures instructions (Instrument 1261, Parr Instruments, Illinois, USA). Pellets 
were made using a pellet press (Parr Instruments, Illinois, USA) and dried overnight 
at 105oC. Pellets were weighed and placed in the bomb combustion chamber which 
is surrounded by water, a 10cm piece of fuse wire was placed as so to be touching 
the sample. After completely combusting the pellet in pure oxygen, the colorimeter 
measures the temperature change of the water and calculates the energy given off in 
KJ/kg. 
 
2.6 HISTOLOGY 
2.6.1 Tissue Fixation and Wax Embedding 
A 2.5cm section from both the jejunum and duodenum was fixed in Bouins fixative 
solution for 6 hours, and then transferred to 70% ethanol for storage until further 
processing.  The tissue was the removed from the 70% ethanol and a section of 5mm 
or less was cut and placed into a histology cassette. The intestinal samples were then 
dehydrated by immersion in an ascending series of aqueous alcohol solutions from 
70% to 100% IMS.  Following dehydration the tissue was cleared with histoclear, a  
substance which is miscible with both alcohol and paraffin wax. The sample was 
them placed in molten wax. The timings for this process are shown in table 2.2. After 
the samples had been infiltrated with wax, they were moved into warm metal moulds, 
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which was then filled with histology grade paraffin wax.  The cassette lid was placed 
on top and the sample cooled immediately to 15°C to prevent the wax fracturing.  
The samples were left to harden completely and then removed from the moulds and 
stored at room temperature in cassette trays.   
 
Table 2.2. Schedule of paraffin wax embedding of gut tissue 
Chemical/Solution Time 
70% IMS Overnight 
70% IMS 1 Hour 
85% IMS 1 Hour 
95% IMS 1 Hour 
100% IMS 1 Hour 
100% IMS 1 Hour 
Histoclear 1 Hour 
Histoclear 1 Hour 
60°C Paraffin Wax 1 Hour 
60°C Paraffin Wax 1 Hour 
 
2.6.2 Sectioning and Mounting 
After embedded the samples were cooled in an ice bath and sectioned to a width of 
8µm in the first trial and 6 µm for the second and third trials using a rotary 
microtome (1512 microtome, Leica, Wetzlar, Germany).  To ensure that individual 
sections presented different villi, only every twentieth section was kept for mounting.  
At least 15 sections were collected for each sample. The cut sections were placed on 
slides, and then floated using 30% IMS on a hot plate set to 40°C to allowed the 
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samples to flatten. Once flattened on the slides the samples were left on the hot plate 
until they had dried and then stored in slide boxes.   
 
2.6.3 Staining  
Once mounted onto slides the samples were run down a series of alcohols to 
rehydrate them prior to staining. The staining method used is laid out in table 2.3. 
Once the staining procedure was complete, the slides were then protected with a 
cover slips. Cover slips had DPX synthetic resin applied to them and were carefully 
placed on the slides with gentle, even pressure being applied until no visible air 
bubbles remained. Finally, they were placed on a hot plate set to 40°C in order to dry 
and set and left overnight.   
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Table 2.3 Tissue staining process  
Chemical/Solution Time 
Xylene 5 minutes 
Xylene 5 minutes 
100% IMS 2 minutes 
100% IMS 2 minutes 
70% IMS 2 minutes 
Distilled Water 3 dips 
Alcian Blue pH 2.5 30 minutes 
Running Tap Water 5 minutes 
Distilled Water 3 dips 
1% Periodic Acid 5 minutes 
Distilled Water 3 dips 
Schiff's Reagent 20 minutes 
Running Tap Water 5 minutes 
Distilled Water 3 dips 
Haematoxylin 3 minutes 
Running Tap Water 5 minutes 
Borate 2 dips 
Running Tap Water 5 minutes 
70% IMS 2 minutes 
100% IMS 2 minutes 
100% IMS 2 minutes 
Xylene 5 minutes 
Xylene 5 minutes 
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2.6.4 Microscopic analysis 
Slides were analysed using an Olympus BX51 microscope fitted with an Olympus 
DP71 camera (Olympus, Pennsylvania, USA).  Olympus Cell F software was used to 
identify and measure villus height, villus width and crypt depth.  For each of the 15 
sections cut from each sample two villi were measured for height and width and two 
crypts were measured for depth.  Where possible the measurements were taken from 
opposite quarters and, if that was not possible, from different halves.  Villi width was 
measured from either edge of the epithelial cells half way down the length of the villi, 
and height was measured from the highest epithelial cells across the top if the villi, 
down the centre, to the point where the crypt began.  Crypt depth was measured from 
the centre of the opening down to the centre of the innermost epithelial cells. 
 
2.7 GENE EXPRESSION 
2.7.1 RNA Purification 
The 0.2cm sections of tissue were taken out -20 oC freezer and placed in an ice box. 
The tissue was then removed from the RNA stabilization reagent (RNAlater, Qiagen, 
Venlo, Netherlands), and placed in a pestle and mortar with liquid nitrogen and 
homogenised. The RNA was then purified using a purification kit (RNeasy Plus 
Mini Kit, Qiagen, Venlo, Netherlands) via the method in table 2.4. 
  
2.7.2 RNA Quality and Quantity 
RNA quality and quantity was accessed using an Agilent 2100 bioanalyzer (Agilent, 
California, USA) at Alltech headquarters, (Nicholasville, Kentucky, USA) using the 
method in table 2.5. RNA Integrity Number (RIN) of 7 or above was required, which 
is a quality measure of the RNA. 
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Table 2.4 The RNA purification method using an RNeasy Plus Mini Kit (Qiagen) 
Step Procedure  
1 Weigh 20-30mg of the homogenized tissue into 2ml micro centrifuge tubes.  
2 Suspend the homogenised tissue in 600µl of RLT buffer.  
3 Apply onto Qiagen shredder column.  
4 Centrifugation at 10,000g for 2 minutes at RT.  
5 Keep the flow through and discard the column  
6 Transfer liquid to gDNA column 
7 Centrifuge for 30s at 8000xg or 10,000rpm 
8 Keep the flow through and discard the column 
9 Add  600µl of 70% ethanol to flow through and mix by pipetting 
10 Transfer 600µl liquid to RNeasy column. 
11 Centrifuge at 10,000g for 15s at RT.  Discard flow through  
12 Repeat step 10. and 11.  
13 Add 700µl of RW1 buffer to the same column and tube 
14 Centrifuge at 10,000g for 1 minute at RT and flow through discarded.  
15 Add 500µl of the RPE buffer to the same column and tube 
16 Centrifuge at 10,000g for 1 minute at RT and flow through discarded.  
17 Add 500µl of the RPE buffer to the same column and tube 
18 Centrifuged at 10,000g for 1 minute at RT and discard flow through  
19 Centrifuge at 10,000g for 3 minute at RT in a new tube 
20 Put the column into a fresh 1.5ml tube (Provided with the kit) 
21 Add 35µl of RNase free water (Qiagen) on to membrane  
22 Let it stand for 3 min at RT 
23 Centrifuge at 10,000g for 3 minute.  
24 The flow through contain the RNA and were stored in -80ºC. 
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Table 2.5 RNA quality and quantity method using an Agilent 2100 bioanalyzer. 
Steps 
 
 PPreparing the Gel 
1 Pipette 550μl of RNA 6000 Pico gel matrix into a spin filter. 
2 Centrifuge at 1500g ± 20 % for 10 minutes at room temperature. 
3 Aliquot 65μl filtered gel into 0.5 ml RNase-free microfuge tubes. 
 Preparing the Gel-Dye Mix 
1 Allow the RNA 6000 Pico dye concentrate to equilibrate to rt for 30 min. 
2 Vortex RNA 6000 Pico dye concentrate for 10s, spin down and add 1μl of dye 
into a 65μl aliquot of filtered gel. 
3 Vortex solution well. Spin tube at 13000g for 10 min at rt.  
 Loading the Gel-Dye Mix 
1 Put a new RNA 6000 Pico chip on the chip priming station. 
2 Pipette 9.0 μl of gel-dye mix in the well marked 
3 Make sure that the plunger is positioned at 1 ml and then close the chip priming 
station. 
4 Press plunger until it is held by the clip. 
5 Wait for exactly 30 seconds then release clip. 
6 Wait for 5s. Slowly pull back plunger to 1ml position. 
7 Open the chip priming station and pipette 9.0 μl of gel-dye mix in the wells 
marked. 
8 Discard the remaining gel-dye mix. 
 Loading the RNA 6000 Pico Conditioning Solution and Marker 
1 Pipette 9.0μl of the RNA 6000 Pico Conditioning Solution  in well marked CS. 
2 Pipette 5μl of RNA 6000 Pico marker in all 11 samples and the marked well. 
 Loading the Diluted Ladder and Samples 
1 Pipette 1 μl of the heat denatured and aliquoted ladder in the well marked . 
2 Pipette 1 μl of sample in each of the 11 sample wells. Pipette 1 μl of RNA 6000 
Pico Marker in each unused sample well. 
3 Put the chip in the adapter of the IKA vortexer & vortex for 1min at 2400 rpm. 
4 Run the chip in the Agilent 2100 bioanalyzer within 5 min. 
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2.7.3 Microarray 
After the 7 samples per treatment were assessed for RNA quality and quantity, the 
samples were assessed for gene expression. This was performed at Alltech 
headquarters, (Nicholasville, Kentucky, USA) using the standard protocol from the 
GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Santa Clara, 
CA). Double-stranded cDNA was first synthesised, purified, and used as a template 
for amplification and label by using the GeneChip Expression 3′-Amplification IVT 
Labeling Kit (Affymetrix Inc., Santa Clara, CA). Then, cDNA was used to 
synthesize cRNA, which was hydrolysed to produce fragmented cRNA in the 35- to 
200-nucleotide size range for proper hybridisation. The fragmented cRNA was 
labelled and further hybridised to the Affymetrix GeneChip Poultry Genome Array. 
Gene microarrays were run to assessed gene expression using a GeneChip Fluidics 
Station, and were scanned with the Affymetrix GeneChip Scanner 3000 (Affymetrix, 
Santa Clara, California) at Alltech headquarters (Nicholasville, Kentucky), using the 
GeneChip Chicken Genome Array. Samples were prepared using a GeneChip 3’IVT 
Express Kit. Fold change and t-tests were then run using GeneSpring GX, 
significance was set at P < 0.05. 
 
2.8 DIGESTIVE ENZYMES 
 
2.8.1 Enzyme Extraction 
Intestinal samples were removed from the -80oC freezer and kept in liquid nitrogen 
until processed. The intestinal sample was placed in a pre-cooled pestle and mortar 
with liquid nitrogen and ground until homogenized. The homogenized tissue was 
then mixed with cold phosphate buffer saline (pH 7.4) at 9 ml per 1g of tissue. This 
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was then centrifuged for 15 minutes at 10,000g. The supernatant was subsequently 
aliquoted and stored at -70oC until  analysed for enzyme activity. 
 
2.8.2 Amylase 
The extracted enzyme aliquots were taken out of the freezer and placed on ice. 
Whilst 2.0% (w/v) Soluble Starch Solution was equilibrated to 25oC. 50μl of the 
extracted enzymes was added to 200μl of water, then 50μl of this diluted enzyme 
extract was added to an micro centrifuge tube. Then 50μl of the starch solution was 
added to the micro centrifuge tube, mixed and incubated for 3 minutes at 25oC. 
Immediately after incubation 100μl of 3,5-Dinitrosalicylic Acid Solution was added 
to the micro centrifuge tube, at this point the enzyme extract was added to the blank 
rather than at the beginning. The micro centrifuge tube was then incubated at 100oC 
for 15 minutes and then cooled to room temperature. Finally, 1ml of deionized water 
was added to the micro centrifuge tube, mixed and absorbance measured at a wave 
length of 530nm using a UV spectrophotometer (Cecil CE3410, Cecil intruments, 
Cambridge, UK). A standard curve was made using the concentration given in table 
2.6 in replacement of the enzyme. Concentration of amylase was calculated using the 
following equation;  
 
Amylase activity (units/ml) = M/1.08 x df 
(M = mg of Maltose released, df = dilution factors) 
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Table 2.6 Amylase standard curve.  
Standard Maltose (μl) Distilled Water (μl) 
1 1 40 
2 2 48 
3 3 47 
4 4 46 
5 5 45 
6 10 40 
7 20 30 
8 30 20 
9 40 10 
10 50 0 
11 0 50 
 
2.8.3 Trypsin 
While Nα-Benzoyl-DL-Arginine-p-Nitroanilide (BAPNA) was equilibrated to 37oC, 
100μl of enzyme extract was pipetted in to a micro centrifuge tube with 100µl 
distilled water. Then 700μl of BAPNA was added into the micro centrifuge tube and 
incubated at 37oC for 10 minutes. Immediately after 10 minutes 100μl of 30% acetic 
acid was added to the micro centrifuge tube to terminate the reaction. For the blank, 
the enzyme extract was added to the micro centrifuge tube at this point rather than 
previously. Absorbance was measured at a wave length of 410nm using a UV 
spectrophotometer (Cecil CE3410, Cecil intruments, Cambridge, UK). 0.01 optical 
density unit represents 1 trypsin unit in 10ml. A standard curve was made by using 
the following solutions in replacement of the enzyme extract (table 2.7). 
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Table 2.7 Trypsin standard curve 
mg trypsin/ml Trypsin solution (ml) 0.001M HCL (ml) 
200 1.000 0.000 
170 0.850 0.150 
140 0.700 0.300 
110 0.550 0.450 
80 0.400 0.600 
60 0.300 0.700 
50 0.250 0.750 
40 0.200 0.800 
30 0.150 0.850 
25 0.125 0.875 
20 0.100 0.900 
15 0.075 0.925 
10 0.050 0.950 
5 0.025 0.975 
0 0.000 1.000 
 
2.8.4 Chymotrypsin 
While N-glutaryl-L-phenylalanine p-nitroanilide solution (GPNA) was equilibrated 
to 25oC, 100μl of enzyme extract pipetted into a micro centrifuge tube with 100µl 
water. Then 1000μl of GPNA was added into the micro centrifuge tube and 
incubated at 25oC for 10 minutes. Immediately after 10 minutes, 200μl of 30% acetic 
acid was added to the micro centrifuge tube to terminate the reaction. For the blank, 
the enzyme extract was added to the micro centrifuge tube at this point rather than 
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previously. Absorbance was measured at a wave length of 410nm using a UV 
spectrophotometer (Cecil CE3410, Cecil intruments, Cambridge, UK). 1.0 optical 
density unit represents 1.02 x 10-5M chymotrypsin. A standard curve was made by 
using the solutions in table 2.8 in replacement of the enzyme extract. 
  
Table 2.8 Chymotrypsin standard curve 
mg Chymotrypsin/ml Chymotrypsin solution (ml) 0.001M HCL (ml) 
1000 1.000 0.000 
750 0.750 0.250 
500 0.500 0.500 
400 0.400 0.600 
300 0.300 0.700 
200 0.200 0.800 
100 0.100 0.900 
75 0.075 0.925 
50 0.050 0.950 
25 0.025 0.975 
0 0.000 1.000 
 
 
2.9 SERUM IMMUNOGLOBULINS 
Levels of IgM, IgA and IgG were measured in serum of the bird using an enzyme 
linked immunosorbent assay (ELISA) micro titre plate for the detection of Chicken 
IgM, IgA or IgG in serum from Bethyl Laboratories Inc. (Montgomery, TX, USA). 
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2.9.1 IgM, IgA and IgG 
Chicken IgM, IgA or IgG present in the sample was measured by their binding to 
anti-chicken IgM, IgA or IgG antibody that had been pre-adsorbed onto the surface 
of microtiter wells. After sample binding the plate was washed to remove unbound 
molecules, and a detection antibody was added to the wells to bind to the IgM, IgA 
or IgG. A strepavidin-conjugated horseradish  peroxidase (SA-HRP) was then added 
to catalyze a colorimetric reaction with the chromogenic substrate TMB (3,3’,5,5’-
tetramethylbenzidine). The colorimetric  reaction produces a blue product, which 
turns yellow when the reaction is  terminated by addition of dilute sulfuric acid. 
Absorbance was measured at a wave length of 450nm using a UV spectrophotometer 
(Cecil CE3410, Cecil intruments, Cambridge, UK). Samples were run in duplicate, 
where there was a variation of more than 10% between replicates repeats were run. 
The absorbance was proportional to the amount of IgM, IgA or IgG present in the 
sample. Before all samples were run optimisation was performed to obtain the 
optimal dilution to use, this resulted in the following dilution being used; IgA – 
1/1000, IgG – 1/100000 and IgM – 1/10000. The IgM, IgA or IgG concentrations in 
the test samples were quantified using a standard curve generated in parallel with the 
samples, which was ran on every plate in triplicate. Typical standard curves are 
given in appendix 1,2 and 3, the full methods used are also given in appendix 4. 
 
2.10 STATISTICAL ANALYSIS 
Through out all studies, one pen was taken to as a single unit for analysis. All data 
analysed via ANOVA was using the SPSS software version 12 or later for Windows. 
All data was analysed for normality by a Kolmogorov-Smirnov test. If the data was 
normally distributed a one-way analysis of variance (ANOVA) was performed, if the 
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data was not normally distributed a Kruskal-Wallis test was performed. Treatment 
means were separated using Tukey’s post hoc test, and statistical significance was 
declared at P < 0.05. Regression analysis was performance using JMP Pro 11 to 
examine the effects of rate of inclusion of NCF on all paramenters measured and to 
establish linear and non linear contrasts via linear, quadratic and cubic partitioning of 
the treatment of sum of squares. Further linear regression analyses were also 
performed via Pearson correlations to examine relationships between live body 
weight and intestinal lengths and weights using SPSS software.  
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CHAPTER 3: TRIAL 1- INVESTIGATION OF THE EFFICACY OF 
ACTIGEN™ (ALLTECH) AT VARYING INCLUSION RATES ON THE 
PERFORMANCE OF BROILERS AND THEIR GUT DEVELOPMENT AT 
SIX WEEKS OF AGE. 
 
3.1 INTRODUCTION 
This project seeks to investigate the effects of a feed supplement, Actigen (NCF), 
from a whole bird response, down to alterations in gene expression. Prebiotics are an 
important feed supplement in the poultry industry, with mannan oligosaccharides 
(MOS) being one of the main prebiotics used in broiler diets. MOS products have 
been associated with a number of improvements in whole bird response through 
effects on performance and health (Santin et al., 2001, Yang et al., 2007). However 
there is little evidence as to whether Actigen (NCF), which is derived from MOS, 
will have a similar effect on broiler performance and health. This study was designed 
in conjunction with the industrial sponsor to investigate the effects of NCF on the 
whole bird performance and examine any associated histological change. This was 
achieved through a 6 week performance trial, with stocking density close to 
commercial stocking density (DEFRA, 2013) to mimic the environmental challenges 
experienced by the bird in a commercial situation, with weekly bird weights and feed 
intakes recorded. The manufacturer’s (Alltech Inc.) recommended inclusion level of 
NFC ranges from 200-800g/t of NFC and currently lacks specific giuldance on 
dosage related to bird age. In order to identify the optimum inclution level, NFC was 
feed at 200g/t, 400g/t and 800g/t. This trial allowed for the evaluation of the ability 
of the poultry research facility at Nottingham Trent University to produce data 
relevant to the UK commercial situation. The effects of NCF on gut health was only 
81 
 
examined at 6 weeks, as to not affect the number of birds per pen, weekly weights or 
feed intakes of the birds, through altered stocking density. 
 
3.2 AIM 
The aim of this trial was to investigate the efficacy of NCF at 200g/t, 400g/t and 
800g/t inclusion rates on the performance of birds in the poultry unit at Nottingham 
Trent University, and gut development of broilers at 6 weeks. 
 
The hypothesis of this trial was that bird age and dietary inclusion level of NCF 
would differentially improve bird performance. Specifically, the highest rate of NCF 
inclusion would show greatest improvement in the starter phase, through accelated 
maturation of the gut.  
 
3.3 MATERIALS AND METHODS 
3.3.1 Bird Husbandry 
A total of 240 one day old male Ross 308 birds from a flock of 50 weeks of age were 
obtained from P.D.Hook Hatcheries Ltd (Cote, Bampton, Oxfordshire, UK). They 
were placed in 48 pens, each containing five birds and fed one of four dietary 
treatments. The diets were allocated using a stratified random allocation.. There were 
four dietary treatments with 12 replicates for each treatment, made up of 12 small 
floor pens (area = 0.43m2). Birds were kept with a stocking density aiming for a 
commercial stocking density of 30kg per m2 at the end of the trial. The litter 
provided was fine dry sand on a concrete floor at a depth of 7cm and was topped up 
if necessary to maintain adequate environmental welfare. 
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3.3.2 Experimental Diets 
The rations were based on the nutritional requirements for the strain of bird and 
contained approximately 50% wheat but no pentosan degrading enzymes, in order to 
provide a digestive challenge.  The basal diet was free of antibiotics and 
manufactured using the formulation in table 3.1. The trial lasted 42 days with a three 
phase feeding programme; starter diets were fed from 1 to 14 days; grower diets 
were fed from 15 to 28 days and finisher diets were fed from 29 to 42 days. The four 
dietary treatments were 1) control diet (NCF free), 2) NCF at 200g per tonne, 3) 
NCF at 400g per tonne, and 4) NCF 800g per tonne.  
 
3.3.3 Determined Parameters 
Birds weight and feed intake per pen were recorded weekly. The weekly FCR was 
calculated using this information for each phase. Foot pad scores, litter dry matter 
and digesta viscosity were taken on day 42 as described in chapter 2. Two birds per 
pen with weights closest to the mean weight for the pen were selected and 
slaughtered on day 42. The whole intestine was removed from one of the birds to 
weigh and measure the length of the part of the intestinal tract, as described in 
chapter 2. From the second bird, tissue samples for histological examination were 
taken and fixed in Bouins. Samples for RNA and digestive enzymes analysis were 
taken and stored as per chapter 2. The feed was analysed for NCF level at The 
Bioscience Centre in Lexington, USA by an assay determining the amount of NCF 
in grams per tonne (Appendix 5). 
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Table 3.1. Composition of basal diet and calculated analysis of the basal diet 
Item  Starter Grower Finisher 
Ingredients (%) 
  
 
Barley 10.61 8.46 7.23 
Wheat 50.00 55.00 60.00 
Soybean meal, 48% CP 26.00 23.00 19.00 
Full fat soybean meal 5.00 5.00 5.00 
L lysine HCL 0.31 0.26 0.25 
DL methionine 0.38 0.35 0.33 
L threonine 0.14 0.13 0.14 
Soya oil 4.00 4.50 4.75 
Limestone 1.25 1.25 1.25 
Monocalcium phosphate 1.50 1.25 1.25 
Salt 0.25 0.25 0.25 
Sodium bicarbonate 0.15 0.15 0.15 
Premix* 0.25 0.25 0.25 
Calculated analysis 
  
 
ME MJ/kg 12.78 13.04 13.2 
CP% 21.75 20.59 19.1 
Lys % 1.37 1.25 1.13 
Met + Cys % 1.01 0.95 0.89 
Ca 0.96 0.90 0.90 
Available P 0.48 0.42 0.65 
*Premix content (volume/kg diet): Mn 100mg, Zn 80mg, Fe 20mg, Cu 10mg, I 1mg, 
Mb 0.48mg, Se 0.2mg, Retinol 13.5mg,Cholecalciferol, 3mg, Tocopherol 25mg, 
Menadione 5.0mg, Thiamine 3mg, Riboflavin 10.0mg, Pantothenic acid 15mg, 
Pyroxidine 3.0mg, Niacin 60mg, Cobalamin 30µg, Folic acid 1.5mg, Biotin 125mg 
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3.3.4 Data Analysis 
All data were analysed using the SPSS software for Windows; a one-way ANOVA 
was used. One pen was used as a unit for analysis. Treatment means were separated 
using the Tukey post hoc test, and statistical significance was declared at P < 0.05. 
Regressions analysis was performed to identify any dose response effects. 
 
3.4 RESULTS 
3.4.1 Body weight and Live weight gain 
The mean live body weights per bird for the four diets over the 6 weeks are shown in 
table 3.2. Table 3.2 shows that the mean body weight per bird on days 14, 21, 28, 35 
and 42 were significantly different between treatments. When comparing body 
weight to breed target, the control birds were 400g behind by 42 day, whereas the 
birds fed NCF were on target or approaching target. This indicates that the birds 
were under physiological pressure through environmental challenge, which was over 
come by NCF supplementation. On day 14, 21, 28 and 35, diets including 200g/t and 
800g/t of NCF significantly increased live weight over the control (P<0.001). On day 
42, it was observed that NCF at 200g/t increased live weight over the control 
(P=0.005). In summary, from week two onwards the inclusion of NCF at 200g/t in 
the diet resulted in an increase in the body weight of the birds compared to the 
control. No effect of diet on body weights were observed at 7 days.  
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Table 3.2. Effect of NCF in broiler diets on the mean weekly body weight (g/bird) 
  
(Differing superscript letters within one week denote means are significantly 
different at P < 0.05. In regression analysis significant relationships are identified as 
follows, Linear (L), Quadratic (Q) and Cubic (C)) 
 
The mean weekly live weight gains per bird for the four diets over the 6 weeks are in 
table 3.3. Table 3.3 illustrates that in the second, third and fourth weeks significant 
differences between treatments in mean live weight gain per bird are recorded. In 
week two it was shown that diets including 200g/t and 800g/t of NCF significantly 
increased live weight gain over the control (P<0.001). In week three it was 
demonstrated that diets including 200g/t of NCF significantly increased live weight 
gain over the control (P=0.007). In week four it was recorded that diets including 
NCF at all three level of inclusion significantly increased live weight gain over the 
control (P<0.001). Regression analysis of NCF rate of inclusion (ROI) against both 
body weight and weekly weight gain showed some complexcity in bird response. On 
day 14 there was a cubic response to increasing NCF levels for both parameters, but 
at later ages all obsevered significant responses were quadratic.  
 
Age SEM P value Regression
P value
1 d 43.33 43.90 43.58 43.05 0.34 a0.851 0.694
7 d 102.44 114.20 106.68 107.05 2.02 a0.227 0.893
14 d 216.99
C
302.66
A
249.85
BC
290.68
AB
8.15 <0.000 0.030
C
21 d 524.63
C
741.19
A
599.76
BC
680.33
AB
20.42 <0.000 0.091
28 d 1026.17
A
1380.77
A
1198.38
AB
1287.23
A
31.17 <0.000 0.031
Q
35 d 1804.11
C
2179.73
A
1943.19
BC
2112.13
AB
36.98 a0.001 0.023
Q
42 d 2593.70
B
2927.65
A
2654.53
B
2841.69
AB
38.69 a0.005 0.073
Dietary treatment
Control NCF 200g/t NCF 400g/t NCF 800g/t
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Table 3.3. Effect of NCF in broiler diets on the mean live weight gain (g/bird).  
 
(Differing superscript letters within one week denote means are significantly 
different at P < 0.05. In regression analysis significant relationships are identified as 
follows, Linear (L), Quadratic (Q) and Cubic (C)) 
 
3.4.2 Feed Intake 
The mean weekly feed intake per bird for the four diets over the six weeks is shown 
in table 3.4, demonstrating that there was significant differences between the 
treatments in weeks two, three, four and five. However when further post hoc tests 
were performed significance was lost in week two and four. In weeks three and 5 
birds fed 200g/t had higher feed intakes that the control birds. Regression analysis of 
NCF ROI against feed intake showed no dose response.  
 
 
 
 
 
 
Age SEM P value Regression
P value
7 d 59.11 70.30 63.10 64.00 1.97 <0.150 0.665
14 d 114.55
B
188.45
A
141.26
B
183.63
A
6.61 <0.001 0.007
C
21 d 293.64
B
438.81
A
336.15
AB
281.66
AB
16.15 <0.007 0.186
28 d 497.93
B
639.58
A
598.61
A
604.80
A
12.45 <0.001 0.009
Q
35 d 739.33 782.17 761.16 794.36 10.04 <0.232 0.077
Q
42 d 751.03 747.55 711.13 681.35 13.49 <0.226 0.482
Dietary treatment
Control NCF 200g/t NCF 400g/t NCF 800g/t
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Table 3.4. Effect of NCF in broiler diets on the mean weekly feed intake (g/bird). 
 
(Differing superscript letters within one week denote means are significantly 
different at P < 0.05.  
 
3.4.3 Feed Conversion Ratio 
The mean weekly feed conversion ratio (FCR) per bird for the four diets over the 6 
weeks is shown in table 3.6. Table 3.6 illustrates that the mean FCR per bird 
between diets for the second week was significantly different. In the second week it 
was shown that diets including 200g/t and 800g/t of NCF significantly decreased the 
FCR over the control (P=0.001). Simularly to body weight response, regression 
analysis of NCF ROI against FCR showed that on day 14 there was a cubic dose 
response to increasing NCF. Table 3.7 reports that the mean FCR between diets over 
the three feeding phases, during the first phase (week one and two) and the second 
phase (week three and four) there was significant differences between the treatments. 
In the first phase of feeding it was recored that diets including 200g/t and 800g/t of 
NCF significantly decreased the FCR over the control (P=0.003). In the second 
phase of feeding it was shown that all diets containing NCF significantly decreased 
the FCR over the control (P=0.011). When investigating the whole six week trial 
period the FCR was not significantly altered by dietary treatment (table 3.7). 
Attribute Age SEM P value Regression
P value
Feed 7 d 131.99 142.41 150.00 136.47 4.66 0.565 0.581
intake (g) 14 d 212.39 260.44 225.05 260.98 7.61 0.041 0.180
21 d 569.43
B
688.72
A
616.65
AB
617.17
AB
14.23 0.024 0.781
28 d 899.28 1030.96 976.69 1024.13 18.93 0.041 0.306
35 d 1228.65
B
1372.97
A
1270.86
AB
1359.00
AB
20.08 0.025 0.307
42 d 1395.48 1439.34 1369.34 1404.59 13.05 0.302 0.754
Dietary treatment
Control NCF 200g/t NCF 400g/t NCF 800g/t
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Table 3.6. Effect of NCF in broiler diets on the weekly feed conversion ratio. 
 
(Differing superscript letters within one week denote means are significantly 
different at P < 0.05. In regression analysis significant relationships are identified as 
follows, Linear (L), Quadratic (Q) and Cubic (C)) 
 
Table 3.7. Effect of NCF in broiler diets on the feed conversion ratio 
 
(Differing superscript letters within one week denote means are significantly 
different at P < 0.05. In regression analysis significant relationships are identified as 
follows, Linear (L), Quadratic (Q) and Cubic (C)) 
 
3.4.4 Litter Dry Matter 
The dry matter of the litter was measured as a measure of litter quality, the higher the 
Age SEM P value Regression
P value
7 d 2.19 2.10 2.46 2.07 0.08 0.231 0.800
14 d 1.92
A
1.40
B
1.68
AB
1.42
B
0.05 0.001 0.019
C
21 d 1.90 1.72 1.76 1.60 0.05 0.153 0.054
28 d 1.83 1.62 1.60 1.66 0.03 0.058 0.091
35 d 1.69 1.70 1.68 1.71 0.02 0.903 0.901
42 d 1.86 1.94 1.94 2.00 0.02 0.233 0.068
Dietary treatment
Control NCF 200g/t NCF 400g/t NCF 800g/t
Attribute Age SEM P value
FCR Wk1+2 2.03
A
1.59
B
1.91
AB
1.61
B
0.05 0.003
Wk3+4 1.85
A
1.61
B
1.63
B
1.63
B
0.03 0.011
Wk5+6 1.76 1.81 1.84 1.82 0.02 0.524
Wk1-6 1.80 1.73 1.76 1.74 0.01 0.308
Control NCF 200g/t NCF 400g/t NCF 800g/t
Dietary treatment
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dry matter content the better the litter quality. The mean dry matters of the litter per 
treatment over the six weeks are shown in table 3.8. Table 3.8 reports that the mean 
dry matter of the litter per treatment were not significantly different. However fresh 
sand was added to pens when litter deteriorated, to keep to welfare standards set by 
Nottingham Trent University.  
 
Table 3.8. Effect of NCF in broiler diets on the mean dry matter of the litter (%)  
 
(Differing superscript letters within one week denote means are significantly 
different at P < 0.05. In regression analysis significant relationships are identified as 
follows, Linear (L), Quadratic (Q) and Cubic (C)) 
 
3.4.5 Viscosity  
The viscosity of the digesta was measured as a measurement of sticky dropping, 
which can cause poor litter quality. The mean viscosity of digesta per treatment is 
reported in table 3.9 and shows that there was no significant effect of NCF on the 
viscosity of the digesta.  
 
Table 3.9. Effect of NCF in broiler diets on the mean viscosity of digesta  
 
Attribute Age SEM P value Regression
P value
Litter Dry d 1 99.80 99.76 99.88 99.80 0.02 0.523 0.629
Matter (%) d 13 98.62 98.51 98.53 98.02 0.10 0.151 0.066
d 27 75.42 68.92 68.99 65.07 1.89 0.280 0.088
d 41 58.62 62.88 67.12 57.88 1.46 0.085 0.837
Dietary treatment
Control NCF 200g/t NCF 400g/t NCF 800g/t
Attribute Age SEM P value Regression
P value
Viscosity d 42 3.20 3.02 2.84 2.93 0.10 0.617 0.135
Dietary treatment
Control NCF 200g/t NCF 400g/t NCF 800g/t
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3.4.6 Foot Pad Score 
Foot pad dermatitis in chickens is a condition that causes lesions on the surface of 
the footpad. The lesions can be scored to determine the level of foot pad dermatitis, 
which can be caused by poor litter quality. All foot pad scores throughout the 
treatment groups for the six weeks were all one. A score of one represents no tissue 
damage, therefore there was no foot pad dermatitis in this trial. However it should be 
noted that extra bedding was added as required to minimise risk of birds welfare 
becoming compromised. 
 
3.4.7 Intestinal Weight and Length 
The mean weight of the intestine per treatment is reported in table 3.10. Table 3.10 
demonstrates that there was no dose response of NCF on intestinal weights and no 
significant effect of NCF on the mean weight of the intestine or pancreas. However 
when examining the weight of the intestines relative to bird body weight, it was 
recorded that the relative duodenum weight and total intestinal weight was 
significantly greater in control fed birds than birds fed 200g/t of NCF (P=0.032, 
P=0.010 respectively). Relative ileum weight was also significantly greater in 
control fed birds than birds fed 200g/t and 400 g/t of NCF (P=0.005).  
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Table 3.10. Effect of NCF in broiler diets on the weight of the intestine (g) 
 
Differing superscript letters within one week denote means are significantly different 
at P < 0.05. Intestinal weight to body weight units are g/100g 
 
The mean lengths of the intestine per treatment are reported in table 3.11, 
demonstrating that the relative duodenum length was significantly greater in control 
fed birds than the birds fed 800g/t of NCF (P=0.038). However, further examination 
through regression analysis indicated a complex response; relative duodenum length 
showed a significant cubic response to NCF ROI. There was also a significant 
dietary effect of 200g/t of NCF increasing the length of the jejunum over the control 
but no overall relationship to ROI of NCF. 
 
 
 
 
 
Attribute SEM P value Regression 
P value
Duodenum wt 12.83 11.97 11.90 12.57 0.24 0.435 0.936
Duodenum wt /body wt 0.50
A
0.41
B
0.46
AB
0.44
AB
0.01 0.032 0.242
Jejunum wt 27.90 29.71 27.86 27.03 0.41 0.111 0.238
Jejunum wt /body wt 1.14 1.01 1.06 0.98 0.02 0.096 0.051
Ilium wt 24.61 23.17 21.91 23.32 0.45 0.181 0.385
Ilium wt /body wt 0.98
A
0.81
B
0.80
B
0.86
AB
0.02 0.005 0.071
Total Intestinal wt 65.52 62.94 61.41 63.05 0.78 0.344 0.445
Total Intestinal wt/body wt2.58
A
2.14
B
2.35
AB
2.28
AB
0.05 0.010 0.065
Panc. wt 4.77 4.88 4.80 4.97 0.11 0.929 0.566
Panc. Wt /body wt 0.19 0.16 0.18 0.17 0.00 0.151 0.5304
Control NCF 200g/t NCF 400g/t NCF 800g/t
Dietary treatment
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Table 3.11. Effect of NCF in broiler diets on the length of the intestine (cm) 
 
(Differing superscript letters within one week denote means are significantly 
different at P < 0.05. In regression analysis significant relationships are identified as 
follows, Linear (L), Quadratic (Q) and Cubic (C)) 
 
3.4.8 Gut Morphology 
Intestinal villus height and crypt depth were measured at 42 days to investigate the 
effects of NCF on gut health. Table 3.12 illustrates that there was no effect of NCF 
on the villus height, villus width, crypt depth or villus to crypt ratio in the duodenum 
or jejunum at 42 days.  
 
 
 
 
 
 
 
Attribute SEM P value Regression
P value
Duodenum length 32.32 32.40 31.83 31.33 0.49 0.865 0.224
Duodenum/ body wt 1.32
A
1.14
AB
1.22
AB
1.11
B
0.03 0.038 0.050
C
Jejunum length 70.48
B
78.70
A
74.97
AB
72.76
AB
0.94 0.011 0.831
Jejunum/ body wt 2.86 2.69 2.87 2.57 0.05 0.140 0.176
Ilium length 75.55 78.80 78.08 74.23 0.92 0.264 0.562
Ilium/ body wt 3.02 2.77 3.00 2.69 0.06 0.090 0.129
Total length 177.89 189.90 184.88 178.31 1.84 0.056 0.446
Total/ body wt 7.21 6.66 7.09 6.31 0.13 0.043 0.095
Dietary treatment
Control NCF 200g/t NCF 400g/t NCF 800g/t
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Table 3.12. Effect of NCF on the gut morphology of the duodenum and jejunum (µm) 
 (Differing superscript letters within one week denote means are significantly 
different at P < 0.05) 
 
3.4.9 Goblet Cell Numbers 
Investigation of goblet cell number and area in the duodenum (table 3.13), revealed 
that the diets including NCF did not significantly affect goblet cell area, goblet cell 
number per 165μm of villi or goblet cell measurements as a ratio. However in the 
jejunum 800g/t NCF significantly (P<0.05) increased goblet cell area over the 
control, but no other parameters were altered in the jejunum. Both goblet cell area 
villi was seen to have a cubic dose response, whereas goblet cell area per 165 μm has 
a linear response to ROI of NCF. 
 
 
 
 
Attribute SEM P value Regression
Control NCF 200g/t NCF 400g/t NCF 800g/t P value
Duodenum
Villus Height 2818.8 2790.8 2891.2 2703.9 52.6 0.682 0.718
Villus Width 274.3 264.8 262.0 281.9 5.5 0.575 0.728
Crypt Depth 209.4 209.1 210.3 212.9 5.6 0.995 0.429
Villus/Crypt Ratio 15.1 13.6 14.2 12.7 0.47 0.361 0.309
Jejunum
Villus Height 1283.8 1284.5 1379.2 1314.8 25.5 0.528 0.345
Villus Width 246.7 235.2 222.7 248.6 5.5 0.351 0.940
Crypt Depth 162.5 151.1 151.6 153.3 2.4 0.304 0.882
Villus/Crypt Ratio 8.1 8.6 8.9 8.4 0.17 0.466 0.373
Dietary treatment
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Table 3.13. Effect of NCF on the goblet cell of the duodenum and jejunum (μm2) 
(Differing superscript letters within one week denote means are significantly 
different at P < 0.05. In regression analysis significant relationships are identified as 
follows, Linear (L), Quadratic (Q) and Cubic (C)) 
 
3.4.10 Mortality 
Mortality for this study is show in table 3.14; there were no significant differences 
between treatments. 
 
Table 3.14. Effect of NCF on mortality 
   
 
3.5 DISCUSSION 
This trial showed that performance of broilers was improved by the supplementation 
of NCF when a commercial stocking density was implemented in the poultry facility 
at Nottingham Trent University. Overall, supplementation with NCF significantly 
increased the weekly body weights compared to control from two weeks onwards. 
Atribute SEM P value Regression
Pvalue
Duodenum
Goblet Cell Area (µm
2
) 59.2 69.4 58.3 62.6 2.5 0.263 0.927
N
o
 of Goblet Cell per 165µm 11.8 11.4 11.7 11.9 0.2 0.860 0.338
Goblet Cell Area per 165µm 683.1 747.0 664.4 719.3 23.6 0.314 0.582
Jejunum
Goblet Cell Area (µm
2
) 67.6
B
68.3
B
73.8
AB
82.8
A
2.2 0.041 0.047
C
N
o
 of Goblet Cell per 165µm 12.4 12.2 12.0 11.8 0.2 0.741 0.444
Goblet Cell Area per 165µm 847.0 868.0 882.1 988.4 21.9 0.089 0.025
L
Dietary treatment
Control NCF 200g/t NCF 400g/t NCF 800g/t
Atribute SEM P value
Mortality % 6.67 6.67 3.33 5.00 0.01 0.308
Control NCF 200g/t NCF 400g/t NCF 800g/t
Dietary treatment
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This trial is in agreement with findings of Benites et al. (2008) who showed that 
diets supplemented with MOS significantly increased body weight at 21, 28, 35 and 
42 day compared to a control. However Benites et al. (2008) did not find this 
increase in body weight resulted in an improvement in weekly FCR, which is in 
contrast with the present study. Other studies were in contrast with the present study 
as they found no significant difference in terms of bird weight when adding MOS 
(Baurohoo, et al., 2007; Brummer, et al. 2010; Kim, et al., 2011). These differences 
between both published work and current study may relate to differences in NCF 
ROI between studies. Where published work uses a single ROI, the current study 
examined 3 levels of NCF and identified biologically unusual cubic response at 14 
days, before returning to a quadratic response to increasing NCF at 28 and 35 days. 
The depression in NCF response seen at 400g/t NCF is difficult to explain but may 
suggest differing mechanism underpin the positive responses to NCF at 200g/t and 
800g/t. This hypothesis is further explored in the general discussion. The increase in 
the body weight over the control in this study may be due to an improvement in the 
microflora populations in the intestinal tract; the binding of pathogenic bacteria to 
MOS results in their evacuation from the intestine with other non-digested feedstuffs 
(Spring, et al., 2000). This may have improved gut health of the birds fed MOS and 
contributed to increased performance compared to the control, due to an increased 
capacity to absorb nutrients (Sun, 2005). 
 
Improvements in the body weight of birds do not always result in an improvement in 
FCR, this trial however showed improvements in both weekly body weights and 
FCR in the starter and grower phase. At 14 days this improvement in FCR was in a 
cubic response, which suggests at 14 days all three inclusion levels are improving 
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FCR, however 200g/t and 800g/t are having a greater effect. MOS improvements in 
body weight may not lead to an FCR effect in some studies, due to a lack of 
challenge on the birds (Benites, et al., 2008; Bazkurt, et al., 2009). The effects of 
MOS on the birds performance appears to be stronger if the birds are under some 
level of challenge, Nolet et al., (2007) in broiler and Castillo et al. (2008) and Che et 
al. (2012) in pigs found that when challenged, animal performance improves when 
fed MOS. In the present trial the birds were kept at a higher stocking density than 
normally maintained in the research facility at Nottingham Trent University’s 
poultry facility, which may have been a factor in the increased level of challenge on 
the birds shown through the reduced body weight of the control birds. This may be 
the reason why performance parameters were improved in this trial but not in other 
trial with no disease or stress challenge on the birds (Morales-Lopez, et al., 2009).  
 
Generally, it was demonstrated that NCF improved FCR in starter and grower 
feeding phases. This suggests that the inclusion of NCF in the diet in the starter and 
grower phase increases the efficiency of the birds. This is in agreement with research 
that found that feeding yeast cell walls in the diet of broiler chicks lowered the 
feed/gain ratio in 0-3wks (P<0.05) (Zhang, et al., 2005). However this conflicts with 
other research that showed; no effect throughout a study; no effect until later in a 
study; or an increase FCR when feeding MOS (Iji, et al., 2001; Sun, et al., 2005; 
Midilli, et al., 2008 respectively). Improved FCR in the starter and grower phase 
may be due to an ideal supplementation time for MOS to support the developing gut. 
MOS has been shown to stimulate the immune system and inhibit pathogenic 
bacterial proliferation, therefore normally leading to an improvement in the birds 
health and growth performance (Iji, et al., 2001; Bozkurt, et al., 2009). Improving 
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gut health should in theory increase performance, as the absorption status should be 
better. It has been reported that MOS in many trials has increased performance 
(Santin, et al., 2001; Zhang, et al., 2005; Chee, 2008). NCF has been developed from 
MOS so may be expected to induce similar modes of action. The performance data 
from this trial supports the hypothesis that NCF is improving the efficiency of the 
bird in the starter period. Hooge (2004) concluded in a meta-analysis improvments 
may be through; binding of pathogenic bacteria; improved intestinal function via 
increases in villus height, uniformity and integrity; and immune modulation. Despite 
extremely rigorous histologyical examination, the current study shows no effect of 
NCF on either VH or CD at 6 weeks post hatch.  However, another mechasnism 
posed by Hooge (2004) is supported by the current study: the significnate increase 
goblet cell area indicates an improment in ability of the bird to mount an immune 
reponse. This means that the significant improvement observed in growth response 
after NCF supplementation may be linked with a series of improvements in intestinal 
mucosal integrity, gut microflora and local intestinal immunoresponse, as has been 
shown with MOS (Spring, et al., 2000; Iji, et al., 2001; Santin, et al., 2001; Uni and 
Smirnov, 2006; Chee, 2008). The possible reason for the FCR being higher in the 
first week than the expected FCR of Ross 308 male broilers, may be due to a feed 
spillage problem. Birds were fed a mash diet, which resulted in the birds in week one 
being able to dust bathing in the fed causing the spillage. 
 
NCF had significantly increased weekly weight gain on days 14, 21 and 28. 
However live weight gain was not significantly different in weeks 5 and 6, which 
may be due to a number of factors. One explanation is that the birds fed NCF had a 
heavier body weight than the control birds in the later stages of the trial and had 
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passed the point of inflection on the growth curve and therefore rate of weight gain is 
slower (Aviagen, 2007). It is also thought that there may be an optimum time for 
MOS to support the developing gut and this may be why the study showed greater 
benefit at the beginning of the trial. It has been reported previously that growth 
response in broilers to MOS is age-dependent with younger birds responding more 
than the older ones (Yang, et al., 2007; Chee, 2008). This may be due to the fact that 
the gut microflora of younger birds is more transient in nature and less mature than 
those older birds. Therefore it may be assumed that feeding of MOS may increase 
the rate of maturation of the gut microflora, leading to better growth performance 
(Yang, et al., 2007). These findings in weight gain are in agreement with Santin et 
al., 2001 and  Chee, 2008, however research in poultry supplementation with MOS 
is contradictory. Midilli, et al. (2008) found body weight gain in poultry was not 
affected by the supplementation of MOS. These conflicting findings have also been 
shown to be the case in other species. In fish; Grisdale-Helland et al., (2008) and  
Dimitroglou, et al., (2010), found no effect of MOS supplementation, whereas 
Torrecillas et al., (2007) found improvements in weight. 
 
Whilst numerically NCF increased the cumulative feed intake for birds on all three 
treatment in every week, only NCF at the lowest inclusion level was shown to 
significantly increase feed intake over the control from 21 days. This may mean that 
NCF at the lowest inclusion level is a feed intake enhancer. An increase in feed 
intake was also seen by Morales-Lopez, et al. (2010) in broilers when feeding YCW, 
while it been reported that feeding MOS does not affect feed intake in broilers 
(Zhang, et al. 2005; Midilli, et al. 2008; Chee, et al. 2010) and in pigs (Castillo, et al. 
2008). Whereas Baurhoo, et al. (2007) and Muthusamy, et al. (2012) reported a 
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decrease in feed intake when feeding MOS. This shows that effects of MOS on feed 
intake as well as growth of broilers is variable, and may also be variable when 
feeding NCF at different levels. 
 
As MOS is generally believed to improve gut health it could be proposed that 
feeding MOS may improve litter quality, due to the bird being able to efficiently 
digest and absorb nutrients and to pass less urine. When analysing the dry matters of 
the litter as a measure of litter quality, it was seen that there was no effect of NCF on 
the quality of the litter. The dry matter results may have been affected by the small 
pen size, as the birds were not able to move around the room like in a commercial 
farm. In addition the disproportionately large bell drinker relative to pen size and 
their tendency to spill, resulted in the need to top up the litter with fresh sand. The 
viscosity of digesta showed that there was no significant effect of NCF on the 
viscosity of the digesta. The dry matter of the litter and viscosity results suggests that 
NCF has no effect on excreta. All foot pad scores throughout the 6 weeks were all 
scored as 1. This means that there were not foot pad problems for any of the birds in 
this trial. This is most probably due to good husbandry practices in this system and 
not diet related, as the study was conducted in a small pen system. This means that 
the whole pen area is relatively close to the water supply and can deteriorate quickly 
due to water spillage. Therefore in this study to keep a high standard of welfare, 
fresh sand was added if there was any water spillage, thereby confounding 
investigation of this parameter.   
 
When looking at the gross gut development at 6 weeks, NCF at 200g/t caused an 
elongation of the jejunum. This was also found in a study by Trevifio (1990), who 
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found chicks receiving oligosaccharide dried extract had a larger relative length of 
jejunum, ileum and caeca than those fed on the control diet. However, Trevifio (1990) 
also found that generally, an increase in oligosaccharide content in the diet 
corresponded to an increase in the length of the different intestinal sections, but the 
present study did not find this. A reason for the increase in jejunum length may be 
due to an increase in the production of epithelial cells in the intestine but not their 
turn over. NCF may be having a combined effect by improving the gut health of 
birds through decreasing the sloughing of the villi caused by toxins from pathogens 
and by increasing the amount of energy available to epithelial cells by increasing 
butyrate levels due to NCF fermentation by microflora. In addition, 200g/t NCF 
decreased duodenum, ilium and the total intestinal weight relative to bird body 
weight, which may be due to a decrease in the thickness on the muscularis. The 
cubic response of duodenum length to body weight ratio to NCF ROI mirrors the 
reponse of several performance paramenters, suggesting duodenum development 
might have some involvement in the possible mechanistic differences occurring at 
200g/t and 800g/t NCF inclusion.  Ferket, et al. (2002) reported that when turkeys 
were fed MOS their muscularis thickness was significantly reduced. An increase in 
the duodenum weight has been associated with inflammation following bacterial 
infection (Baurhoo, et al., 2007), therefore the reduced weight of the duodenum and 
the rest of the intestine may mean that NCF is reducing the pathogenic bacteria in the 
birds GI tract. Chee, (2008) concluded that MOS-supplemented birds have a thinner 
gut and therefore have a lower gut mass to maintain. This therefore would decrease 
the energy needed to maintain the gut and leave more energy for growth. Bozkurt, et 
al. (2009) also found that MOS decreases intestinal weight, however other research 
is conflicting and reports no effect of MOS on the weight of the intestinal tract in 
101 
 
broilers (Iji, et al., 2001; Baurhoo, et al. 2007). Consideration of possible 
relationships between body weights and intestinal lengths and weights showed that 
there were little (0.10-0.29) or no correlations (<0.1). This means that the weights of 
the birds did not appear to affect the gross gut morphology. 
 
When feeding NCF to broilers, it could be postulated that birds will have longer VH 
and shorter CD via a reduction in sloughing. Spring, et al. (2000) reported that 
pathogens with the mannose-specific type-1 fimbriae, such as some strains of 
Escherichia coli, Salmonella typhimurium and Salmonella enteritidis, are attracted to 
mannans, which are reported to be present in NCF (Che, et al., 2012), and will 
readily bind with them instead of attaching to intestinal epithelial cells (Castillo, et 
al., 2008). Consequently these pathogenic bacteria cannot colonise the GI tract and 
release toxins. These bacterium and their toxins can cause inflammation that in turn 
causes atrophy of the epithelial cells of the villi (Gao, et al., 2008), thus reducing the 
absorptive function of the gut through shorter VH and deeper CD (Yason, et al., 
1987). If NCF binds the pathogenic bacteria and reduce the level of these bacteria in 
the GI tract, there will be less villi damage in the gut, therefore improving the gut 
health of the bird. To compensate for this atrophy the bird has to increase its tissue 
turn over, and as epithelial cells are produced in the crypts and migrate along the villi 
to the tip, it is thought that the higher turnover in the crypt cell cause it to become 
deeper (Gao, et al., 2008). Therefore shallower CD are considered a good indicator 
of gut health. MOS has also been reported to increase levels of Bifidobacterium and 
Lactobacillus in broilers (Fernandez, et al., 2002; Baurhoo, et al., 2007), this 
increases the competition against pathogenic bacteria for nutrients and binding sites, 
and secreting compounds that are noxious to pathogenic bacteria. Lactobacilli 
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secrete bacteriocins and bifidobacteria produce organic acids, such as butyrate, 
which can suppress the colonization of the intestines by pathogenic bacteria, thereby 
reducing the intestinal population of pathogens (Rolfe, 2000). In addition butyrate 
can be used by the epithelial cells for energy (Jozefiak, et al., 2004), which may 
contribute to an improvement in gut health parameters.  
 
Morphometric analysis at 6 weeks revealed that NCF had no significant effect on the 
gut morphology of the birds at this time point. A possible reason why no effect was 
evident in the gut morphology and performance of birds fed NCF at 6 weeks, may be 
due to the birds not being challenged with pathogenic microbes at this time. This 
trial supports the VH findings of White, et al. (2002) in pigs and Yitbarek, et al. 
(2012) and Sohail, et al. (2012) in broilers when feeding MOS. However, Iji, et al. 
(2001) and Zhang, et al. (2005) found that birds fed yeast cell wall fractions had 
longer VH than control birds at 21 days. Similarly, Baurhoo, et al. (2007) measured 
VH and found that MOS improved VH at 28 days but not at 42 days. A similar, early 
age response may have occurred in this present study, but as histological measures 
were not taken at 21 or 28 days this cannot be verified.  
 
When looking at CD, Zhang, et al. (2005), Yitbarek, et al. (2012) and Sohail, et al. 
(2012) found feeding MOS had no effect on CD in birds, which was also shown in 
this study. Santin, et al. (2001) also saw no effect of MOS at 42 days, however 
decreased CD was seen when feeding MOS at 7 days. In addition, this present trial 
found no effect on VCR, which can be used as a marker of overall intestinal health 
as it takes into account both CD and VH. This trial included a total of 240 measures 
for each treatment, which is a considerable amount and therefore it should be noted 
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that taking more measures to try and reduce associated error would have major time 
and cost implications. The inherent variability both in this study and other studies 
suggests that measuring VH and CD may not be an optimal approach to quantifying 
gut health.  
 
This study showed that the greatest benefit of NCF on FCR occurred at the 
beginning of the trial, indicating there may be an optimum time for the 
supplementation of NCF to increase the efficiency of the birds. This may be due to 
the fact that the gut microflora of younger birds is more transient in nature and less 
established than in older birds and therefore more susceptible to colonisation by 
pathogenic bacteria. Therefore prebiotic intervention may shorten the time required 
to create a beneficial microflora population if it is offered early in life. In this study it 
was generally shown that NCF improved FCR over the starter and grower feeding 
phases. This suggests that the inclusion of NCF in the diet at both the starter and 
grower phase, increases the efficiency of the birds. This concurs with Zhang, et al. 
(2005), although, other studies have shown no early response (Iji, et al., 2001; Sun, 
et al., 2005; Midilli, et al., 2008). Therefore it could be hypothesised that the 
improvements observed in FCR early on in the study when feeding NCF may have 
been due to an increase in absorptive area, due to an increase in lactobacilli and 
bifidobacterial populations and a reduction in pathogenic bacteria. This has been 
seen in other studies where improvements in gut morphology is associated with 
increased lactobacilli and bifidobacterial populations (Baurhoo, et al., 2009). 
However, improvements in gut health were not observed in this present study as 
histological measurements were only recorded at 6 weeks, when the microflora is 
already established with a population of beneficial bacteria. This means that birds on 
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all treatment groups were not under any challenge and it was seen that NCF had no 
effect on the performance in the last phase of the trial, which is consistent with the 
histological measurements at 6 weeks. 
 
The variability seen within and between trials may be due to a number of reasons. 
Firstly the variability in the yeast cell wall products being fed in the trial might affect 
the levels of the compounds that induce the proposed effects of the yeast cell wall 
product. The composition of a yeast cell product depends on many factors including 
source and processing technique. Second, the variability between experimental 
conditions and the health status of the birds, may mean that the birds are under 
differing levels of environmental challenge and therefore will respond differently to 
a prebiotic. 
 
There is no consensus on whether an increase in goblet cell numbers and area is 
considered an improvement in bird health. Increasing the number and area of goblet 
cells is thought to increase the volume of mucin stored in the GI tract and possibly 
its production (Brümmer, et al., 2010). Mucin is essential for a number of brush 
border processes, including facilitating absorption of nutrients, containing enzymes, 
lubrication and decreasing the binding and colonisation of pathogenic bacteria to the 
intestine (Blomberg, et al., 1993; Smirnov, et al., 2004). Therefore an increase in the 
level of mucin could have a beneficial effect on the first line of defence of the 
immune system (Baurhoo, et al., 2009) and the absorptive function of the gut. In 
contrast, overproduction of mucin may result in a negative effect, by increasing the 
mucus thickness on the GI tract wall to a level that might impair the ability of 
nutrients to pass through to the gut epithelial to be absorbed (Smirnov, et al., 2004; 
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Brummer, et al., 2010), as well as increasing the energy partitioned away from tissue 
growth to mucin production.  
 
In this trial, the number and area of goblet cells in the duodenum were not affected 
by the supplementation of NCF to 42 days. This would suggest that NCF has no 
effect on the mucin profile of broilers in the duodenum in this study. This absence of 
response was also reported by Castillo, et al. (2008) and Yitbarek, et al. (2012), 
however Baurhoo, et al. (2007; 2009); Chee, et al. (2010); Morales-lopez, et al. 
(2010) and Muthusamy, et al. (2012) all found goblet cell numbers were increased 
by yeast cell wall product supplementation. In the jejunum it was seen that NCF 
increases the area of goblet cells and there was a trend for increasing goblet cell area 
per 165 μm of villi, suggesting that NCF at 800g/t affects the mucin profile of 
broilers in the jejunum. The responses of goblet cell area to increasing NCF were 
both cubic, showing that 200g/t and 800g/t were having a greater effect. Published 
data on goblet cell area is very limited: Brummer, et al. (2010) also found that the 
area of goblet cells increased with supplementation of MOS. Insight into the 
mechanisms behind this goblet cell response would be highly beneficial to 
understanding the effect of MOS supplementation on gut health.  
 
An increase in goblet cell area is thought to show that the storage capacity of the 
goblet cell for mucin has increased (Smirnov, et al., 2005). The increase in mucin 
storage may suggest that the bird is more capable of forming a protective layer on 
the villi, thereby helping protect the intestine from damage caused by 
enteropathogens if there was a challenge from pathogenic bacteria (Smirnov, et al., 
2006; Brümmer, et al., 2010). One suggested mechanism of MOS on mucin 
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production is through changing the gene expression of key genes through direct 
crosstalk between beneficial intestinal microbes and goblet cells, (Mack, et al., 1999; 
Freitas, et al., 2003; Smirnov, et al., 2005; Uni and Smirnov 2006; Chee, 2008). The 
effects of NCF on the goblet cell area observed in the current study agree with this 
suggestion, that goblet cell area increased with increased supplementation level, but 
it is also possible that NCF is having a direct effect on mucin production and 
subsequently increasing bifidobacteria due to the increase in mucin production, as 
bifidobacteria can produce enzymes allowing them to utilise and proliferate on 
mucin glycoproteins (Katayama, et al., 2005; Jung, et al., 2008; Ruas-Madiedo, et 
al., 2008). 
 
3.6 CONCLUSION 
In conclusion, this trial indicates that NCF had a positive effects on performance and 
limited effects on gut health at 6 weeks. Regarding performance, 200g/t and 800g/t 
NCF in particular improved FCR, but the growth response to NCF is age-dependent 
with the bird responding more at a earlier age than the later in it life. This has also 
been shown by Tucker, et al. (2003) using MOS, at a higher inclusion than NCF. 
This could be explained by the fact that the gut microflora of younger birds are less 
mature than older birds. Therefore it may be assumed that feeding of MOS may 
increase the rate of maturation of the gut microflora, leading to better growth 
performance (Yang, et al., 2007). This trial showed that NCF improved body weight, 
body weight gain, FCR and performance of the birds to some degree earlier on in the 
trial, however this cannot be related to gut morphology of the bird as it was not 
measured earlier on in the trial. It may be postulated that NCF improved gut health 
of bird in the starter and growth phase of feeding as FCR was improved. However 
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without gut morphology being measured at this time point, this cannot be proved. 
The published research appears to be variable, which may be due to differences in 
the type of MOS product, experimental conditions, diet formulation and health status 
of the birds. The performance data from this trial supports the hypothesis that NCF is 
improving the efficiency of the bird in the starter period, but the dose response was 
not linear. The cubic response observed for many parameters measured suggest 
differing mechanisms underpin the improve performance as 200g/t and 800g/t NCF. 
Therefore, future studies are warranted to explore further the interactions between 
NCF and the development of the gut and modulation of intestinal morphology over 
time. 
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CHAPTER 4: TRIAL 2 - INVESTIGATION OF THE EFFICACY OF THE A 
NATURAL CARBOHYDRATE FRACTION (NCF) ACTIGEN AT VARYING 
DIETARY INCLUSION RATES ON THE GUT DEVELOPMENT OF 
BROILERS OVER THE TRIAL. 
 
4.1 INTRODUCTION 
After observing the performance improvements in Trial 1 in the starter and grower 
phases, but generally no effect of NCF on microscopic gut morphology at 6 weeks, it 
was deemed appropriate to investigate the effects of NCF on parameters prior to 6 
weeks to detect possible modes of action of NCF in the starter and grower periods. 
Therefore Trial 2 was carried out to investigate the effects of NCF on microscopic 
changes in the GI tract over the life of the bird, as well as elucidate any links to bird 
performance. Trial 2 investigated the effects of NCF at 200, 400 and 800g/t on bird 
gut morphology at intervals throughout the trial period at 7, 14, 21, 28 and 42 days, 
to investigate the development of the gut over time. This study also examined the 
effects of NCF on gross gut development, linking it to microscopic gut development 
and performance. This trial continues to use the inclusion levels of 200g/t, 400g/t 
and 800g/t used previously, but sequentially examines bird development on a weekly 
basis to investigate the mechanisms behind the cubic responses seen in the previous 
trial.   
 
4.2 AIM 
The aim of Trial 2 was to investigate the efficacy of NCF at 200g/t, 400g/t and 
800g/t inclusion rates on the microscopic gut development of broilers over the trial 
period, whilst linking this to performance and gross gut development. 
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The hypothesis of this trial was that improvements in performance seen with 
supplementation of NCF are linked to altered gut devoloment in early life, with 
differing developmetal responses to differeing ROI of NCF. 
 
4.3 MATERIALS AND METHODS 
4.3.1 Bird Husbandry 
A total of three hundred and sixty 1 day old male Ross 308 birds from a flock of 43 
weeks of age were obtained from P.D.Hook Hatcheries Ltd (Cote, Bampton, 
Oxfordshire, UK). They were placed in 36 pens, each containing 10 birds and fed on 
1 of 4 dietary treatments. The diets were stratified allocated to remove any effect of 
the room environment on the study. There were 4 dietary treatments with 8 replicates 
per treatment, made up of 8 small floor pens (area = 0.43m2) with one extra pen per 
treatment holding spare birds for replacement of birds culled due to health reasons 
during the trial. The litter provided was wood shavings on a concrete floor at a depth 
of 6cm topped up as necessary to maintain adequate environmental welfare. 
 
4.3.2 Experimental Diets 
Trial 2 lasted 42 days with a three phase feeding programme: starter diets were fed 
from 1 to 14 days, grower diets from 15 to 28 days and finisher diets from 29 to 42 
days. The 4 dietary treatments were: 1) control diet (NCF free), 2) NCF at 200g per 
tonne, 3) NCF at 400g per tonne and 4) NCF at 800g per tonne. The rations were 
based on the nutritional requirements for the strain of bird (as defined by Aviagen) 
and contained rye and no pentosan degrading enzymes. The formulations were 
checked by an independent nutritionist. The basal diet was free of antibiotics and 
manufactured using the formulation in table 4.1, by Target Feeds, a commercial feed 
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mill. 
Table 4.1. Composition of basal diet and calculated analysis of the basal diet 
Item  Starter Grower Finisher 
Ingredients (%) 
  
 
Barley 5.50 0.90 0.00 
Rye 10.00 15.00 20.00 
Wheat 45.00 47.00 47.00 
Soybean meal, 48% CP 26.00 23.00 19.00 
Full fat soybean meal 5.00 5.00 5.00 
L lysine HCL 0.40 0.30 0.30 
DL methionine 0.40 0.35 0.30 
L threonine 0.15 0.15 0.15 
Soya oil 4.00 4.50 4.75 
Limestone 1.25 1.25 1.25 
Monocalcium phosphate 1.50 1.25 1.25 
Salt 0.25 0.25 0.25 
Sodium bicarbonate 0.15 0.15 0.15 
Premix* 0.40 0.40 0.40 
Calculated analysis 
  
 
ME MJ/kg 12.75 12.99 13.11 
CP% 21.75 20.49 18.91 
Lys % 1.45 1.29 1.17 
Met + Cys % 1.04 0.96 0.87 
Ca 0.96 0.91 0.91 
Available P 0.48 0.42 0.42 
*Premix content (volume/kg diet): Mn 100mg, Zn 80mg, Fe 20mg, Cu 10mg, I 1mg, 
Mb 0.48mg, Se 0.2mg, Retinol 13.5mg,Cholecalciferol, 3mg, Tocopherol 25mg, 
Menadione 5.0mg, Thiamine 3mg, Riboflavin 10.0mg, Pantothenic acid 15mg, 
Pyroxidine 3.0mg, Niacin 60mg, Cobalamin 30µg, Folic acid 1.5mg, Biotin 125mg 
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4.3.3 Determined Parameters 
Bird weight and feed intakes per pen were recorded weekly. The FCR was calculated 
using this information on a weekly basis and for each phase. On days 7, 14, 21, 28 
and 42, two birds per pen were selected and slaughtered. The whole intestine from 
one of the birds was removed and weighed. The length of the separate parts of the 
intestinal tract as described in Chapter 2, were measured. A blood sample was taken 
from the second bird and its serum removed and frozen at -20oC for later analysis. 
The second bird was then dissected to remove the small intestine tissue sections from 
the duodenum and jejunum for detailed intestinal and general intestinal structure 
examination. The tissue samples from the duodenum and jejunum were fixed in 
Bouins solution prior to histological procedures including staining with Periodic 
Acid Schiff’s and Alcian Blue (pH 2.5). In addition tissue samples were taken and 
snap frozen in dry ice and industrial methylated spirits and stored at -80oC for later 
analysis of digestive and immune markers. Standard feed analyses were carried out 
on the three basal diets (Appendix 6). The feed was also analysed for NCF levels at 
the Alltech’s Bioscience Centre in Dunboyne, Ireland by an assay determining the 
amount of NCF in grams per tonne. 
 
4.3.4 Data Analysis 
All data were analysed using the SPSS software for Windows. A 1-way ANOVA 
analysis was applied. One pen was used as a unit for analysis. Treatment means were 
separated using the Tukeys post hoc test, and statistical significance was declared at 
P < 0.05. Regression analysis was also performed to identify any dose response to 
increasing levels of NCF. 
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4.4 RESULTS 
4.4.1 Body Weight and Live Weight Gain 
Whilst body weight and live weight gain was recorded, the pen size (80x80cm) and 
weekly reduction in stocking density limited the commercial relevance of this data.  
The mean weekly live body weights per bird for the 4 diets over the 6 weeks are 
shown in Table 4.2, with the mean weekly body weight per bird on days 1 and 21 
showing a significant difference between treatments. On day 1, it was shown that the 
birds on diet 200g/t of NCF had a significantly heavier live weight over the control 
(P=0.025). On day 21 it was shown that NCF at 800g/t increased live weight over the 
control and 400g/t (P=0.023). The regession anaylsis showed no dose reponse to 
NCF level. 
 
The mean weekly live weight gains per bird for the 4 diets over the 6 weeks are 
given in Table 4.3, illustrating that the mean weekly live weight gain per bird on 
days 21 and 35 was significantly different between the treatments. On day 21, 800g/t 
of NCF increased weight gain over the other two inclusion levels of NCF but not the 
control (P=0.008). Contrastingly, on day 35, 800g/t of NCF significantly decreased 
the live weight gain compared to the control (P=0.011). The regression analysis 
showed that on day 35 that increasing levels of NCF resulted in a negative linear 
response in weight gain. Weight gain do not make up the difference between weekly 
live body weights due to birds being culled weekly, this means that the end live 
weight of a pen for a week (e.g. 6 bird) is not the same at the start live weight for the 
next week (e.g. 4 birds (2 birds culled)). 
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Table 4.2. Effect of NCF in broiler diets on the mean weekly body weight (g/bird ) 
Differing superscript letters within one week denote means are significantly different 
at P < 0.05 
 
Table 4.3. Effect of NCF in broiler diets on the mean weekly live weight gain (g/bird) 
 
(Differing superscript letters within one week denote means are significantly 
different at P < 0.05. In regression analysis significant relationships are identified as 
follows, Linear (L), Quadratic (Q) and Cubic (C)) 
 
4.4.2 Feed Intake 
The mean weekly feed intakes per bird for the 4 diets over the 6 weeks are shown in 
Table 4.4 indicating that 800g/t NCF increased feed intake over the control birds on 
Age SEM P value Regression
P value
1 d 42.7
B
44.2
A
43.5
AB
43.1
AB
0.18 0.025 0.810
7 d 142.0 150.9 143.0 152.7 1.99 0.135 0.717
14 d 409.4 429.9 416.3 442.0 4.59 0.055 0.911
21 d 871.0
B
880.9
AB
863.6
B
929.9
A
8.44 0.023 0.934
28 d 1455.2 1516.5 1491.1 1546.1 15.50 0.212 0.731
35 d 2203.0 2314.8 2253.5 2179.5 23.60 0.177 0.236
42 d 3040.1 3103.5 3046.3 3002.0 28.32 0.671 0.473
Dietary treatment
Control NCF 200g/t NCF 400g/t NCF 800g/t
Age SEM P value Regression
P value
7 d 99.3 106.7 99.5 109.7 1.97 0.159 0.709
14 d 267.0 279.7 272.9 290.3 3.37 0.089 0.925
21 d 464.1
AB
443.9
B
451.9
B
484.2
A
4.58 0.008 0.965
28 d 579.6 622.3 601.3 603.7 12.73 0.723 0.745
35 d 854.1
A
792.8
AB
756.6
AB
715.3
B
15.77 0.011 0.042
L
42 d 846.4 788.7 792.8 822.5 20.33 0.753 0.741
Dietary treatment
Control NCF 200g/t NCF 400g/t NCF 800g/t
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day 7. No other significant differences between the treatments were demonstrated 
and no dose response to NCF observed. The cumulative mean feed intakes per bird 
for the 4 diets over the 6 weeks are shown in Table 4.5 where a significant difference 
between the treatments in weeks 1 and 3 was evident as 800g/t NCF increased feed 
intake over the control.  
 
Table 4.4. Effect of NCF in broiler diets on the mean weekly feed intake (g/bird) 
Differing superscript letters within one week denote means are significantly different 
at P < 0.05 
 
Table 4.5. Effect of NCF in broiler diets on the cumulative mean feed intake (g/bird)  
(Differing superscript letters within one week denote means are significantly 
different at P < 0.05.) 
Attribute Age SEM P value Regression
P value
Feed 7 d 115.1
B
126.3
AB
120.1
AB
132.2
A
2.22 0.032 0.884
intake (g) 14 d 376.2 392.7 390.8 401.0 4.19 0.216 0.984
21 d 687.4 715.4 717.0 726.8 6.77 0.200 0.392
28 d 1044.7 1078.8 1093.6 1072.9 12.78 0.609 0.394
35 d 1440.3 1471.8 1461.7 1437.1 18.6 0.905 0.894
42 d 1649.8 1651.7 1673.3 1649.4 22.60 0.981 0.891
Dietary treatment
Control NCF 200g/t NCF 400g/t NCF 800g/t
Attribute Age SEM P value
Feed 7 d 115.1
B
126.3
AB
120.1
AB
132.2
A
2.22 0.032
intake (g) 14 d 491.3 519.0 510.8 533.3 5.77 0.072
21 d 1178.8
B
1234.4
AB
1227.8
AB
1260.0
A
10.47 0.041
28 d 2223.5 2313.2 2321.4 2346.0 19.04 0.109
35 d 3663.7 3785.0 3783.1 3816.3 32.16 0.362
42 d 5313.5 5436.7 5456.3 5477.1 43.77 0.568
Control NCF 200g/t NCF 400g/t NCF 800g/t
Dietary treatment
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4.4.3 Feed Conversion Ratio 
The mean weekly FCRs per bird for the 4 diets over the 6 weeks are shown in Table 
4.6 with the mean weekly FCR per bird between diets not showing a significant 
difference, except on day 21 where 200g/t increased FCR over the control (P = 
0.010). Table 4.6 also shows there was no dose effect of NCF inclusion level on 
FCR. Table 4.7 illustrates that there was no significant difference between dietary 
treatments on the mean FCR per phase of feeding. Furthermore throughout the whole 
6 week trial period the FCR was not significantly altered by dietary treatment.  
 
Table 4.6. Effect of NCF in broiler diets on the weekly feed conversion ratio. 
 Differing superscript letters within one week denote means are significantly 
different at P < 0.05 
 
Table 4.7. Effect of NCF in broiler diets on the phase feed conversion ratio 
   
Attribute Age SEM P value Regression
P value
FCR 7 d 1.17 1.18 1.21 1.23 0.02 0.540 0.149
14 d 1.42 1.40 1.43 1.38 0.02 0.808 0.810
21 d 1.48 B 1.61 A 1.59 AB 1.50 AB 0.02 0.010 0.328
28 d 1.84 1.74 1.83 1.78 0.03 0.717 0.908
35 d 1.84 1.86 1.93 2.01 0.03 0.070 0.239
42 d 1.94 2.17 2.11 2.13 0.05 0.396 0.548
Dietary treatment
Control NCF 200g/t NCF 400g/t NCF 800g/t
Attribute Age SEM P value
Control NCF 200g/t NCF 400g/t NCF 800g/t
FCR Wk1+2 1.35 1.34 1.37 1.35 0.01 0.848
Wk3+4 1.67 1.69 1.72 1.66 0.02 0.597
Wk5+6 1.92 1.98 2.02 2.08 0.03 0.236
Wk1-6 1.77 1.79 1.83 1.84 0.01 0.144
Dietary treatment
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4.4.4 Intestinal Weight and Length 
The mean weekly intestinal weight, lengths and ratios to body weight for the 4 diets 
are shown in tables 4.8, 4.9, 4.10, 4.11 and 4.12, the pancreas weights and ratios to 
body weight are in table 4.13. Quadratic dose responses to NCF were seen on day 14 
in duodenum, jejunum and ilium length to body weight ratio and on day 21 in 
duodenum weight to body weight ratio. Generally on day 14 and 21 NCF increased 
length on the intestine. There was also a quadratic dose response on day 14 for  
pancrease weight and jejunum weight. A significant difference was observed in the 
intestinal measurements on day 42, when analysing the length of the jejunum as a 
ratio of cm per 100g body weight. It was found that 800g/t NCF increased the 
jejunum over 200g/t NCF (P=0.034). Two other significant differences were 
observed one at day 7 and one at day 28, however significance was lost at post hoc 
level. 
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Table 4.8 Effect of dietary treatment in broiler diets on the length and weight of the intestine at 7 days 
    
Weight (g), Length (cm), DWBWR = grams of duodenum tissue per 100g bird body weight, DLBWR = centimetre of duodenum tissue 
per 100g bird body weight, JWBWR = grams of jejunum tissue per 100g bird body weight, JWBWR = centimetre of jejunum tissue per 
100g bird body weight, IWBWR = grams of ileum tissue per 100g bird body weight, g/cmPBWR = grams/centimetre of pancreas tissue 
per 100g bird body weight, IWBWR = centimetre of ileum tissue per 100g bird body weight, g/cmPBWR = grams/centimetre of 
pancreas tissue per 100g bird body weight.  
 
Diet Weight Length DWBWR DLBWR Weight Length JWBWR JLBWR Weight Length IWBWR ILBWR Weight Length
NCF 0g/t 1.64 15.98 11.09 1.13 2.76 36.65 25.50 1.92 1.91 35.23 24.56 1.43 6.48 87.85
NCF 200g/t 1.89 16.43 10.48 1.21 3.35 37.89 25.21 2.07 2.49 37.34 24.29 1.60 7.73 90.64
NCF 400g/t 1.46 15.74 10.89 1.06 2.77 37.53 27.64 1.99 2.23 33.95 24.87 1.60 6.05 88.63
NCF 800g/t 1.44 15.54 10.75 0.98 2.56 35.67 25.12 1.77 1.86 34.39 24.17 1.22 5.94 88.05
SEM 0.07 0.30 0.28 0.04 0.13 0.56 0.43 0.07 0.11 0.62 0.47 0.07 0.26 1.03
p values 0.052 0.773 0.647 0.110 0.142 0.551 0.394 0.612 0.111 0.218 0.660 0.162 0.044 0.769
Regression 0.247 0.324 0.577 0.883 0.218 0.740 0.671 0.383 0.314 0.088 0.743 0.947 0.753 0.430
Total Duodenum Jejunum Ileum
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Table 4.9 Effect of dietary treatment in broiler diets on the length and weight of the intestine at 14 days 
  Weight (g), Length (cm), DWBWR = grams of duodenum tissue per 100g bird body weight, DLBWR = centimetre of duodenum tissue 
per 100g bird body weight, JWBWR = grams of jejunum tissue per 100g bird body weight, JWBWR = centimetre of jejunum tissue per 
100g bird body weight, IWBWR = grams of ileum tissue per 100g bird body weight, g/cmPBWR = grams/centimetre of pancreas tissue 
per 100g bird body weight, IWBWR = centimetre of ileum tissue per 100g bird body weight, g/cmPBWR = grams/centimetre of 
pancreas tissue per 100g bird body weight. In regression analysis significant relationships are identified as follows, Linear (L), 
Quadratic (Q) and Cubic (C)) 
 
Diet Weight Length DWBWR DLBWR Weight Length JWBWR JLBWR Weight Length IWBWR ILBWR Weight Length
NCF 0g/t 4.09 20.81 5.10 1.00 7.25 51.33 12.65 1.78 6.09 50.33 12.40 1.50 17.43 122.46
NCF 200g/t 4.15 21.18 4.93 0.96 7.49 51.25 11.94 1.74 6.22 49.59 11.55 1.44 17.86 122.01
NCF 400g/t 4.30 20.61 4.96 1.03 8.36 50.11 12.06 2.02 6.44 49.36 11.88 1.56 19.39 120.09
NCF 800g/t 4.68 21.80 4.90 1.06 8.70 51.46 11.64 1.91 6.68 47.94 10.84 1.51 20.05 121.14
SEM 0.14 0.36 0.09 0.03 0.26 0.79 0.24 0.06 0.20 0.86 0.26 0.05 0.54 1.80
p value 0.464 0.743 0.878 0.775 0.156 0.933 0.537 0.404 0.763 0.825 0.216 0.876 0.286 0.971
Regression 0.112 0.594 0.833 0.021
Q
0.025
Q
0.870 0.800 0.010
Q
0.294 0.387 0.354 0.005
Q
0.726 0.057
IleumDuodenum Jejunum Total 
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Table 4.10 Effect of dietary treatment in broiler diets on the length and weight of the intestine at 21 days 
 Weight (g), Length (cm), DWBWR = grams of duodenum tissue per 100g bird body weight, DLBWR = centimetre of duodenum tissue 
per 100g bird body weight, JWBWR = grams of jejunum tissue per 100g bird body weight, JWBWR = centimetre of jejunum tissue per 
100g bird body weight, IWBWR = grams of ileum tissue per 100g bird body weight, g/cmPBWR = grams/centimetre of pancreas tissue 
per 100g bird body weight, IWBWR = centimetre of ileum tissue per 100g bird body weight, g/cmPBWR = grams/centimetre of 
pancreas tissue per 100g bird body weight. In regression analysis significant relationships are identified as follows, Linear (L), 
Quadratic (Q) and Cubic (C)) 
 
Diet Weight Length DWBWR DLBWR Weight Length JWBWR JLBWR Weight Length IWBWR ILBWR Weight Length
NCF 0g/t 7.67 24.39 2.81 0.90 13.99 66.07 7.32 1.58 10.66 60.06 7.13 1.23 32.32 150.24
NCF 200g/t 7.85 24.84 2.82 0.89 13.77 62.16 7.06 1.55 10.99 57.93 6.44 1.25 32.59 143.67
NCF 400g/t 8.14 25.37 2.89 0.94 13.31 63.16 7.34 1.55 10.39 59.01 6.85 1.23 31.98 147.05
NCF 800g/t 9.09 26.10 2.81 0.98 14.40 66.68 7.12 1.55 11.37 59.43 6.56 1.22 34.86 149.59
SEM 0.24 0.38 0.04 0.03 0.31 0.92 0.12 0.03 0.30 0.85 0.12 0.03 0.71 2.17
P value 0.188 0.451 0.905 0.675 0.660 0.238 0.790 0.977 0.734 0.863 0.160 0.994 0.523 0.718
Regression 0.180 0.047
L
0.042
Q
0.231 0.852 0.317 0.826 0.346 0.634 0.267 0.693 0.324 0.790 0.341
Duodenum Jejunum Ileum Total 
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Table 4.11 Effect of dietary treatment in broiler diets on the length and weight of the intestine at 28 days 
  Weight (g), Length (cm), DWBWR = grams of duodenum tissue per 100g bird body weight, DLBWR = centimetre of duodenum tissue 
per 100g bird body weight, JWBWR = grams of jejunum tissue per 100g bird body weight, JWBWR = centimetre of jejunum tissue per 
100g bird body weight, IWBWR = grams of ileum tissue per 100g bird body weight, g/cmPBWR = grams/centimetre of pancreas tissue 
per 100g bird body weight, IWBWR = centimetre of ileum tissue per 100g bird body weight, g/cmPBWR = grams/centimetre of 
pancreas tissue per 100g bird body weight. 
 
 
Diet Weight Length DWBWR DLBWR Weight Length JWBWR JLBWR Weight Length IWBWR ILBWR Weight Length
NCF 0g/t 9.88 28.44 1.97 0.68 19.54 66.78 4.61 1.26 15.34 67.18 4.65 1.07 45.77 165.64
NCF 200g/t 10.48 28.21 1.86 0.69 18.70 65.13 4.30 1.23 15.40 63.11 4.27 1.01 44.48 154.60
NCF 400g/t 9.30 26.88 1.81 0.63 18.12 68.48 4.60 1.22 15.10 69.84 4.71 1.01 42.51 164.53
NCF 800g/t 11.17 28.87 1.87 0.72 19.53 67.06 4.31 1.32 15.98 66.76 4.11 1.04 46.68 163.50
SEM 0.35 0.36 0.03 0.02 0.56 0.96 0.07 0.03 0.76 1.12 0.09 0.03 1.27 1.66
p value 0.265 0.237 0.398 0.622 0.786 0.695 0.209 0.687 0.905 0.237 0.041 0.935 0.700 0.071
Regression 0.811 0.886 0.621 0.915 0.874 0.534 0.990 0.734 0.718 0.990 0.999 0.537 0.686 0.985
Duodenum Jejunum Ileum Total 
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Table 4.12 Effect of dietary treatment in broiler diets on the length and weight of the intestine at 42 days 
  Weight (g), Length (cm), DWBWR = grams of duodenum tissue per 100g bird body weight, DLBWR = centimetre of duodenum tissue 
per 100g bird body weight, JWBWR = grams of jejunum tissue per 100g bird body weight, JWBWR = centimetre of jejunum tissue per 
100g bird body weight, IWBWR = grams of ileum tissue per 100g bird body weight, g/cmPBWR = grams/centimetre of pancreas tissue 
per 100g bird body weight, IWBWR = centimetre of ileum tissue per 100g bird body weight, g/cmPBWR = grams/centimetre of 
pancreas tissue per 100g bird body weight.  
 
 
Diet Weight Length DWBWR DLBWR Weight Length JWBWR JLBWR Weight Length IWBWR ILBWR Weight Length
NCF 0g/t 13.04 32.53 1.07 0.43 27.85 80.01 2.63
AB
0.92 23.72 82.53 2.72 0.78 65.35 195.06
NCF 200g/t 13.86 33.73 1.09 0.45 27.67 75.95 2.42
BC  
0.89 22.56 77.46 2.50 0.73 64.10 183.91
NCF 400g/t 11.10 31.89 1.05 0.37 25.98 75.03 2.47
AB
0.85 23.02 80.85 2.65 0.76 60.96 187.76
NCF 800g/t 13.22 31.79 1.07 0.45 26.91 82.64 2.77
AC
0.91 23.09 84.77 2.82 0.77 63.20 198.71
SEM 0.39 0.45 0.02 0.01 0.90 1.21 0.05 0.03 0.68 1.04 0.45 0.02 1.79 2.42
p value 0.423 0.416 0.910 0.103 0.890 0.075 0.035 0.899 0.953 0.094 0.070 0.851 0.862 0.122
Regression 0.181 0.318 0.146 0.797 0.391 0.337 0.258 0.706 0.978 0.669 0.793 0.932 0.408 0.447
Duodenum Jejunum Ileum Total 
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Table 4.13 Effect of dietary treatment in broiler diets on the weight of the pancreas over time 
   
Weight (g), PBWR = grams of pancreas tissue per 100g bird body weight In regression analysis significant relationships are identified 
as follows, Linear (L), Quadratic (Q) and Cubic (C)) 
 
Diet Weight PBWR Weight PBWR Weight PBWR Weight PBWR Weight PBWR
NCF 0g/t 0.49 3.39 1.40 3.43 2.90 3.32 3.82 2.62 5.39 1.78
NCF 200g/t 0.65 4.17 1.38 3.21 2.97 3.38 3.57 2.35 5.72 1.84
NCF 400g/t 0.56 3.94 1.58 3.81 2.63 3.04 3.92 2.64 5.05 1.66
NCF 800g/t 0.53 3.53 1.75 3.99 3.17 3.40 3.74 2.53 5.11 1.75
SEM 0.03 0.20 0.06 0.12 0.09 0.09 0.11 0.07 0.15 0.05
p values 0.266 0.358 0.052 0.097 0.265 0.515 0.708 0.522 0.364 0.664
Regression 0.905 0.753 0.021
Q
0.726 0.741 0.790 0.768 0.686 0.505 0.408
Day 28Day 21Day 7 Day 14 Day 42
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4.4.5 Gut Morphology 
The mean weekly jejunum VH, VW, CD and VCR for weeks 1, 3 and 6 for the 4 
diets are shown in Tables 4.14, 4.15 and 4.16 respectively. Significant differences 
were only observed in week 3. Control birds had longer VH than birds fed 400g/t 
NCF and wider VW than birds fed 800g/t NCF. No dose responses to NCF were 
seen when regression analysis were undertaken. 
 
Table 4.14. Effect of NCF on the gut morphology of the jejunum in week 1 (µm) 
   
 
Table 4.15. Effect of NCF on the gut morphology of the jejunum in week 3 (µm) 
  Differing superscript letters within one week denote means are significantly 
different at P < 0.05 
 
Attribute SEM P value Regression
Control NCF 200g/t NCF 400g/t NCF 800g/t P value
Jejunum
Villus Height 1027.6 961.0 885.8 1090.7 50.5 0.537 0.876
Villus Width 185.4 171.6 180.3 188.8 4.9 0.650 0.627
Crypt Depth 127.1 126.1 123.9 140.2 4.0 0.508 0.645
Villus/Crypt Ratio 8.1 7.8 7.2 8.1 0.3 0.635 0.713
Dietary treatment
Attribute SEM P value Regression
P value
Jejunum
Villus Height 2307.1
A
2241.5
AB
2025.0
B
2115.3
AB
36.5 0.017 0.402
Villus Width 238.5
A
216.6
AB
205.9
AB
200.9
B
5.1 0.047 0.052
Crypt Depth 166.4 175.0 170.3 173.7 2.8 0.745 0.845
Villus/Crypt Ratio 12.6 13.3 12.1 13.0 0.3 0.667 0.821
Dietary treatment
Control NCF 200g/t NCF 400g/t NCF 800g/t
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Table 4.16. Effect of NCF on the gut morphology of the jejunum in week 6 (µm) 
  
 
4.4.6 NCF Levels 
Diets were analysed for NCF levels at the Alltech Bioscience Centre in Dunboyne, 
Ireland by an assay determining the amount of NCF in grams per tonne, using the 
control as a comparative base line (method was not supplied due to Patent 
application in process). The first assay results produced unexpected NCF levels in 
the diet, therefore a further two assays were carried one at Dunboyne, Ireland and 
one at The Alltech Bioscience Centre in Lexington, USA. These further assays also 
showed unexpected results that were not consistent as illustrated in Table 4.17. This 
could be due to a number of factors: firstly the assay may not be reliable, secondly 
there is a factor in the feed interacting with the NCF or assay, thirdly there was a 
problem with the NCF and finally the mix of NCF in the feed was not homogenous. 
  
 
 
 
 
Attribute SEM P value Regression
Control NCF 200g/t NCF 400g/t NCF 800g/t P value
Jejunum
Villus Height 2665.2 2641.3 2804.1 2591.3 40.0 0.284 0.514
Villus Width 234.1 241.4 245.1 255.1 4.5 0.417 0.496
Crypt Depth 201.1 197.9 207.3 199.2 7.4 0.974 0.914
Villus/Crypt Ratio 14.1 14.1 14.5 13.4 0.6 0.932 0.793
Dietary treatment
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Table 4.17. Levels of measured NCF in feed 
Attribute 
Supposed levels 
  
NCF 200g/t NCF 400g/t NCF 800g/t 
Assay 1 
      
Starter  
152 434 467 
Grower 
307 247 431 
Finisher 
95 183 349 
Assay 2 
      
Starter  
182 322 734 
Grower 
213 240 389 
Finisher 
65 112 380 
Assay 3 
      
Starter  
218 431 570 
Grower 
488 597 1033 
Finisher 
87 283 745 
 
 
4.4.7 Mortality 
There was no difference between diets in mortality for this study as shown in Table 
4.18.  
 
Table 4.18 Effect of NCF on mortality 
 
 
Attribute P value
Control NCF 200g/t NCF 400g/t NCF 800g/t Total 
Mortality (%) 0.7 0.4 1.1 0.0 2.2 0.780
Dietary treatment
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4.5 DISCUSSION 
Due to the design of Trial 2 (weekly sampling days) it is difficult to draw a 
conclusion from the bird weight data, limiting its commercial application. This is 
due to the requirement to cull birds each week for the sample. Selection of the birds 
occurred randomly to limit the potential to skew the data by choosing either the 
smallest, largest or middle sized birds. Therefore little importance can be placed on 
the body weight or gain, although some significances were found. At 1 day old the 
birds were weighed and placed into pens with other birds within 10g of each other, 
however as the bird uniformity was very good the mean pen weights ranged from 
41.8g to 46.2g, which is commercially regarded as a small range in newly hatched 
chickens. This meant that the small difference of 1.5g between control birds and 
200g/t NCF birds on day 1 showed up as significantly different. Supplementation of 
800g/t NCF significantly increased the weekly body weights on days 21 over control 
and 400g/t NCF. This is supported by the findings of Benites et al. (2008) who 
showed that diets supplemented with MOS significantly increased body weight at 21 
days. However Benites et al. (2008) also found significant differences at 28, 35 and 
42 days, which conflicts with the present study where significant differences after 
day 21 were not observed. The significant difference illustrated between body 
weights of 800g/t and 400g/t NCF fed birds, with 800g/t heavier may be due to 
different mechanisms occurring at varying levels of NCF. This indicates that there 
may be two mechanisms behind the observed response to supplementation; one 
occurring at the lowest/middle inclusion and one occurring at the highest inclusion. 
A possible mechanism that may be having the apparent antagonist effects at the 
middle inclusion level, is an increase in the readiness of the immune system, causing 
a higher energy partition to immune rather than growth.  
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When looking at body weight gain at 21 days, 800g/t NCF increased weight gain 
over 200g/t and 400g/t NCF. This may be due to mechanisms at lower inclusion 
levels causing an increase in energy requirements of the birds, however as explained 
earlier the performance data may not be reliable due to weekly sampling of birds. At 
35 days weight gain had a negative quadratic reponse to increasing NCF, 800g/t had 
lower weight gains than birds on the control. This may be due to 800g/t birds being 
significantly heavier at 21 days and numerically at 28 days than control birds, 
meaning that they were further along their developmental growth curve and therefore 
the rate of bird growth had started to slow in the week up to 35 days (figure 4.1).  
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Figure 4.1 NCF effect on live body weight and weight gain.  
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NCF generally had no effect on FCR throughout Trial 2, which may be due to the 
environment of the birds not being challenging, due to reduced stocking density. 
Dietary raw materials may also contribute a physiological challenge to fast growing 
strains of broiler, so a dietary challenge was implemented to compensate for the 
reduced stocking density. Rye exerts a dietary challenge on broilers through high 
levels of pentosans which result in decreased digestive efficiency and therefore 
increase risk of pathogenic chanllenge to the gut (Antoniou, et al. 1981). However 
the birds grew ahead of breed target and were not affected by rye. Another factor that 
may have contributed to the performance improvements seen between trial 1 and 2 
was the type of litter used. In trial 1 sand was used as standard for this poultry unit 
(to avoid ingestion of litter), but by the second trial standard practice had altered to 
use of wood shavings to improve bird welfare.   
 
One significant difference in FCR was observed in this trial: at 21 days that 200g/t 
increased FCR over control. As 24 FCR significance values were generated for this 
study, it is possible that significant finding is simply a Type 1 Error.  However if this 
result is a true finding, it may be related to an immune response to NCF inclusion. 
One possible mode of action of MOS is to modulate the immune system to aid in 
response to a pathogenic challenge to prevent a negative response in bird 
performance. Therefore, although MOS is commonly cited as leading to an 
improvement in the health and growth performance of the bird (Iji et al. 2001; 
Bozkurt et al. 2009), it would be more correct to state MOS prevents a performance 
deteriation under pathogenic challenge. This outlook on MOS is further supported by 
Briggs et al. (2007); Baurhoo, et al. (2009) and Brummer et al. (2010), found that 
where there was no pathogenic challenge, there was no significant effect of feeding 
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MOS on bird performance. This may be due to MOS stimulating the immune system 
when there is no need, and negatively affecting performance, due to redirection of 
energy from growth to immune response (Huff, et al., 2006). In these situations the 
energy cost associated with immune response results in overall gain to the bird, by 
preventing pathogenic damage to the digestive capacity.  This argument is further 
verified by studies artificially invoking the reverse situation: Nollet, et al. (2007) in 
broilers and Che, et al. (2012) in pigs found improvements in performance when 
feeding MOS over a control when animals were dosed with a pathogenic bateria. 
This shows that the effect of MOS and NCF supplementation on bird performance is 
variable.  
 
Supplements that are thought to work through changing the bacterial load of an 
animal or through up-regulating the immune system, have been observed to have 
variable effects on performance. This may be due to the environment and 
management of the birds ranging from high pathogenic challenge through to a 
moderate to low challenge. Therefore if the pathogenic challenge of the bird alters, 
the effectiveness of feeding a gut health supplement will change. An animal with a 
healthy GI tract, with no pathogenic infection that is fed on a supplement that will 
modify the microflora population or immune defence, will gain little benefit from a 
supplement. This will occur whether it is through an antimicrobial mechanism or a 
pre/probiotic mechanism as no impediment exists to prevent the bird from meeting 
its growth potential. However, the supplement may in fact reduce growth due to the 
partitioning of energy away from growth to the immune system. Therefore the NCF 
effects, as with other supplements on the performance of the bird, appear to be 
stronger if the birds have some level of challenge or stress.  
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NCF at the highest inclusions level was shown to significantly increase cumulative 
feed intake at day 7 and 21. This may mean that NCF is promoting an increase in 
feed intake, which was also numerically higher in Trial 1. An increase in feed intake 
was also illustrated by Morales-Lopez, et al. (2010) in broilers when feeding yeast 
cell wall. However, previous findings observed that feeding MOS does not affect 
feed intake (Zhang, et al., 2005; Midilli, et al., 2008).  
 
These results show that whilst NCF appears not to affect intestine, pancreas or 
pancreas to body weight ratio, it may cause elongation of the jejunum. This was also 
found in a study by Trevifio (1990), who found chicks receiving oligosaccharide 
dried extract had a larger relative length of jejunum, ileum and caeca than those fed 
on the control diet (P< 0.05). However they also found that in general, an increase in 
oligosaccharide content in the diet corresponded to an increase in the length of the 
different intestinal sections. Trial 2 did not find this as the increase in length of the 
jejunum when feeding 800g/t NCF was not significantly longer than the control, only 
in the birds fed 200g/t NCF. Increasing the amount of MOS in the diet may have an 
effect on the amount of SCFA in the intestine available for the epithelial cells to use 
as an energy source. This is due to the fermentation of MOS in the caecal, which 
may result in higher turnover of cells and longer, heavier GI tract (Juskiewicz, et al., 
2003). However several studies found no effect of MOS on the weight or length of 
the intestinal tract (Iji, et al., 2001; Juskiewicz, et al., 2003; Baurhoo, et al., 2007; 
Bozkurk, et al., 2009). The lack of effect of NCF on intestinal length and weight 
may be due to the fact that there was no stocking density challenge on the birds in 
Trial 2, as in Trial 1. However Castillo, et al. (2008) in pigs and Iji, et al. (2001) in 
broilers found no effect of MOS on the intestine gross gut development even with a 
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challenge.  
  
When investigating whether there was a correlation between the birds body weight 
and intestinal lengths and weights, it was seen that there were larger correlations 
between body weight and intestine length and weight when birds were younger. It 
was also observed that the weight of the intestine had larger correlations than length 
of the GI tract. 
 
Table 4.19 Regressions of the correlation between live body weight and intestinal 
lengths and weights. 
 
**means are significantly different at P < 0.01, * means are significantly different at 
P < 0.05 
 
It has been reported previously that growth response in broilers to MOS is age-
dependent with a greater response in younger birds than older ones (Yang, et al., 
2007; Chee, 2008). This is due to earlier maturation of the gut microflora improving 
the integrity of the GI tract of birds. Therefore it could be postulated that birds fed 
NCF will have longer VH and shorter CD via a reduction in sloughing, because 
pathogenic bacteria cannot colonise the GI tract and release toxins. However, if there 
Day
Duodenum Jejunum Ileum Total Panc Duodenum Jejunum Ileum Total
7 0.617** 0.556** 0.605** 0.562** 0.481** 0.525** 0.580** NS 0.726**
14 0.493** 0.593** 0.374* 0.560** 0.535** NS NS NS NS
21 NS 0.543** NS 0.441* 0.485** NS NS NS NS
28 NS 0.437* NS NS NS NS NS NS NS
42 NS 0.350* 0.356* 0.376* NS NS NS NS NS
Weight Length
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are no or little unwanted bacteria in the GI tract, then adding NCF to the bird’s diet 
will have no effect on the gut morphology.  In Trial 2 NCF had little effect on VH or 
CD, which is supported by the findings of White, et al. (2002) in pigs and Yitbarek, 
et al. (2012) and Sohail, et al. (2012) in broilers when feeding MOS. However, 
others have reported that VH is longer with MOS supplementation (Iji, et al., 2001; 
Zhang, et al., 2005; Baurhoo, et al., 2007). When investigating CD, Zhang, et al. 
(2005), Yitbarek, et al. (2012) and Sohail, et al. (2012) found feeding MOS had no 
effect on CD in birds, which was also shown in Trial 2.  
 
There was little effect of NCF inclusion on the birds’ performance, gross gut or 
microscopic development. This may be due to a problem with the NCF in the diet as 
the analysed levels of NCF in the diets produced unexpected results. This 
inconsistency in NCF may be due to a number of factors: the assay may not be 
reliable; there is a factor in the feed interacting with the NCF or assay; there was a 
problem with the NCF; or the mix of NCF in the feed was not homogenous. As 
shown in figure 4.2, the standard deviation of the average Actigen assay results are 
very high, therefore the reliability of data generated from Trial 2 may be 
questionable. Rye was added to the diets in this trial, which may be a factor in the 
diets causing an interaction with the assay causing the unpredicted results. However 
as this assay method is not in the public domain it is difficiult ascertain whether rye 
was considered in the methods validation. 
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Figure 4.2 Average levels of measured NCF in feed with standard deviations. 
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4.6 CONCLUSION 
These data indicate that, while some significant differences between treatments were 
observed, NCF did not show a pronounced effect on bird performance in Trial 2. 
This may be due to the lack of pathogenic challenge or stress on the birds in 
Nottingham Trent University poultry facility. There have been many studies showing 
that MOS improves performance and there are several theories into the mode of 
action of MOS in relation to improved gut health and performance. However, the 
published research appears to be variable with some trials demonstrating that MOS 
has no effect or a negative effect on performance. This may be due to differences in 
the type of MOS product, experimental conditions, diet formulation and health status 
of the birds. Therefore Trial 2 illustrates that the observed variability in the effects of 
MOS in other studies, is also evident when feeding NCF, however, whether this is 
due to product variability or environmental conditions, is still unclear. 
 
 
 
 
 
 
 
136 
 
CHAPTER 5: TRIAL 3 - INVESTIGATION OF THE EFFICACY OF A 
NATURAL CARBOHYDRATE FRACTION (NCF), CALCIUM BUTYRATE, 
SODIUM BUTYRATE AND THEIR COMBINATIONS. 
 
5.1 INTRODUCTION 
This chapter studies the effects of 2 commercial forms of butyrate salts on broiler gut 
health, performance, immune status and digestive enzyme activity, both singly and in 
combination with NCF. Butyrate salts have been reported to have similar effects to 
NCF on gut health and performance. However their modes of action are thought to 
be through different mechanisms. Trial 3 may help to illustrate the mechanisms 
involved when feeding these supplements and demonstrate if their combined 
treatment has a greater effect on the birds, either positive or detrimental. The 
inclusion levels of the butyrate salts in the diets were set by manufacturers’ 
recommendations, however NCF was added at 200g/t, as in previous trials (chapter 3 
and 4) this level showed the greatest effect. This trial was designed to investigate the 
effects in young broilers of NCF compared to another type of feed supplement also 
thought to improve gut health (butyrate salts). This trial used the same diet as trial 1 
as to eliminate any possible effects of rye NCF on activity highlighted in trial 2.  
 
5.2 AIM 
The aim of Trial 3 was to investigate the effect of butyrate addition on efficacy of the 
NCF. Therefore Trial 3 compared the effects of feeding NCF, calcium butyrate (Ca 
But) or sodium butyrate (Na But) alone or using a butyrate salt in addition to NCF 
on bird gut morphology through the trial period at 7, 14, and 21 days post hatch and 
attempted to link microscopic gut development and performance.  
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The hypotheses of this trial was that the butyrates and NCF may have similar effects 
on the bird performance when fed singally, but show incompletely additive response 
when fed in combination, through sharing modes of action. 
 
5.3 MATERIALS AND METHODS 
5.3.1 Bird Husbandry 
A total of 384, one day old male Ross 308 birds from a flock of 35 weeks of age 
were obtained from P.D.Hook Hatcheries Ltd (Cote, Bampton, Oxfordshire, UK). 
They were placed in 48 pens, each containing 8 birds and fed on 1 of 6 dietary 
treatments. The diets were allocated using a stratified random allocation. There were 
6 dietary treatments with 8 replicates for each treatment, made up of 8 small floor 
pens (area = 0.43m2). The litter provided was wood shavings on a concrete floor at a 
depth of 6cm, which was topped up if necessary to maintain adequate environmental 
welfare 
 
5.3.2 Experimental Diets 
Trial 3 lasted 21 days with a 2 phase feeding programme: starter diets were fed from 
1 to 14 days and grower diets from 15 to 21 days. The 6 dietary treatments are shown 
in table 5.1 and were: 1) control diet, 2) NCF (Actigen), 3) Ca But (Globamax 
performant), 4) Na But (Adimix 30 Coated) 5) Ca But plus NCF and 6) Na But plus 
NCF. The rations were based on the nutritional requirements for the strain of bird (as 
defined by Aviagen) and contained no pentosan degrading enzymes in order to 
provide some digestive challenge. The formulations were checked by an independent 
nutritionist to ensure accuracy. The basal diet was formulated by Target feeds (the 
basal diet details are given in Table 5.2) and made at Nottingham Trent University. 
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Table 5.1 Inclusion levels of the dietary treatments 
Dietary Treatment Supplement inclusion level 
 Starter period Grower period 
Control  None None 
NCF 200g/t NCF 200g/t NCF 
Ca But 300g/t Ca But 300g/t Ca But 
Na But 1000g/t Na But 750g/t Na But 
NCF/Ca But 200g/t NCF+300g/t Ca But 200g/t NCF+300g/t Ca But 
NCF/Na But 200g/t NCF+1000g/t Na But 200g/t NCF+750g/t Na But 
 
5.3.3 Determined Parameters 
Bird weight and feed intakes per pen were recorded weekly. The FCR was calculated 
using this information on a weekly basis and for each phase. On days 7, 14 and 21, 
two birds per pen were selected and slaughtered. The whole intestine from one of the 
birds was removed. The length and weight of the separate parts of the intestinal tract 
were measured as described in Chapter 2. A blood sample was taken from the heart 
of the second bird using a 10ml syringe, its serum was collected and frozen at -20oC 
for later analysis. The second bird was then dissected to remove the small intestine 
tissue sections from the duodenum and jejunum for detailed intestinal and general 
intestinal structure examination. Tissue samples from the duodenum and jejunum 
were fixed in Bouins solution prior to histological procedures, including staining 
with Periodic Acid Schiff’s and Alcian Blue (pH 2.5), as described in chapter 2. In 
addition, tissue samples were taken and snap frozen in dry ice and industrial 
methylated spirits and stored at -80oC for later analysis of digestive and immune 
markers. An extra bird per pen was culled on day 21 for digesta pH measurements of 
the gizzard, duodenum, jejunum, ileum and caeca. 
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Table 5.2. Composition of basal diet and calculated analysis of the basal diet 
Item  Starter Grower 
Ingredients (%) 
  Barley 10.61 8.46 
Wheat 50.00 55.00 
Soybean meal, 48% CP 26.00 23.00 
Full fat soybean meal 5.00 5.00 
L lysine HCL 0.31 0.26 
DL methionine 0.38 0.35 
L threonine 0.14 0.13 
Soya oil 4.00 4.50 
Limestone 1.25 1.25 
Monocalcium phosphate 1.50 1.25 
Salt 0.25 0.25 
Sodium bicarbonate 0.15 0.15 
Premix* 0.25 0.25 
Calculated analysis 
  ME MJ/kg 12.78 13.04 
CP% 21.75 20.59 
Lys % 1.37 1.25 
Met + Cys % 1.01 0.95 
Ca 0.96 0.90 
Available P 0.48 0.42 
*Premix content (volume/kg diet): Mn 100mg, Zn 80mg, Fe 20mg, Cu 10mg, I 1mg, 
Mb 0.48mg, Se 0.2mg, Retinol 13.5mg,Cholecalciferol, 3mg, Tocopherol 25mg, 
Menadione 5.0mg, Thiamine 3mg, Riboflavin 10.0mg, Pantothenic acid 15mg, 
Pyroxidine 3.0mg, Niacin 60mg, Cobalamin 30µg, Folic acid 1.5mg, Biotin 125mg 
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5.3.4 Data Analysis 
All data were analysed using a incomplete 3 way ANOVA using JMP software for 
Windows. One pen was used as a unit for analysis. Treatment means were separated 
using the Tukeys post hoc test, and statistical significance was declared at P < 0.05. 
 
5.4 RESULTS 
5.4.1 Body Weight and Live Weight Gain 
Whilst body weight and live weight gain were recorded, the pen size (80x80cm) and 
weekly reduction in stocking density limit the relevance of this data.  The mean 
weekly live body weights per bird for the 6 diets over the 3 weeks are shown in 
Table 5.3. The most notable effect in performance was observed at 21 days when 
feeding Na But, where an abormally low body weight was achieved. Additionally, an 
interaction response between NCF and Na But was observed at 21 days, which 
indicates that feeding NCF and Na But together improved body weight over NCF 
and Na But fed individually. Little difference was seen between dietary treatments 
other than the weekly body weigh on days 21. On day 21, it was shown that the birds 
fed Na But were significantly lighter than birds fed any diet containing NCF 
(P=0.001). 
Table 5.3. Effect of dietary treatment in broiler diets on the mean weekly body 
weight (g/bird) 
Differing superscripts within a week denote means are significantly different P< 0.05. 
Attribute Age SEM P value
NCF*Ca B NCF*Na B
Body 1 35.8 36.1 36.5 36.9 36.4 37.4 0.25 0.412 0.928 0.755
weight (g) 7 127.3 123.3 122.2 129.6 131.7 129.3 1.71 0.570 0.120 0.663
14 373.9 388.8 370.0 408.0 378.8 386.4 4.39 0.178 0.808 0.423
21 761.1
AB
782.8
A
766.9
AB
660.3
B
774.4
A
832.6
A
12.24 0.001 0.787 0.004
InteractionDietary treatment
Control NCF 200g/t Ca But Na But NCF/Ca NCF/Na
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The mean weekly live weight gained per bird for the 6 diets over the 6 weeks are 
given in Table 4. There was interactions seen when NCF and Na But were fed in 
combination between 15-21 days and 0-21 days, which indicates that feeding NCF 
and Na But together improved body weight gain over NCF and Na But fed 
individually. As with live body weight, there were minimal significant differences 
between treatments, other than the mean live weight gain per bird on day 21 and over 
the whole trial period. On day 21, Na But had a lower weight gain over all the other 
diets (P=0.001), this was also seen over the whole trial period. 
 
Table 5.4. Effect of dietary treatment in broiler diets on the mean weekly live weight 
gain (g/bird) 
  Differing superscript letters within one week denote means are significantly 
different at P < 0.05 
 
5.4.2 Feed Intake 
The mean weekly feed intakes per bird for the 6 diets over the 6 weeks are shown in 
Table 5.5. In a similar pattern to that seen for other performance parameters, there 
was an interaction seen when NCF and Na But were fed in combination between 15-
21 days, which indicates that feeding NCF and Na But together increased feed intake 
over NCF and Na But fed individually. Feed intake was generally not affected by 
dietary treatments other than on day 21 where birds fed Na But had a significantly 
Attribute Age SEM P value
NCF*Ca B NCF*Na B
Weight 1-7 90.5 86.1 85.0 91.9 94.3 91.8 1.68 0.575 0.103 0.756
gain (g) 8-14 245.1 263.7 248.9 274.2 247.1 255.0 3.88 0.242 0.298 0.474
15-21 381.9
A
428.9
A
423.2
A
277.0
B
414.7
A
443.8
A
10.41 0.000 0.937 0.002
1-21 724.3
AB
745.7
A
729.7
A
622.6
B
737.0
A
794.8
A
12.24 0.001 0.792 0.006
InteractionDietary treatment
Control NCF 200g/t Ca But Na But NCF/Ca BNCF/Na B
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lower feed intake than birds fed NCF or NCF/Na But. 
 
Table 5.5. Effect of dietary treatment in broiler diets on the mean weekly feed intake  
 Differing superscript letters within one week denote means are significantly 
different at P < 0.05 
 
5.4.3 Feed Conversion Ratio 
The mean weekly FCRs per bird for the 6 diets over the 6 weeks are shown in table 
5.6. The mean weekly FCR per bird between diets showed that there were no effects 
of dietary treatment in the first two weeks, however there were significant 
differences between dietary treatments on day 21 and over the whole 3 week trial 
period. There was interactions seen when NCF and Na But were fed in combination, 
which indicates that feeding NCF and Na But together improved FCR over NCF and 
Na But fed individually at 15-21 days and over Na But between 0-21 days. In the 
third week it was shown that birds fed Na But had significantly increased FCR over 
the other treatment groups (P=0.001), and over the whole trial period birds fed Na 
But had significantly increased FCR over NCF, Ca But and Na But treatment groups 
(P=0.001). 
 
 
 
Attribute Age SEM P value
NCF*Ca B NCF*Na B
Feed 1-7 104.0 98.7 102.9 106.5 118.0 107.7 2.17 0.179 0.054 0.531
intake (g) 8-14 322.8 329.3 317.6 337.7 330.9 337.8 3.50 0.504 0.895 0.402
15-21 609.9
AB
635.4
A
615.6
AB
535.9
B
609.7
AB
655.5
A
9.74 0.007 0.878 0.034
1-21 825.2 830.0 860.2 810.2 894.7 889.1 12.76 0.275 0.631 0.235
InteractionDietary treatment
Control NCF 200g/t Ca But Na But NCF/Ca B NCF/Na B
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Table 5.6 Effect of dietary treatment in broiler diets on the weekly FCR. 
Differing superscript letters within one week denote means are significantly different 
at P < 0.05 
 
 5.4.4 Intestinal Weight and Length 
The mean weekly intestinal weight and lengths and pancreas weights for the 6 diets 
on day 7, 14 and 21 are shown in tables 5.7, 5.8 and 5.9 respectively. There were 
interactions observed at 7 days between NCF and Ca But, as the trend toward 
significant improvement in both duodenal weight and DWBWR observed with Ca 
But supplementation is lost when fed in combination with NCF. On day 7 birds fed 
solely Ca But supplement had significantly heavier jejuna than birds fed NCF 
(P=0.039). Also on day 7 birds fed the control diet and the Na But/NCF diet had 
lighter mean PBWR than birds fed diets just containing Ca But or Na But (P = 
0.001). On day 14 there were no significant differences between diets on intestinal 
weights or lengths. There were interactions observed at 21 days between NCF and 
Ca But, where numerical decreases compared to control in ileum and total intestinal 
length observed when feeding NCF but not Ca But alone, were also observed when 
feeding Ca But and NCF together. A second interation was also observed at 21 days 
between NCF and Na But; Na But increased the pancrease weight relative to body 
weight, but this effect was not seen when fed in combination with NCF.  On day 21 
birds fed Na But had significantly longer DLBWR than birds fed NCF, Na But and 
Attribute Age SEM P value
NCF*Ca B NCF*Na B
FCR 1-7 1.15 1.16 1.22 1.16 1.25 1.17 0.01 <0.053 0.161 0.669
8-14 1.34 1.31 1.33 1.34 1.34 1.32 0.01 <0.901 0.263 0.453
15-21 1.56
B
1.49
B
1.49
B
1.95
A
1.46
B
1.39
B
0.03 <0.001 0.420 0.001
1-21 1.21
AB
1.11
B
1.18
B
1.30
A
1.22
AB
1.13
B
0.01 <0.001 0.070 0.006
InteractionDietary treatment
Control NCF 200g/t Ca But Na But NCF/Ca B NCF/Na B
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Ca But/Act. Ca But fed birds also had significantly shorter DLBWR than control 
birds (P=0.006). Also on day 21 JLBWR was significantly different between 
treatments; birds fed Na But had a longer jejunum than birds fed NCF, Ca But/Act 
and Na But/Act. Birds fed Na But similarly had a significantly longer ILBWR than 
other treatment groups. Birds at 21 days fed Na But and the control diet had heavier 
PBWR than birds fed Ca But/Act or Na But/Act. However effects of Na But at 21 
days on gross gut morphology may be unreliable due to the unusual growth 
performance which suggested that the Na But diet composition may be incorrectly 
manufactured. However feed samples could not be analysed for composition due to 
samples getting wet during storage, causing mould growth.   
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Table 5.7 Effect of dietary treatment in broiler diets on the length and weight of the intestine and pancreas development at 7 days 
 
Weight (g), Length (cm), DWBWR = grams of duodenum tissue per 100g bird body weight, DLBWR = centimetre of duodenum tissue per 100g 
bird body weight, JWBWR = grams of jejunum tissue per 100g bird body weight, JLBWR = centimetre of jejunum tissue per 100g bird body 
weight, IWBWR = grams of ileum tissue per 100g bird body weight, ILBWR = centimetre of ileum tissue per 100g bird body weight, PBWR = 
grams of pancreas tissue per 100g bird body weight. Differing superscript letters denote means are significantly different at P < 0.05 
Diet Weight Length DWBWR DLBWR Length JWBWR JLBWR Weight Length IWBWR ILBWR Weight Length Weight
Control 1.40 14.7 1.21 11.91 2.93
AB
32.9 2.46 26.26 2.06 33.0 1.65 27.20 6.35 81.5 0.50 3.9
B
200g/t NCF 1.67 14.5 1.32 12.33 2.90
B
32.3 2.36 27.23 1.80 30.5 1.44 26.83 6.37 78.6 0.54 4.4
AB
Ca But 1.97 15.3 1.49 12.15 3.42
AB
32.3 2.68 25.82 2.16 33.2 1.67 25.74 7.93 81.7 0.62 5.0
A
So But 1.79 15.8 1.35 11.88 3.18
AB
33.8 2.61 26.46 2.11 32.0 1.62 25.15 7.31 81.5 0.61 5.0
A
NCF/Ca But 1.65 15.2 1.23 11.31 4.00
A
33.3 2.82 25.59 2.26 34.0 1.67 25.58 8.03 83.3 0.54 3.8
B
NCF/Na But 1.54 13.7 1.46 12.46 3.10
AB
33.7 2.76 29.63 1.71 31.5 1.52 28.39 6.59 78.1 0.53 4.7
AB
SEM 0.06 0.24 0.03 0.28 0.46 0.06 0.54 0.07 0.49 0.04 0.59 0.23 0.90 0.02
P value 0.075 0.209 0.090 0.890 0.905 0.234 0.285 0.226 0.355 0.628 0.627 0.087 0.530 0.195
NCF*Ca B 0.597 0.212 0.031 0.417 0.191 0.340 0.566 0.252 0.180 0.209 0.552 0.510 0.276 0.193 0.826
NCF*Na B 0.685 0.365 0.929 0.906 0.644 0.735 0.934 0.750 0.783 0.522 0.369 0.359 0.629 0.563 0.470
0.112
0.854
Total PancreasIleumJejunumDuodenum
0.11
0.039
Weight
0.11
0.001
PBWR
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Table 5.8 Effect of dietary treatment in broiler diets on the length and weight of the intestine and pancreas development at 14 days 
  
Weight (g), Length (cm), DWBWR = grams of duodenum tissue per 100g bird body weight, DLBWR = centimetre of duodenum tissue per 100g 
bird body weight, JWBWR = grams of jejunum tissue per 100g bird body weight, JLBWR = centimetre of jejunum tissue per 100g bird body 
weight, IWBWR = grams of ileum tissue per 100g bird body weight, ILBWR = centimetre of ileum tissue per 100g bird body weight, PBWR = 
grams of pancreas tissue per 100g bird body weight. Differing superscript letters denote means are significantly different at P < 0.05 
Diet Weight Length DWBWR DLBWR Weight Length JWBWR JLBWR Weight IWBWR ILBWR Weight Length Weight PBWR
Control 4.89 20.1 1.31 5.41 8.96 45.5 2.41 12.23 5.96 44.3
C
1.61 11.74 19.81 108.6 1.41 3.8
200g/t NCF 4.65 19.6 1.21 5.13 9.20 47.7 2.38 12.81 5.87 47.6
ABC
1.53 12.70 19.72 113.1 1.49 3.9
Ca But 4.55 20.9 1.19 5.72 8.06 49.0 2.35 12.82 5.77 47.8
AB
1.61 13.00 18.37 118.3 1.73 4.6
So But 4.18 20.0 1.19 5.18 9.30 47.1 2.42 11.62 6.04 49.0
AB
1.56 12.14 19.90 116.1 1.60 4.1
NCF/Ca But 4.68 19.5 1.24 5.17 8.67 45.0 2.45 11.87 6.37 45.7
BC
1.69 12.10 20.36 110.2 1.54 4.1
NCF/Na But 4.79 20.6 1.23 5.34 9.40 47.5 2.43 12.31 6.83 49.8
A
1.77 12.77 21.02 119.2 1.76 4.5
SEM 0.12 0.29 0.03 0.11 0.31 0.62 0.07 0.20 0.17 0.05 0.17 0.55 1.22 0.05 0.12
P value 0.675 0.719 0.914 0.636 0.841 0.463 0.999 0.439 0.468 0.683 0.233 0.849 0.060 0.121 0.155
NCF*Ca B 0.734 0.743 0.560 0.874 0.816 0.212 0.634 0.477 0.999 0.840 0.888 0.830 0.502 0.685 0.685
NCF*Na B 0.608 0.213 0.394 0.170 0.558 0.787 0.758 0.710 0.802 0.532 0.609 0.885 0.844 0.799 0.885
0.992
0.908
PancreasDuodenum Jejunum Ileum Total 
Length
0.51
0.015
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Table 5.9 Effect of dietary treatment in broiler diets on the length and weight of the intestine and pancreas development at 21 days 
 
Weight (g), Length (cm), DWBWR = grams of duodenum tissue per 100g bird body weight, DLBWR = centimetre of duodenum tissue per 100g 
bird body weight, JWBWR = grams of jejunum tissue per 100g bird body weight, JLBWR = centimetre of jejunum tissue per 100g bird body 
weight, IWBWR = grams of ileum tissue per 100g bird body weight, ILBWR = centimetre of ileum tissue per 100g bird body weight, PBWR = 
grams of pancreas tissue per 100g bird body weight. Differing superscript letters denote means are significantly different at P < 0.05
Diet Weight Length DWBWR Weight Length JWBWR Weight Length IWBWR Weight Length Weight
Control 7.64 25.0 1.02 3.33
AB
15.30 56.8 2.05 7.57
AB
12.09 60.1 1.61 7.63
B
35.03 141.9 2.77 3.6
AB
200g/t NCF 6.91 25.4 0.89 3.18
BC
14.72 54.2 1.89 6.99
B
11.33 55.8 1.45 7.17
B
32.95 134.7 2.42 3.1
BC
Ca But 7.53 25.1 1.05 3.31
ABC
16.88 59.0 2.25 7.80
AB
12.52 60.3 1.75 7.51
B
36.29 144.4 2.29 3.0
BC
Na But 7.49 25.3 1.16 3.69
A
15.10 57.0 2.32 8.71
A
10.55 58.0 1.62 8.87
A
33.13 140.2 2.58 3.9
A
NCF/Ca But 6.79 23.4 0.88 2.89
C
14.45 55.1 1.87 6.98
B
10.52 56.1 1.48 7.25
B
31.93 133.4 2.23 2.9
C
NCF/Na But 7.77 24.9 0.93 3.05
BC
15.26 57.0 1.82 6.83
B
11.71 59.2 1.41 7.08
B
34.73 141.0 2.39 2.8
C
SEM 0.19 0.29 0.03 0.30 0.77 0.06 0.24 0.82 0.05 0.58 1.56 0.05
P value 0.580 0.443 0.138 0.266 0.594 0.067 0.082 0.467 0.285 0.311 0.280 0.057
NCF*Ca B 0.996 0.745 0.269 0.884 0.994 0.274 0.573 0.046 0.506 0.088 0.898 0.049 0.173
NCF*Na B 0.086 0.504 0.492 0.634 0.131 0.942 0.077 0.642 0.343 0.689 0.167 0.860 0.412
0.983
0.021
0.142
0.594
0.161
0.948
Duodenum Jejunum Ileum Total 
DLBWR
0.06
0.006
PBWR
0.10
0.002
Pancreas
0.18
0.019
JLBWR ILBWR
0.16
0.005
148 
 
5.4.5 Gut Morphology 
The mean jejunum VH, VW, CD and VCR for weeks 1 for the 6 diets are shown in 
table 5.10. There were no interactions seen when NCF and Na But or Ca But were 
fed in combination. No significant differences were observed between dietary 
treatments, however there was a trend for NCF/Ca But to have higher VCR 
(P=0.068). The mean jejunum VH, VW, CD and VCR for weeks 2 and 3 for the 6 
diets are shown in table 5.11 and 5.12, which shows no significant differences 
between dietary treatments. 
 
Table 5.10. Effect of NCF on the gut morphology of the jejunum in week 1 (µm) 
 
 
Table 5.11. Effect of NCF on the gut morphology of the jejunum in week 2 (µm) 
 
 
 
 
Attribute SEM P value
Control NCF 200g/t Ca But Na But NCF/Ca But NCF/Na But NCF*Ca B NCF*Na B
Jejunum
Villus Height 725.3 814.4 795.0 774.4 885.4 788.0 23.3 0.533 0.614 0.205
Villus Width 183.2 172.9 176.8 181.6 174.8 182.1 2.9 0.881 0.467 0.354
Crypt Depth 125.1 129.3 136.8 135.4 130.2 126.1 1.9 0.398 0.203 0.338
VCR 5.9 5.6 5.9 5.9 6.9 6.1 0.12 0.063 0.902 0.366
Dietary treatment Interaction
Attribute SEM P value
Control NCF 200g/t Ca But Na But NCF/Ca But NCF/Na But NCF*Ca B NCF*Na B
Jejunum
Villus Height 1187.2 1305.0 1158.2 1263.2 1221.3 1201.9 32.8 0.830 0.694 0.200
Villus Width 204.0 218.2 190.6 209.8 192.1 212.2 4.0 0.245 0.405 0.403
Crypt Depth 155.6 172.4 168.4 167.6 161.5 171.0 3.4 0.743 0.140 0.421
VCR 7.8 7.7 7.0 7.6 7.8 7.2 0.12 0.357 0.240 0.395
Dietary treatment Interaction
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Table 5.12. Effect of NCF on the gut morphology of the jejunum in week 3 (µm) 
 
 
5.4.6 Goblet cells 
Investigation of goblet cell number and area in the jejunum (table 5.13), revealed 
that there were no interactions seen when NCF and Na But or Ca But were fed in 
combination, and that diets including supplements did not significantly affect goblet 
cell area, goblet cell number per 165μm of villi or goblet cell measurements as a 
ratio. However in the jejunum calcium butyrate tended (P<0.1) to increased goblet 
cell area per 165μm of villus over the NCF/Na But treatment group. 
 
Table 5.13. Effect of NCF on the goblet cells of the jejunum in week 1 (µm2) 
 
GC= Goblet cell 
 
5.4.7 Intestinal pH 
The mean intestinal pH per bird for the 6 diets at 21 days is shown in Table 5.14, 
Attribute SEM P value
Control NCF 200g/t Ca But Na But NCF/Ca But NCF/Na But NCF*Ca B NCF*Na B
Jejunum
Villus Height 1346.3 1302.6 1453.0 1396.4 1375.6 1348.6 25.4 0.660 0.793 0.597
Villus Width 261.6 245.4 243.5 227.4 236.9 234.8 4.4 0.301 0.686 0.321
Crypt Depth 162.3 150.4 159.2 171.7 153.2 155.7 2.9 0.331 0.114 0.829
VCR 8.5 8.9 9.1 8.5 8.8 9.0 0.18 0.888 0.204 0.880
Dietary treatment Interaction
Atribute SEM P value
Control NCF Ca But Na But NCF/Ca B NCF/ Na B NCF*Ca B NCF*Na B
Jejunum
GC Area (µm
2
) 75.5 73.4 81.4 80.9 76.7 62.5 2.1 0.108 0.332 0.596
N
o
 of GC per 165µm 12.7 14.1 15.0 12.5 13.9 13.5 0.3 0.154 0.058 0.724
GC Area per 165µm 949.0 1031.7 1193.0 980.6 1038.6 834.8 34.8 0.072 0.568 0.607
Dietary treatment Interaction
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which shows that there were no interations or significant effect of dietary treatment 
on the pH of the separate parts of the intestine. 
 
Table 5.14. Effect of dietary treatment on the intestinal pH. 
  
5.4.8 Mortality 
There was no difference between diet treatments in mortality for this study, shown in 
Table 5.15.  
Table 5.15. Effect of dietary treatment on mortality 
  
5.5 DISCUSSION 
Performance parameters, in general were not affected by dietary treatment. The only 
significant performance effects seen between diets were on day 21, where Na But 
substantially decreased body weight, weight gain, feed intake and increased FCR 
over some or all of the other diets. At this time point it was also recorded that there 
was an interaction when feeding NCF and Na But, which showed an increased body 
weight, weight gain, feed intake and improved FCR over NCF and Na But fed 
separately. This could be due to a negative effect of Na But on the bird, but this 
degree of negative response seems unlikely in a licenced feed product, and is more 
Tissue SEM P value
Control NCF Ca But Na But NCF/Ca But NCF/Na But NCF*Ca B NCF*Na B
Gizzard 2.70 2.70 2.52 2.56 2.66 2.66 0.105 0.996 0.829 0.871
Duodenum 6.06 6.11 5.97 6.06 6.00 6.08 0.033 0.417 0.289 0.261
Jejunum 6.03 5.93 5.99 5.96 6.03 5.93 0.021 0.611 0.615 0.835
Ileum 6.80 6.87 6.98 6.94 6.59 6.91 0.077 0.733 0.359 0.604
Caeca 5.87 5.58 5.74 5.77 5.70 5.50 0.052 0.372 0.144 0.342
Dietary treatment Interaction
Attribute
Control NCF 200g/t Ca But Na But NCF/Ca But NCF/Na But Total 
Mortality (%) 1.8 1.3 0.5 1.3 0.0 0.8 5.7
Dietary treatment
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likely due to a diet manufacturing fault resulting in the grower diet of birds fed Na 
But being deficient in some way. The lack of treatment differentiation in terms of 
performance effects in the starter phase of Trial 3 may be due to the lack of 
challenge on the birds. This is in agreement with other studies in chickens (Leeson, 
et al., 2005; Zhang, et al., 2011b; Czerwinski et al 2012) and Piglets (Biagi, et al., 
2007; Tonel, et al., 2010), that demonstrated no effect on performance from either 
sodium butyrate, calcium butyrate or butyric acid when there were no challenges 
placed on the animal. When a challenge was present in other studies improvements 
in growth parameters were reported in piglets (Piva, et al., 2002; Manzanilla, et al., 
2006; Le Gall, et al., 2009) and broilers (Leeson, et al., 2005; Zhang, et al., 2011; 
Zhang, et al., 2011b) by feeding sodium butyrate. It is thought that sodium or 
calcium butyrate may have a growth promoting effects through providing energy for 
the epithelium and altering antimicrobial activity. Conversely, performance 
improvements have been observed in one study where broilers were fed sodium 
butyrate without any recorded challenge (Smulikoska, et al., 2009). In further 
contradiction, Hu and Gao (2007) reported that feeding butyrate to unchallenged 
broilers negatively affected FCR, which may explain the effects seen when feeding 
Na But at 21 days. These studies show that the growth promoting effects of butyrate 
salts are inconsistent, probably due to variability in the type of environment and 
management conditions of the trials. 
 
It is possible that the growth inhibiting effect of high pathogen burden associated 
with a poor environment is mitigated by butyrate usage. This suggests that broilers 
reared in a low pathogen environment do not have ‘promoted’ growth due to 
butyrate supplementation, because the animals already have a high health status and 
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are therefore performing at optimum growth rate. When butyrate is not protected by 
a fat coating it is readily taken up by the GI tract epithelium, where it is metabolised 
for energy though the TCA cycle. This means that the host animal can gain a 
substantial supply of energy from butyrate (Lawhon, et al., 2002; Guilloteau, et al., 
2010), which may lead to increased proliferation of intestinal cells (Kripke, et al., 
1989; Friedel and Levine, 1992). Therefore the negative performance effects 
observed when feeding Na But up to 21 days may in part be due to an increase in the 
maintenance needs of the GI tract from increased proliferation of intestinal cells. 
However, this is unlikely to be the main cause of the negative performance effects, 
as the negative effect seen was abnormally large and may be due to problems with 
the feed. 
 
Investigation of gross gut morphology showed showed little effect overall, however  
there were interactions observed at 7 days between NCF and Ca But, as the trend 
toward significant improvement in both duodenal weight and DWBWR observed 
with Ca But supplementation is lost when fed in combination with NCF. The 
improvement observed when feeding Ca But alone may be due increased 
proliferation of duodenal epithelium cells in response to additional energy supplied 
via butyrate ions (Jozefiak et al., 2004). The contrasting decrease in weight observed 
when feeding Ca But in combitation with NCF may be due to diversion of this 
energy from epithelial proliferation to upregulation of immune system (Spring et al., 
2000).  
 
Additionally, on day 7 birds fed the control diet and the Na But/NCF diet had lighter 
mean PBWR than birds fed diets just containing Ca But or Na But. This may mean 
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that Ca But and Na But have a greater ability to produce pancreatic enzymes than 
control birds or Na But/NCF. On day 14 there were no significant differences 
between treatments on gross gut morphology. However on day 21 birds fed Na But 
had significantly longer DLBWR, jejunum and ILBWR than some or all other 
treatment groups. This increase in intestinal length could be due to the birds fed Na 
But diverting too much energy in to development of the intestinal tract rather that 
carcass growth, as growth performance was negatively affected in the same birds. 
However this may also be due to a problem with the diet, meaning that the birds 
have compensated by increased the length of their intestine to try increase their 
ability to absorb nutrients. PBWR at 21 days was heavier in birds fed Na But and the 
control than birds fed Ca But/NCF or Na But/NCF, this may be due to the birds fed 
Ca But/Act or Na But/Act having heavier body weight. Also at 21 days Ca But fed 
birds had significantly shorter DLBWR than control birds. When examining this 
body of evidence as a whole, no consistent pattern of effect emerged. The few 
significant differences recorded may be due to type 1 errors, which would be 
expected when examining so many parameters.  
 
As there were no clear treatment patterns in the gross gut development, data from all 
diets was pooled to examining the relationship between body weight and organ 
development over the first three weeks post hatch (table 5.15). When investigating 
whether there was a relationship between the bird body weight and intestinal lengths 
and weights, it was seen that there were stronger correlations between body weight 
and intestine length and weight when birds were younger. It was also seen that the 
weight of the intestine had stronger correlations to body weight than length of the 
intestine, as seen in Trial 2. Similarly, pancreas weight to body weight ratio was also 
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significantly correlated at day 7 and 14 but not at day 21.  
 
Table 5.15 Regressions of the correlation between live body weight and intestinal 
length and weight. 
**means are significantly different at P < 0.01, * means are significantly different at 
P < 0.05 
 
Microscopic gut morphology at day 7 revealed no significant differences between 
treatments, however a trend (P = 0.058) was seen when expressing villus height and 
crypt depth as a ratio, VCR. NCF/Ca But birds tended to have higher VCR than birds 
fed NCF, suggesting that NCF/Ca But have better gut health, as higher VCR 
indicates longer villi and shallower crypts. This indicates improved gut health, as 
longer villi are considered to indicate that the bird will have a better ability to absorb 
nutrients, due to the increased surface area (Gao, et al., 2008). Conversely, deeper 
CDs are considered a negative indication of gut health because, to compensate for 
villi atrophy, the bird has to increase rate of tissue turn over.  As epithelial cells are 
produced in the crypts and migrate along the villi to the tip, it is thought that the 
higher turnover in the crypt cell causes it to become deeper (Gao, et al., 2008). A 
higher VCR of birds fed NCF/Ca But may be a result of Ca But providing extra 
energy to the epithelium cells of the jejunum, thus allowing them to proliferate and 
increase their VCR, in combination with NCF decreasing the pathogenic load of the 
birds and therefore reducing presence of toxic products. Smulikowska et al. (2009) 
Day
Duodenum Jejunum Ileum Total Panc Duodenum Jejunum Ileum Total
7 0.591** 0.719** 0.606** 0.664** 0.634** 0.350* 0.529** 0.280 0.351*
14 0.137 0.236 0.130 0.209 0.301* -0.141 -0.180 0.001 0.057
21 -0.130 -0.080 0.008 -0.076 -0.030 -0.090 -0.140 -0.024 -0.101
Weight Length
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also found no significant effect of feeding sodium butyrate on the microscopic gut 
morphology of 8 day old broilers. However they did not measure VCR, but did see a 
numerical increase in VH and decreases in CD, which may have resulted in a higher 
VCR as seen numerically in this trial. 
 
Mean jejunum VH, VW, CD and VCR at week 2 and 3 for the 6 diets showed no 
significant differences. Leeson et al. (2005) at 21 day and Czerwinski et al. (2012) at 
30 day in broilers and Tonel et al. (2010) at 56 day in piglets supports this finding, as 
these authors also found no effect of butyrate on gut morphology. However, 
Manzanilla et al. (2006) reported an increased jejunum crypt depth (CD) in piglets 
and Hu and Guo (2007) at 21 days found an improved VCR when feeding sodium 
butyrate to broilers. In common with mannan oligosaccharides and other feed 
supplements, feeding butyrate seems to have variable effects on gut health 
parameters. Positive effects of butyrate on gut health may be through butyrate 
decreasing pathogenic load and therefore harmful toxins, and/or increasing energy 
available to the epithelial cells (Sunkara et al., 2011). A lack of butyrate present in 
the GI tract, whether from the diet or bacterial fermentation, can lead to nutritional 
deficiencies of the epithelium and result in atrophy (Hamer, et al., 2008).  As with 
additives, such as MOS, the variability reported in gut morphology when feeding 
butyrate may be due to differences in environmental and health statuses of the birds. 
Butyrate may only have an effect when the bird is not meeting its optimum 
performance due to some level of challenge. In the present trial there was no 
environmental challenge applied to the birds, and hence no impairment to gut 
development, which may be the reason why no effects were observed at 21 days of 
dietary treatment on the microscopic gut morphology. 
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When investigating the effects of the supplements on goblet cells it was seen that 
there were no significant differences between diets, however there was a trend 
demonstrated when investigating the goblet cell area per 165μm of villus. It was seen 
numerically that both Ca But and NCF/Ca But treatment groups increased goblet cell 
area per 165μm of villus over Na But and NCF/Na But. This suggests that calcium 
butyrate is having a larger effect on the bird than sodium butyrate. This may be due 
to calcium butyrate containing a different level of butyric acid, calcium butyrate is 
bound to two butyric acids whereas sodium is bound to one. This suggested increase 
in goblet cell area per 165μm of villus may mean that there is an increased storage 
and production of mucin, which may be considered an improvement in bird health. 
Mucin is essential for a number of brush border processes, including facilitating 
absorption of nutrients, containing enzymes, lubrication and decreasing the binding 
and colonisation of pathogenic bacteria to the intestine (Blomberg, et al., 1993; 
Smirnov, et al., 2004). Therefore an increase in the level of mucin could have a 
beneficial effect on the first line of defense of the immune system (Baurhoo, et al., 
2009) and the absorptive function of the gut. In contrast, overproduction of mucin 
may result in a negative effect, by increasing the mucus thickness on the GI tract 
wall to a level that might impair the ability of nutrients to pass through to the gut 
epithelial to be absorbed (Smirnov, et al., 2004; Brummer, et al., 2010), as well as 
increasing the energy partitioned away from tissue growth to mucin production.  
 
In this trial, there were no significant differences between diets when investigating 
the number and area of goblet cells in the jejunum at 7 days, only a trend. This 
would suggest that the supplements had only a small or no effect on the mucin 
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profile of broilers in the jejunum in this study, which links to the lack of 
performance effect seen. This absence of response was also reported by Castillo, et 
al. (2008) and Yitbarek, et al. (2012), however Baurhoo, et al. (2007; 2009); Chee, et 
al. (2010); Morales-lopez, et al. (2010) and Muthusamy, et al. (2012) all found 
goblet cell numbers were increased by yeast cell wall product supplementation. To 
the authors knowledge there is no published studies on the effects of butyrate salts 
on goblet cells in broilers, however it has been seen in one paper that sodium 
butyrate had no effect on goblet cell number in pigs (Manzanilla et al., 2006). In 
contrast to this Nahrling et al (2010) reported that butyrate in piglets increased 
MUC2 expression, which is key in mucin production. The lack of data in this area 
makes it difficult to drawn conclusion, however it suggests that butyrate may be 
affecting mucin production. 
 
Sodium and calcium butyrate have antimicrobial activity due to their ability to 
acidify bacteria cell cytoplasm (Sunkara et al., 2011). Butyrate salts can cross a 
bacterial cell wall when bound but dissociate once in the more alkaline content of the 
cell to proton which disrupts the internal pH, and the anion, causes a lowering in the 
pH of cytoplasm (Fernandez Rubio, et al., 2009). The molecular composition of 
butyrate salts suggest that when fed to poultry, it may act as an acidifier. Indeed, 
Biagi et al. (2007) reported an increase in pH of the caecum when feeding sodium 
butyrate, and Czerwinski, et al. (2012) saw an increase in pH in the ileal digesta but 
not in the caecal digesta. However, Trial 3 showed no significant effect of diet on the 
pH of the intestine on day 21. This is likely be due to the dietary inclusion levels of 
butyrate salt not reaching a level that would not be considered an acidifier; acidifiers 
can be added into water or feed and have been added at inclusion levels of 3-9g/kg of 
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feed (Brzóska, et al., 2013). This finding is supported by Manzanilla, et al. (2006); 
Smulikowska, et al. (2009) and Zhang, et al. (2011) who all similarly reported that 
GI tract pH was not affected when feeding sodium butyrate.   
 
The effect of NCF on performance parameters in Trial 3 are similar to observed 
results in Trial 2. The data indicate that 200g/t NCF did not show a marked effect on 
bird performance in Trial 2 or 3. This may be due to the weekly sampling making it 
difficult to assess the performance data, limiting its commercial application. 
However, the effect of feeding 200g/t NCF on other measurement parameters in 
Trial 2 and 3 also show little difference to the control, which may be due to a lack of 
pathogenic challenge or stress on the birds in Nottingham Trent University’s poultry 
facility. 
 
5.6 CONCLUSION 
These data indicate that, while some significant differences between treatments were 
observed, NCF, Ca But and Na But did not show a pronounced effect on bird 
performance, gross GI tract morphology, microscopic GI tract morphology or digesta 
pH in Trial 3. This may be due to the lack of pathogenic challenge or stress on the 
birds in Nottingham Trent University’s poultry facility. There have been many 
studies showing that MOS, Ca But and Na But improves performance and there are 
several theories into the mode of action in relation to improved gut health. However, 
the published research appears to be variable with some trials demonstrating they 
have no effect or a negative effect on performance. This may be due to differences in 
the type of product, experimental conditions, diet formulation and health status of the 
birds. 
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CHAPTER 6: INVESTIGATION INTO THE EFFECTS OF NCF AND 
BUTYRATE SUPPLEMENTS ON POTENTIAL EARLY DETERMINANTS 
OF GUT HEALTH AND PERFORMANCE.  
 
6.1 INTRODUCTION 
This thesis seeks to provide insight into the mechanisms behind the effects of the 
feed supplements, NCF, Ca and Na butyrate, by investigating parameters from a 
whole bird response down to alterations in gene expression. Where previous chapters 
have examined direct performance measures and development of the gut itself, this 
chapter reports on upstream factors with the potential to subsequently influence gut 
health and performance. Measures reported in the present chapter include; gene 
regulation of immune and metabolic processes in birds fed NCF; digestive enzymes 
activity in broilers fed NCF, sodium butyrate and calcium butyrate supplements; and 
immunoglobulin levels in broilers fed NCF, sodium butyrate and calcium butyrate 
supplements. Therefore this chapter explores the genetic and molecular changes 
resulting from NCF supplementation that may elucidate the observed whole bird 
performance effects. This chapter reports on the expression of genes associated with 
immune and metabolic processes from Trial 1, and any changes in concentration of 
immunoglobulins (IgG, IgM and IgA) and activity of amylase, chymotrypsin and 
trypsin digestive enzymes from Trials 1 and 3.  
 
6.2 AIM 
The aim of the work reported in this chapter was to identify the key immune and 
metabolic gene expressions, which are affected by NCF supplementation in broilers 
and to examine the effects of NCF, sodium butyrate and calcium butyrate on 
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digestive enzyme activity and immunoglobulin levels in broilers. 
 
This chapter investigates two distinct mechanisms that may support previously 
observed performance responses. The first hypothesis is that NCF alters immune-
related gene expression and increases immunoglobulin levels in the blood to support 
bird defence against pathogenic bacteria. The second hypothesis is that NCF 
increases levels of digestive enzymes in the GIT due to improved gut morphology 
and development. 
  
6.3 MATERIALS AND METHODS 
6.3.1 Experimental design 
Bird husbandry for Trial 1 is as stated in Chapter 3 and for Trial 3 as stated in 
Chapter 5. Trial 1 lasted 42 days with a 3 phase feeding programme, providing 
starter diets from 1 to 14 days, grower diets from 15 to 28 days and finisher diets 
from 29 to 42 days. Trial 3 lasted 21 days with a 2 phase feeding programme, 
providing starter diets from 1 to 14 days and grower diets from 15 to 21 days. Trial 1 
had four dietary treatments containing increasing levels of NCF, whereas Trial 3 had 
six dietary treatments of various combinations of NCF and butyrate salt supplements. 
The diets in both trials were allocated using a stratified random allocation. The litter 
provided was fine dry sand in Trial 1 and shavings in Trial 3, both on a concrete 
floor to a depth of 6cm. Bedding substrate was added to maintain adequate 
environmental welfare standards. 
 
6.3.2 Experimental Diets 
The diets were based on the nutritional requirements for the strain of bird and 
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contained approximately 50% wheat but no pentosan degrading enzymes; in order to 
provide a small digestive challenge. The basal diets for both trials were free of 
antibiotics and manufactured using the formulation in table 6.1. The four dietary 
treatments in Trial 1 were 1) control (NCF free), 2) NCF at 200g per tonne, 3) NCF 
at 400g per tonne, and 4) NCF 800g per tonne. The 6 dietary treatments in Trial 3 
were 1) Control diet (NCF free), 2) NCF at 200g per tonne, 3) Ca But (300g/t), 4) Na 
But (Starter:1000g/t, Grower:750g/t) 5) Ca But plus NCF, and 6) Na But plus NCF. 
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Table 6.1. Composition and calculated analysis of the basal diet for Trial 1 and 3. 
Item Starter Grower Finisher 
Ingredients (%) 
  
 
Barley 10.61 8.46 7.23 
Wheat 50.00 55.00 60.00 
Soybean meal, 48% CP 26.00 23.00 19.00 
Full fat soybean meal 5.00 5.00 5.00 
L lysine HCL 0.31 0.26 0.25 
DL methionine 0.38 0.35 0.33 
L threonine 0.14 0.13 0.14 
Soya oil 4.00 4.50 4.75 
Limestone 1.25 1.25 1.25 
Monocalcium phosphate 1.50 1.25 1.25 
Salt 0.25 0.25 0.25 
Sodium bicarbonate 0.15 0.15 0.15 
Premix* 0.25 0.25 0.25 
Calculated analysis 
  
 
ME MJ/kg 12.78 13.04 13.20 
CP% 21.75 20.59 19.10 
Lys % 1.37 1.25 1.13 
Met + Cys % 1.01 0.95 0.89 
Ca 0.96 0.90 0.90 
Available P 0.48 0.42 0.65 
*Premix content (volume/kg diet): Mn 100mg, Zn 80mg, Fe 20mg, Cu 10mg, I 1mg, 
Mb 0.48mg, Se 0.2mg, Retinol 13.5mg,Cholecalciferol, 3mg, Tocopherol 25mg, 
Menadione 5.0mg, Thiamine 3mg, Riboflavin 10.0mg, Pantothenic acid 15mg, 
Pyroxidine 3.0mg, Niacin 60mg, Cobalamin 30µg, Folic acid 1.5mg, Biotin 125mg 
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6.3.3 Determined Parameters 
For immunoglobulin measurement, one bird per pen was selected and slaughtered on 
day 42 in Trial 1. In Trial 3, one bird per pen was selected and slaughtered on days 7, 
14 and 21. Immediately after death blood was removed from the bird and allowed to 
clot for 2-4 hours. The blood was then centrifuged and the serum poured off and 
stored at -20oC. Levels of IgM, IgA and IgG were measured in serum of the bird 
using an enzyme linked immunosorbent assay (ELISA) micro titre plate for the 
detection of chicken IgM, IgA or IgG in serum from Bethyl Laboratories Inc. 
(Montgomery, TX, USA) as described in Chapter 2.  
 
In order to measure digestive enzyme activity, one bird per pen was selected and 
slaughtered on day 42 in Trial 1 and on days 7, 14 and 21 in Trial 3. Tissue samples 
were taken from two intestinal regions, the duodenum and the jejunum. Details of 
sample removal and storage are given in chapter two. The tissue samples were later 
analysed to determine the activity levels of trypsin, chymotrypsin and amylase 
enzymes. 
 
Tissue samples from the jejunum were taken from one bird per pen in Trial 1 on day 
42 and stored for microarray analysis as per the method stated in Chapter 2. The 
RNA was purified and its quality and quantity measured prior to conducting gene 
microarrays to assess gene expression using a GeneChip Fluidics Station, and were 
scanned with the Affymetrix GeneChip Scanner 3000 (Affymetrix, Santa Clara, 
California, USA) at Alltech headquarters (Nicholasville, Kentucky, USA), using the 
GeneChip Chicken Genome Array. The gene expression data produced was analysed 
using Genespring GX software (Affymetrix, Santa Clara, California, USA), IPA 
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(Ingenuity Systems Inc, California, USA) and LifeGenDB.  
 
6.3.4 Data Analysis 
GeneSpring GX a molecular analysis software package was used to identify 
significant differences between the control birds gene expression and the treatment 
birds, significance was set at P<0.05. GeneSpring produced a fold change value from 
the control bird for each gene and a measure of significance (P value) based on an 
unpaired t-test. Immunoglobulin and digestive enzyme data was analysed via 1-way 
ANOVA using the SPSS software for Windows. was used. Statistical significance 
was declared at P<0.05 and treatment means were separated using the Tukey post 
hoc test.  
 
6.4 RESULTS 
6.4.1 Gene Expression 
Change in gene expression was measured in birds fed varying levels of NCF against 
a control to illustrate any immune or metabolic effects of the supplement on the birds. 
 
6.4.1.1 Heat Map 
In Trial 1 transcription changes in intestinal samples of broilers fed NCF were 
analysed. Figure 6.1 shows a cluster analysis in the form of a microarray heat map of 
the four treatment groups. The heat map uses colours to represent the intensity of 
expression of a gene and shows any similarities between samples using a 
dendrogram to hierarchically cluster genes (a tree diagram). Figure 6.1 shows that 
each treatment group had a similar effect on the gene expression of the birds within 
the separate treatments as they have been grouped together. Figure 6.2 is also a 
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microarray heat map which shows the similarities between the average gene 
expressions of the dietary treatment group. It shows that the control and 800g/t 
treatment group had higher correlation between their changes in gene expression 
than between control, 200g/t NCF and 400g/t NCF dietary treatment gene 
expressions.  
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Figure 6.1. Sectional image of approximately 30 of the 28,000 genes used in cluster  
analysis of the gene expression of the 10,000 of birds fed one of the four treatments, 
representing the similarities between samples using a dendrogram. 
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Figure 6.2. Sectional image of approximately 30 of the 28,000 genes used in cluster  
analysis of the gene expression of the 10,000 of birds fed one of the four treatments, 
representing the similarities between samples using a dendrogram. 
 
6.3.1.2 Venn diagram and Volcano Plot 
Figure 6.3 is a Venn diagram showing gene expression changes and over laps 
between dietary treatments. It demonstrates that expression of 41 genes were altered 
with all supplementation levels of NCF compared to the control birds.  
 
Control 800g/t NCF 200g/t NCF 400g/t NCF 
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Figure 6.3 Venn diagram comparing changes in gene expression when broilers are 
fed varying levels of NCF over a control. 
 
Of the 962 genes changed when feeding 200g/t NCF from the control, 395 were 
found to be down regulated and 567 up regulated. Of the 1476 genes changed when 
feeding 400g/t NCF, 432 were found to be down regulated and 1044 up regulated, 
and of the 942 genes changed when feeding 800g/t NCF, 375 were found to be down 
regulated and 567 up regulated. When further analysis was performed on the data, it 
was seen that just 40, 33 and 28 genes showed a difference of greater than 1.5 fold 
change from the control. when birds were fed 200g/t, 400g/t and 800g/t respectively. 
The volcano plots shown in figures 6.4, 6.5 and 6.6 highlight clearly that, whilst 
many genes are significantly altered in their expression (left image), few are altered 
more than 1.5 fold (right image). 
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Figure 6.4. Volcano plot representing the distribution of genes expressed in intestine 
for 200g/t vs. 0g/t NCF. Right image illustrates genes significantly altered (P<0.05) 
and left image illustrating genes significantly altered more than 1.5-fold. 
 
         
Figure 6.5. Volcano plot representing the distribution of genes expressed in intestine 
for 400g/t vs. 0g/t NCF. Right image illustrates genes significantly altered (P<0.05) 
and left image illustrating genes significantly altered more than 1.5-fold. 
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Figure 6.6. Volcano plot representing the distribution of genes expressed in intestine 
for 800g/t vs. 0g/t NCF. Right image illustrates genes significantly altered (P<0.05) 
and left image illustrating genes significantly altered more than 1.5-fold. 
 
6.4.1.3 GO Analysis  
Metabolic activities were highly represented in the 400g/t treatment group, with 
primary metabolic processes (GO:0044238; 760 probes) and nitrogen compound 
metabolic processes (GO:0006807; 377 probes). In the 200g/t treatment group 
responses were seen in glutamine family amino acid metabolic processes 
(GO:0009064; 15 probes) and steroid biosynthetic  processes  (GO:0006694; 11 
probes). In the 800g/t treatment group responses were only seen in helicase activity 
(GO:0004386; 24 probes) (figure 6.7). Immune response terms were also identified, 
400g/t had an effect on immune system development (GO:0002520; 65 probes; FDR 
0.38) and 800g/t on cytokine stimulus (GO:0034097; 26 probes; FDR 0.40) and 
defence response to bacterium (GO:0042742; 23 probes; FDR  0.40). However as 
these genes had a false discovery rate (FDR) over 0.1, they may indicate a 
noteworthy effect but these data cannot be relied upon as representing a true effect.
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Figure 6.7 Effects of dietary treatments on biological processes and molecular functions.  
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6.4.1.4 IPA Canonical Pathways 
When looking at more specific canonical pathways using IPA software analysis, it 
was shown that immune and metabolic pathways were affected by NCF, which is 
shown in table 6.3. These pathways contain numerous genes that were up or down 
regulated by NFC that can have interaction with other processes and pathways.  
 
Table 6.3 Specific canonical pathways affected by NFC supplementation. 
Diet Canonical Pathway 
200g/t NCF Biosynthesis of steroids 
 Role of Wnt/GSK-3b Signalling in the Pathogenesis of Influenza  
 Role of IL-17F in Allergic Inflammatory Airway Diseases 
 Maturity Onset Diabetes of Young (MODY) Signalling 
 Urea Cycle and Metabolism of Amino Groups 
400g/t NCF G-Protein Coupled Receptor Signalling  
 T Cell Receptor Signalling 
 Atherosclerosis Signalling 
 Reg. of IL-2 Expression in Activated & Anergic T Lymphocytes 
 Phospholipase C Signalling 
800g/t NCF Glyoxylate and Dicarboxylate Metabolism  
 Linoleic Acid Metabolism 
 G-Protein Coupled Receptor Signalling 
 IL-17A Signalling in Fibroblasts 
 Citrate Cycle 
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6.4.2 Immunoglobulins 
Immunoglobulins were measured periodically in birds fed NCF, Ca But and Na But 
as a gauge to investigate their effects on the immune system over time. It was seen 
that there were no interactions between feeding NCF and Na But and no significant 
differences between treatment on broiler immunoglobulin levels in serum at days 7, 
14, 21 or 42 (tables 6.4 and 6.5). However there was interaction observed at 21 days 
between NCF and Ca But, Ca But feed on its own did not alter IgG levels, where as 
a trend was seen when NCF was fed on it only and in combination with Na But to 
decreased IgG levels. 
Table 6.4 Effect of dietary supplements on immunoglobulin levels in serum (mg/ml). 
  
 
 
 
 
 
 
Attribute Age SEM P value
Control NCF 200g/t Ca But Na But NCF/Ca But NCF/Na But NCF*Ca B NCF*Na B
IgA 7 0.085 0.064 0.082 0.081 0.097 0.074 0.006 0.708 0.306 0.765
IgM 0.070 0.069 0.067 0.061 0.074 0.070 0.005 0.988 0.658 0.588
IgG 1.906 1.553 1.555 1.387 1.515 1.718 0.077 0.466 0.698 0.170
IgA 14 0.161 0.130 0.172 0.154 0.211 0.151 0.009 0.137 0.404 0.915
IgM 0.118 0.104 0.172 0.152 0.166 0.122 0.009 0.185 0.556 0.916
IgG 1.058 1.098 1.040 1.045 1.126 1.101 0.085 1.000 0.571 0.866
IgA 21 0.225 0.194 0.237 0.189 0.232 0.224 0.011 0.718 0.975 0.550
IgM 0.080 0.080 0.107 0.119 0.103 0.131 0.010 0.595 0.733 0.884
IgG 2.976 2.656 2.961 4.456 2.418 2.662 0.209 0.058 0.047 0.410
Dietary treatment Interaction
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Table 6.5 Effect of NCF on the immunoglobulin levels in serum of broilers (mg/ml). 
  
Figure 6.8, 6.9 and 6.10 shows the immunoglobulin levels in serum of broilers over 
time in Trial 3. Levels of IgA increased with age, whereas IgM increased from 7 to 
14 days, then decreased at 21 days before IgM substantially increased in Trial 1 to its 
highest level at 42 days. In contrast, IgG decreased from 7 to 14 days, before greatly 
increased to its highest level at 21 days and was approximately maintained at 42 days 
in Trial 1. 
Attribute Age SEM P value
Control NCF 200g/t NCF 400g/t NCF 800g/t
IgA 42 0.239 0.217 0.240 0.212 0.012 0.802
IgM 0.214 0.261 0.262 0.230 0.017 0.735
IgG 2.822 2.748 1.928 3.211 0.191 0.108
Dietary treatment
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Figure 6.8 Immunoglobulin G levels in serum of broilers of increasing ages. 
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Figure 6.9 Immunoglobulin M levels in serum of broilers of increasing ages. 
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Figure 6.10 Immunoglobulin A levels in serum of broilers of increasing ages. 
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6.4.3 Digestive Enzymes 
Feeding NCF, Ca But and Na But had no significant effect on activity of the broiler 
digestive enzymes; amylase, chymotrypsin and trypsin in the duodenum and jejunum 
at days 7, 14, 21 or 42 (tables 6.6, 6.7, 6.8, 6.9). However, it could be seen that 
amylase, chymotrypsin and trypsin levels were higher in the jejunum than the 
duodenum up to day 21. 
 
Table 6.6 Effect of fed supplements at 7d on digestive enzymes activity of broilers 
(units/g protein) 
  
 
 
 
 
 
 
Amylase Chymotrypsin Trypsin Amylase Chymotrypsin Trypsin
Control 11.6 48.2 1.4 22.6 139.6 2.8
NCF 200g/t 8.8 53.7 1.7 21.9 142.3 2.7
Na But 7.9 51.6 1.3 19.7 125.6 2.7
Ca But 10.4 69.9 2.3 18.7 144.1 2.7
Na But/NCF 8.7 48.1 1.3 17.1 155.6 2.8
Ca But/NCF 7.0 68.3 2.4 19.3 134.8 2.8
SEM 0.7 3.8 0.2 1.1 7.0 0.2
P value 0.451 0.378 0.556 0.763 0.900 1.000
Duodenum Jejunum
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Table 6.7 Effect of fed supplements at 14d on digestive enzymes activity of broilers 
(units/g protein) 
  
 
Table 6.8 Effect of fed supplements at 21d on digestive enzymes activity of broilers 
(units/g protein) 
  
 
 
Amylase Chymotrypsin Trypsin Amylase Chymotrypsin Trypsin
Control 11.3 83.5 0.9 17.7 128.8 5.4
NCF 200g/t 8.5 79.2 0.8 15.6 126.8 6.8
Na But 10.4 63.7 1.1 14.5 110.6 5.5
Ca But 10.3 61.5 0.6 20.1 129.4 6.4
Na But/NCF 9.8 82.6 1.1 17.9 125.8 6.2
Ca But/NCF 11.7 89.1 1.1 18.5 137.1 7.0
SEM 0.6 4.2 0.1 1.1 7.4 0.4
P value 0.698 0.315 0.701 0.734 0.955 0.823
Duodenum Jejunum
Amylase Chymotrypsin Trypsin Amylase Chymotrypsin Trypsin
Control 5.2 51.7 0.4 6.8 57.9 5.1
NCF 200g/t 4.5 59.3 0.4 6.9 54.7 5.9
Na But 4.1 53.3 0.4 7.1 53.1 4.9
Ca But 4.1 52.1 0.4 8.1 72.1 5.1
Na But/NCF 4.3 65.5 0.5 7.1 45.1 4.3
Ca But/NCF 4.8 68.5 0.5 7.5 48.5 5.5
SEM 0.2 3.3 0.03 0.3 3.5 0.4
P value 0.383 0.544 0.924 0.897 0.311 0.915
Duodenum Jejunum
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Table 6.9 Effect of fed supplements at 42d on digestive enzymes activity of broilers 
(units/g protein) 
  
 
6.5 DISCUSSION 
The effects of varying levels of NCF in the diet of broilers on the regulation of gene 
expression of Trial 1 are discussed in this section, as well as the effects of NCF and 
butyrate salt supplementation in Trial 1 and 3 on immunoglobulin serum levels and 
digestive enzyme activities. 
 
6.5.1 Gene expression 
The cluster analysis (heat map – figure 6.1) showed similarities in the gene 
expression of individual birds on the same diet and clear differentiation between 
groups of birds on the same diet. This suggests that the diets and hence differing 
inclusion levels of NCF are having a consistent effect on the regulation of gene 
expression.  The cluster analysis of the average gene expression of the dietary 
treatment group (figure 6.2) indicates that the control and 800g/t treatment group had 
higher correlation between their regulation of gene expression than between the 
Amylase Chymotrypsin Trypsin Amylase Chymotrypsin Trypsin
Control 13.1 82.0 1.9 11.3 56.9 2.9
NCF 200g/t 11.1 77.3 2.0 12.1 67.5 3.4
NCF 400g/t 11.3 66.6 2.1 12.4 63.5 3.1
NCF 800g/t 9.2 64.7 2.2 12.8 61.4 2.9
SEM 1.4 3.4 0.2 1.0 3.8 0.2
P value 0.967 0.215 0.880 0.964 0.805 0.668
Duodenum Jejunum
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other dietary treatment gene expressions. This suggests that 200g/t and 400g/t 
dietary inclusions of NCF are  having a greater effect on gene expression compared 
to the control birds than 800g/t NCF. However, a cluster analysis only provides a 
general view of gene expression changes. The Venn diagram shows that a total of 
962,1476 and 942 genes were significantly  up or down regulated compared to the 
control with inclusion of 200g/t, 400g/t and 800g/t NCF, with a number of genes 
changing in two or all three NCF dietary treatment groups. This suggests that 
feeding NCF at differing inclusion levels had a similar effect on the regulation of a 
number of genes. However, it also showed an altered regulation of different genes 
depending on the NCF inclusion level. When these are plotted on a volcano plot it 
can be seen that the levels of change in expression relative to the control varies; only 
40, 33 and 28 genes showed an expression difference of greater than 1.5 fold change 
from the control. This indicates that the changes in individual gene expression from 
the control in the NCF treatment groups are small, suggesting that NCF 
supplementation may only be having small effects on gene expressions. It has been 
reported by Ibuki et al, (2010) that when feeding a prebiotic that there were 171 
genes up or down regulated by more than 1.5 fold change, which is substantially 
more than were found in the present trial. 
  
The gene ontology analysis describes gene changes in terms of their associated 
biological processes, cellular components and molecular functions. In this study, it 
was seen that metabolic activities (relating to carbohydrate, lipid, protein and cellular 
amino acid metabolic processes) were highly represented. In the 400g/t treatment 
group, primary metabolic processes and nitrogen compound metabolic processes 
were flagged by Lifegen as greatly affected, suggesting that the main effects on 
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performance of birds fed of 400g/t NCF may be through modifying the metabolic 
processes of the broiler.  
 
In the 200g/t treatment group, changes were shown to affect the chemical reactions 
and pathways involving amino acids of the glutamine family, comprising of arginine, 
glutamate, glutamine and proline. Steroid biosynthetic processes were also affected 
by 200g/t NCF supplementation, which suggest impact via bile acid, vitamin D and 
glucocorticoid biosynthetic processes. Glucocorticoid has been reported to have 
effects on inflammation and immunity (Proszkowiec-Weglarz and Porter 2010), thus 
providing a possible mechanism for 200g/t NCF to affect inflammation and 
immunity of the birds fed this level of NCF supplement. However it not possible 
from the available data and published literature to determine whether this change 
will invoke an overall positive or negative effect on immune status of the bird. 
 
In contrast to the lower NCF supplementation levels,  the 800g/t treatment group 
only showed responses in helicase activity. This catalyses the reaction: NTP + H2O 
= NDP + phosphate, to drive the unwinding of a DNA or RNA helix, suggesting that 
800g/t NCF may be affecting cell proliferation (AmiGO: helicase activity Details. 
2013). Immune responses were also identified, although the false discovery rates 
(FDR) were over 0.1 which means that they have been identified but are not 
unreliable. It was seen that 400g/t may have had a small effect on immune system 
development (FDR 0.38) and 800g/t on cytokine stimulus (FDR 0.40) and defence 
response to bacterium  (FDR  0.40). 
 
When looking at more specific canonical pathways using IPA it was shown that 
183 
 
immune and metabolic pathways were affected by NCF. These pathways contain 
numerous genes that were up or down regulated by NFC that can have interaction 
with other processes and pathways. Key genes that are up or down regulated in these 
pathways are shown in table 6.10 and discussed later. 
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Table 6.10 Key genes effected by NCF supplementation 
Gene Up/down 
regulated 
Function/effect 
200g/t NCF   
IDDI  Increased activation of γδ T cells 
NCoA-1  Effect IL4 mediated biological response 
Act1  Decreases numbers of B cells 
C-RAF  Effect inflammation, increased tight junction proteins & 
improved barrier function 
HNF-1α  Increase glucose uptake by the liver 
INSR  Improved uptake of glucose 
  Effect epithelial cell proliferation 
CPS-I  Decrease in inflammation 
400g/t NCF   
Syk  Decrease B cell development 
Egr-1  Suppressed immune system 
NFATc3  Cytokines transcription 
NF-kB1  Increased immune factors 
C-RAF  Effect inflammation, increased of tight junction proteins 
and improved barrier function of the intestine 
SLP-76  Decreased development of thymocytes 
TIFA  Innate immunity 
PDE7A  Suppress the immune system 
Gs-coupled 
receptor 
 Movement of natural killer cells and cytotoxic abilities 
800g/t NCF   
ACO2  TCA cycle 
HOGA  Metabolism of 4-hydroxyproline, glyoxylate, and 
pyruvate - TCA cycle 
MTHFD1  Folate metabolism 
PLA2G10  Decreases pro-inflammatory intermediates 
FADS1  Increased levels of the pro-inﬂammatory arachidonic acid 
Gs-coupled 
receptor 
 Movement of natural killer cells and their cytotoxic 
abilities 
Gi coupled 
receptor 
 production of nitric oxide 
PDE- 
5A/11A 
 increase immune and inflammation response 
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6.5.1.1 Biosynthesis of steroids 
When investigating in further detail, one of the pathways that was affected when 
NCF was supplemented at 200g/t was the steroid biosynthesis pathway. This 
pathway has interaction with the function, expansion of gamma-delta T lymphocytes 
(γδ T cells). γδ T cells are thought to be an important element in the innate immune 
system and may be the first line of defence (Price et al., 2006; Chen et al., 2005). In 
cattle it had been shown that production of interferon (IFN)-C by γδ T cells post-
infection may have a role in linking the innate and adaptive immune responses (Price 
et al., 2006). The interaction of this pathway with γδ T cells in this study may be 
through the down regulation of Isopentenyl-diphosphate Delta-isomerase (IDDI) (-
1.446, P = 0.0397), which is involved in the reaction of isopentenyl diphosphate ↔ 
dimethylallyl diphosphate. Isopentenyl diphosphate (IPP) has been reported to 
activate γδ T cells in humans (Chen et al., 2005). Activation of γδ T cells leads to the 
production of cytokines and chemokines involved in the initiation of inflammatory 
and immune responses, as well as in the generation of T cells with cytotoxic activity 
(Cipriani et al., 2000; Chen et al., 2005). Therefore, the down regulation of 
Isopentenyl-diphosphate Delta-isomerase may mean that there is an increased level 
of IPP and increased activation of γδ T cells. This may lead to the increase in 
readiness of the immune function of birds fed 200g/t NCF, resulting in a decrease in 
the time for the bird to defend itself against a pathogenic challenge. 
 
6.5.1.2 Role of Wnt/GSK-3b Signalling in the Pathogenesis of Influenza  
NCF at 200g/t was also shown to have an effect on a pathway involving 
Wnt/glycogen synthase kinase 3 (GSK3)-β signalling (Figure 6.10). Figure 6.10 also 
indicates links between genes in this pathway to other signalling pathways and 
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functions. The Wnt signalling pathway has been reported to trigger a β-catenin/TCF-
induced IFN production (Ingenuity Systems, 2013), which allows for communication 
between cells to trigger the protective defences of the immune system to fight the 
pathogen. The pathway also has interaction with the protein kinase A signalling and 
integrin-linked kinase (ILK) signalling pathways. One of the genes significantly up 
regulated in this pathway is Nuclear Receptor Coactivator 1 (NCoA-1), part of p160 
steroid receptor coactivator (1.102 P=0.0339). NCoA-1 acts as a co-activator for 
signal transducer and activator of transcription 6 (STAT6) (Nuclear receptor 
coactivator 1, 2013). STAT6 is activated in response to interleukin–4 (IL-4) and 
interleukin–13 (IL-13), and has a crucial role in exerting IL4 mediated biological 
response. IL-4 regulates immune and anti-inflammatory responses, through 
promoting the differentiation of T helper precursors, inhibiting T helper 1 
development and stimulates B-cells to change Immunoglobulins (Ig) to IgE isotype 
(Litterst and Pfitzner., 2001). Therefore, the up regulation of NCoA-1 by 200g/t 
NCF may have had significant effects on the immune system of the birds. 
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Figure 6.10. Wnt/glycogen synthase kinase 3-β signalling pathway. CP = canonical pathway, each line between a canonical pathway and a gene 
indicates a link between the pathway and a gene with at least one published paper indicating a link. 
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6.5.1.3 Role of IL-17F in Allergic Inflammatory Airway Diseases 
Another canonical pathway that was significantly affected by 200g/t NCF involves 
IL-17F, which has interactions with the inflammatory response and attraction of 
leukocytes. IL-17F has also been shown to be important in the pathogenesis of 
allergic airway inflammation, and has been associated with inflammatory bowel 
disease (Chen et al., 2009). Interleukin-17 has been reported to stimulate the 
production of other cytokines and chemokines such as IL-1β, IL-6, IL- 8 (Shaw et al., 
2011). However, the mechanisms and function of IL-17F in the intestine is unclear. 
In mice, gut microflora has been reported to induce T helper cells 17 (Th17), which 
produce IL-17, playing an important role in the maturation of the gut immune system 
(Crhanova et al., 2011). Interestingly, IL-17 has been shown to be important for 
defence against bacterial and fungal pathogens and maybe regulating the immune 
response as IL-17 receptors have been found on macrophages and T lymphocytes 
(Crhanova et al., 2011).  
 
The IL-17F pathway also has interaction with the inflammatory response function 
through the gene Act1, which was up regulated (1.769 P= 0.0243). Act1 is a key 
component in IL-17A signalling and has been linked to CD40 mediated B cell 
survival. It has been shown that Act1-deficient B cells mice have increased CD40, 
which indicates that Act1 negatively regulates B cell survival (Qian et al., 2004). 
This suggest that the up regulation of Act1 in birds fed 200g/t NCF decreases 
numbers of B cells, and may have decreased the energy need for the immune system. 
C-RAF was also up regulated (1.196 P=0.0028), which is a functional protein that 
activates mitogen-activated protein kinase (MEK1/2). MEK1/2 is involved in 
activating extracellular-signal-regulated kinases (ERK1/2). Interleukin-1 is also 
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involved in the activation of ERK1/2 to regulate certain pro-inflammatory genes 
(Perera et al., 2010). This suggests that the up regulation of C-FAF may have an 
effect on inflammation. In addition, ERK 1/2 is thought to be (Takahashi, et al., 
2012) involved in the proliferation and differentiation of cells. It has been seen in the 
lungs that a reduction in ERK-1/2 signalling correlates with an inhibition of lung 
branching morphogenesis in vitro. This infers that ERK-1/2 activation may mediate 
lung growth and development (Kling et al., 2002). This may also be the mechanism 
of ERK 1/2 in the intestine on the development of the intestinal wall. It has been 
proposed that ERK1/2 may be involved in the regulation of tight junctions and that a 
decreased ERK1/2 activity may lead to an increased level of tight junction proteins 
and improved barrier function of the intestine (Zimmerman et al., 2011).  
 
6.5.1.4 Maturity Onset Diabetes of Young (MODY) Signalling 
200g/t NCF also had a significant effect on the maturity onset diabetes of young 
(MODY) signalling pathway, and a number of these genes have interaction with 
metabolism and transport of carbohydrates, homeostasis of D-glycogen and the 
transport of fatty acids. One of these genes is Hepatic Nuclear Factor 1 (HNF-1α), 
which was up regulated (1.210 P=0.0147) and is a key component of a pathway that 
is essential for normal glucose-induced insulin secretion (Shih et al., 2002). It has 
been reported that mice deficient in HNF-1α have a reduced uptake of glucose by the 
kidney (Pontoglio et al., 2000). This suggests that feeding NCF may increase 
glucose uptake by the liver. Another key gene that was up regulated in this pathway 
was INSR (1.052 P=0.0312), which encodes for an insulin receptor, that plays an 
important role in the regulation of glucose homeostasis and metabolism (Kim et al., 
2001). The binding of insulin to INSR results in the uptake of glucose; therefore, the 
190 
 
up regulation of INSR may mean that the ability of the chicken to take up glucose is 
improved. It has also been seen that in ruminants INSR is involved in ruminal 
epithelial cell proliferation (Baldwin, 1999), and that insulin can regulate ruminal 
epithelial cell proliferation in combination with their receptors (Naeem et al., 2012). 
 
6.5.1.5 Urea Cycle and Metabolism of Amino Groups 
200g/t NCF was demonstrated to have an effect on a number of genes involved in 
the urea cycle and metabolism of amino groups. This pathway has gene interaction 
with the metabolism of protein, and amino acid synthesis and uptake. The enzyme 
carbamoyl phosphate synthase I (CPS-I) was down regulated in this pathway (-1.189 
P= 0.0048). CPS-I is involved in the production of citrulline from ammonia. 
Citrulline is an important component in the arginine biosynthetic pathway. Arginine 
has many roles in the intestine, including protein synthesis, cell proliferation (Buga 
et al., 1998), polyamine synthesis (Wu et al., 2000), and maintenance of the 
epithelial barrier function (Mueller et al., 2000; Dekaney et al., 2003). Mueller et al. 
(2000) reported in rats that in small bowel transplantation experiments the 
application of L-arginine increased inflammation, which may mean that the down 
regulation of CPS-I could have led to a decrease in inflammation in the GI tract. 
 
6.5.1.6 B cell signalling pathway 
When investigating in further detail the pathways changed when NCF was 
supplemented at 400g/t, it was seen that the B cell signalling pathway was affected. 
Signals through the B cell antigen receptor are crucial to the development, survival 
and activation of B lymphocytes (Ingenuity Systems, 2013). This pathway has gene 
interaction with the development process of lymphocytes and immune response 
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(figure 6.11). One gene that was down regulated was spleen tyrosine kinase (Syk) (-
1.257 P=0.0374). Syk function is through transmitting signals from mature antigen 
receptors, downstream of the pre-B cell antigen receptor in immature B cells, and 
therefore is involved in early steps of lymphoid development. It has been reported by 
Turner, et al (1995) Syk gene knockout mice have blocked B-cell development, 
resulting in a failure to produce mature B-cells. Therefore, the down regulation of 
Syk could suggest there will be a decrease in B cell development. Early growth 
response 1 (Egr-1) is another gene in this pathway that has been significantly down 
regulated by 400g/t NCF (-1.584 P=0.0210). Egr-1 is thought to be important in the 
development of thymocytes. T cell precursors are double-negative, which progress 
through a series of maturational steps to form double-positive thymocytes that 
express both CD4 and CD8, and then finally to mature single-positive thymocytes 
that express either CD4 or CD8. This development depends upon pre-T cell receptor 
signalling to engage a number of molecules. Egr are critical effectors of the signals 
that promote this developmental transition (Carter et al., 2007: Carleton et al., 2002). 
From the down regulation of genes in this pathway by 400g/t NCF it may mean that 
the immune system is being suppressed. 
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Figure 6.11. B cell signalling pathway showing gene interaction with the development process of lymphocytes and immune response.  
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6.5.1.7 Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes 
The pathway regulating the expression of IL-2 in activated and anergic T 
lymphocytes was indicated to have been affected by 400g/t NCF, with a number of 
genes significantly affected having known functions in the immune response and 
development of lymphocytes. Nuclear factor of activated T-cells (NFATc3) was up 
regulated (1.266 P=0.0169) by 400g/t NCF compared to the control, and has been 
reported to control transcription of a number of genes, including those encoding a 
variety of cytokines when it is dephosphorylated and translocated into the nucleus 
(Bopp et al., 2005). Nuclear Factor Kappa-B1 (NF-kB1) was down regulated (1.134 
P=0.0491) by 400g/t NCF. NF-kB is a pro-inflammatory factor. With the deletion of 
NF-kB1 in mice it has been reported that lipopolysaccharide (LPS) induces higher 
levels of the genes for IFN-b and IL-12 (p40) in macrophages. The transcription 
factor NF-kB plays a role in regulating innate immune gene expression by inhibiting 
lipopolysaccharide (LPS)-induced gene expression. Therefore, it is thought that NF-
kB1 is an inhibitor of some immune-regulatory genes (Zhao et al., 2012), and the 
down regulation of this gene by NCF may have caused an increase in immune 
factors. In this pathway C-RAF was also up regulated (1.224 P=0.0327), which was 
similarly reported when feeding 200g/t NCF. As explained earlier, this may have an 
effect on inflammation and the tight junctions of the intestinal epithelial membrane.  
T cell antigen receptors recognise and bind to major histocompatibility complex 
(MHC) associated antigenic peptides that are presented by antigen presenting cells. 
Binding leads to the activation of several downstream signalling pathways, including 
the activation of IL-2 promoter (Luo et al., 2011). Functions that are related to this 
pathway are the development of leukocytes and lymphocytes. One gene that was 
down regulated (1.368 P=0.0236) by 400g/t NCF is SLP-76, which is a leukocyte-
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specific adapter molecule. It was reported that mice that were deficient in SLP-76 
expression had no peripheral T cells as a result of an early block in thymopoiesis. 
Therefore, it is thought that the SLP-76 adapter protein is essential for thymocyte 
development and plays a vital role in translating signals mediated by pre-T cell 
receptors (Clements et al., 1998). The down regulation on SLP-76 may mean the 
NCF decreased the development of thymocytes. NFATc3 was up regulated (1.266 
P=0.0169) and NF-kB1 down regulated which were discussed earlier, and are also 
important in this T cell antigen receptors signalling pathway. 
 
6.5.1.8 p38 Mitogen-activated protein kinase (MAPK) signalling pathway 
400g/t NCF also had an effect on the p38 Mitogen-activated protein kinase (MAPK) 
signalling pathway (Figure 6.12), which is activated by a range of environmental 
stresses and inflammatory cytokines. The activation of p38MAPKs results in the 
downstream phosphorylation of several protein kinases termed MAPK-activated 
protein kinases (MKs). MAPK signal transduction pathway plays a significant role 
in the recruitment of leukocytes to sites of inflammation, and a p38MAPK inhibitor 
would lead to a reduction in the production of inflammatory mediators (Herlaar and 
Brown 1999). Therefore, the supplementation of NCF may affect the immune system 
though this pathway. The gene encoding for TRAF-interacting protein with 
forkhead-associated domain (TIFA) was up regulated (1.143 P=0.0190) by 400g/t 
NCF. It has been reported that TIFA mediates IL-1 signalling and may have a 
function in innate immunity (Takatsuna et al., 2003). TIFA is also thought to play a 
role in the activation of macrophages by lipopolysaccharides (LPS), which are 
mediated by Toll-like receptor 4 (TLR4). TLRs transmit signals when going through 
the recruitment of adaptor proteins including tumor necrosis factor-associated factor 
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6 (TRAF6), which mediates the activation of IkB kinase (IKK). TIFA has been 
shown to bind to TRAF6 and activate IKK (Minoda et al., 2006). 
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Figure 6.12. p38 Mitogen-activated protein kinase (MAPK) signalling pathway showing gene interactions with the protein kinase cascade.  
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6.5.1.9 G-Protein Coupled Receptor Signalling 
The G-Protein Coupled Receptor Signalling canonical pathway was affected by 
400g/t NCF. G proteins are key in trans-membrane signalling by coupling a 
multitude of receptors to enzymes, channel proteins and other effector molecules. 
Phosphodiesterase 7A (PDE7A) is a gene involved in the g-protein coupled receptor 
signalling pathway, which was down regulated (-1.222 P=0.0029) by 400g/t NCF. 
PDE7A is thought to have a vital role in T cell activation, as a study showed that 
when PDE7A expression was blocked it inhibited T cell proliferation and IL-2 
production (Yang et al., 2003). Therefore, the down regulation of PDE7A may mean 
that NCF suppresses the immune system; however, there is little data about the 
effects of PDE7A, and more research is needed.  
400g/t also up regulated a number of genes involved in the Gs-coupled receptor 
which regulates human G protein alpha s (Gαs). Kveberg et al., (2002) reported that 
Gαs mediates movement/chemotaxis of human natural killer cells through 
chemokine ligand 5 (RANTES) and sphingosine-1-phosphate. Natural killer cells 
play an important role in the early defence against viruses and are cytotoxic 
lymphocytes. Therefore, the up regulation of the Gs-coupled receptor may have a 
knock- on effect on the movement of natural killer cells and their cytotoxic abilities. 
 
6.5.1.10 MIF-mediated Glucocorticoid Regulation 
MIF-mediated Glucocorticoid Regulation was also seen to be affected by 400g/t of 
NCF compared to the control. Glucocorticoids inhibit production of several 
cytokines, enzymes and cell surface molecules essential for immune function and the 
inflammatory process (Almawi and Melemedjian, 2002). The gene Nuclear factor-
kB1 (NK-KB1) was down regulated (1.134 P=0.0491) by 400g/t NCF. In this 
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pathway, NK-KB1 activation leads to transient up regulation of a number of genes 
encoding cytokines, growth factors, immunomodulatory molecules, apoptosis related 
genes and others (Blackwell et al., 2009) As you can see from Figure 6.13, this 
pathway is also linked to Inducible nitric oxide synthase (iNOS) signalling. iNOS is 
an enzyme that produces nitric oxide (NO). Macrophages when stimulated with 
microbial components or cytokine produce iNOS. NO has antimicrobial functions 
and therefore has an influential role in immune responses (Bogdan, 2001; Blanchette 
et al., 2003; Bogdan et al., 2000; MacMicking et al., 1997; Cheeseman et al., 2008). 
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Figure 6.13. MIF-mediated Glucocorticoid Regulation pathway with interactions with iNOS signalling. 
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6.5.1.11 Glyoxylate and Dicarboxylate Metabolism  
The Glyoxylate and Dicarboxylate Metabolism canonical pathway was affected by 
800g/t NCF. In this pathway Aconitase 2 (ACO2) was down regulated (1.089 
P=0.0241). ACO2 is an enzyme that catalyses the inter-conversion of citrate to 
isocitrate via cis-aconitate in the second step of the TCA cycle (Wang et al., 2013). 
The down regulation of ACO2 may mean there is a decreased ability for citrate to be 
changed into isocitrate, which may affect the energy produced by the TCA cycle. 4-
hydroxy-2-oxoglutarate aldolase (HOGA) is also an enzyme in this pathway, which 
was up regulated (1.123 P=0.0099). It breaks down 4-hydroxyproline into glyoxylate 
and pyruvate, which can be then broken down into glycine, oxalate and glycolate 
(Riedel et al., 2011). The up regulation of HOGA suggest the 800g/t is having an 
effect on the metabolism of 4-hydroxyproline and glyoxylate, and may be feeding 
pyruvate into the TCA cycle. 
 
800g/t NCF in the Glyoxylate and Dicarboxylate Metabolism canonical pathway 
down regulated (1.162 P=0.0497) methylenetetrahydrofolate dehydrogenase 1 
(MTHFD1) which encodes for three enzymes; methylenetetrahydrofolate 
dehydrogenase, methenyltetrahydrofolate cyclohydrolase and formate–
tetrahydrofolate ligase (Figure 6.14). MTHFD1 is key in folate metabolism 
(Krajinovic et al., 2004). The B-vitamin folate is essential for many biochemical 
reactions and metabolic functions through providing methyl groups in several 
reactions (McCann et al., 2004). One of these carbon transfer reactions is involved in 
purine synthesis (Selhub et al., 2009). Therefore, the down regulation of MTHFD1 
may affect a number of metabolic functions in the bird.  
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Figure 6.14. Part of the folate metabolism pathway showing three enzymes: methylenetetrahydrofolate dehydrogenase, methenyltetrahydrofolate 
cyclohydrolase and formate–tetrahydrofolate ligase, encoded by methylenetetrahydrofolate dehydrogenase 1 (MTHFD1).  
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6.5.1.12 Linoleic Acid Metabolism 
The linoleic acid metabolism pathway was affected by 800g/t NCF compared to the 
control. Phospholipases A2, group X (PLA2G10) was down regulated (1.143 P=0.0029). 
Phospholipases A2 are enzymes that release fatty acids from the second carbon group of 
glycerol. This particular phospholipase specifically recognizes acyl bond at the sn-2 
(phospholipase A2) position of phospholipids and releases arachidonic acid and 
lysophospholipids. There are numerous links of PLA2 with function in the body which 
include the immune system and phospholipid digestion and metabolism (Dennis 1994). 
PLA2 is thought to be the first step in the eicosanoid cascade and the generation of pro-
inflammatory intermediates, including prostaglandins and leukotrienes (Sandercock and 
Mitchell, 2004). Therefore, the down regulation of PLA2 may mean the production of 
pro-inflammatory intermediates through the eicosanoid cascade was reduced. 
The gene encoding for fatty acid desaturase 1 (FADS1) in the linoleic acid metabolism 
pathway was up regulated (1.143 P=0.0220), which is a member of the linoleoyl-CoA 
desaturase (Gene View: FADS1). The enzymes FADS2 and FADS1 are important in the 
production of arachidonic acid (20:4n-6) and docosahexaenoic acid (22:6n-3), from 
linoleic acid (18:2n-6) and α-linolenic acid (18:3n-3), as shown in Figure 6.15 (Das 
2006; Arbo et al., 2011). Increased fatty acid desaturase activity in erythrocytes due to 
high n-6 to n-3 ratios, is suggested to promote endogenous production of pro-
inﬂammatory arachidonic acid (Martinelli et al., 2008; Arbo et al., 2011). Therefore, the 
up regulation of FADS1 when feeding 800g/t may increase the levels of the pro- 
inﬂammatory arachidonic acid in broilers. 
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Figure 6.15 The n-3 and n-6 fatty acid metabolism pathways (Martinelli et al., 2008). 
 
6.5.1.13 G-Protein Coupled Receptor Signalling 
Like 400g/t NCF, the G-protein coupled receptor signalling canonical pathway was also 
affected by 800g/t NCF. However, 400g/t NCF up regulated a number of genes 
involved in the Gs-coupled receptor, whereas 800g/t up regulated DRD1 and HRH2 and 
down regulated CNR1 and MC2R. The effect of 800g/t NCF on the Gs-coupled 
receptor, may as with 400g/t NCF effected Gas and the movement of natural killer cells 
and their cytotoxic abilities, as reported earlier. The Gi coupled receptor was also 
affected by 800g/t NCF, with a number of genes up or down regulated. The Gi coupled 
receptor regulates G-alpha i/o (Gαi/o). The inhibition of G-alpha i/o in humans has been 
reported to decrease production of nitric oxide in cultured endothelial cells (eNOS) 
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(McGuane et al., 2011). It has been reported that endogenous eNOS plays an important 
role in angiogenesis in vitro and in vivo (Ziche et al., 1994).  Murohara et al., (1999) 
demonstrated that endogenous eNOS contributes to endothelial cell migration in vitro. 
Phosphodiesterase (PDE)  5A and 11A are genes involved in the g-protein coupled 
receptor signalling pathway, which were up regulated by 800g/t of NCF (1.380 P = 
0.005; 1.144 P=0.010 respectively). PDE11A catalyses the production of adenosine 
monophosphate (AMP) from cyclic AMP (Fawcett et al., 2000). It has been reported 
that an increase in cyclic AMP can result in a decreased cytokine response of immune 
cells and decreased inflammatory response in organisms (Ernst et al., 2010; Lin et al., 
2011). This could suggest that an up regulation of PDE with NCF supplementation may 
result in a decrease in cyclic AMP, and an increase in immune and inflammation 
response. 
 
6.5.2 Immunoglobulin 
The interaction observed between NCF and Ca But on IgG levels in the bird at day 21, 
indicated that the sole supplementations of Ca But did not alter IgG levels from the 
control, where as NCF on it only and in combination with Ca But decreased IgG levels. 
This may be due to NCF having an immune modulating effect on the bird (Lyons and 
Bourne, 1995; Kelly, 2004; Ewing, 2008; Vondruskova et al., 2010), which is not a 
mode of action seen with Ca But supplementation. However, when looking at the 
treatment effect at 21 days on IgG, there was a trend but not a significant difference. No 
significant effect were observed when feeding NCF, Ca But and Na But had on broiler 
immunoglobulin levels in serum at days 7, 14, 21 or 42. This illustrates that any effect 
that NCF or Butyrate has on the immune system of the bird is not through changing the 
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concentrations of immunoglobulin. However this lack of effect may be due to the 
variability between replicates, which has been reported by other authors (Janardhara et 
al., 2009; Kim et al., 2011). The lack of effect of the supplements on the levels of IgG, 
IgM, and IgA in blood serum was also found in a number of studies when feeding MOS 
in broilers (Midilli et al., 2008; Janardhana et al., 2009; Kim et al., 2011), horse 
(Gurbuz et al., 2010) and pigs (White et al., 2002). This may be due to the lack of 
immune challenge or physiological stress on the birds. As with this study, all of these 
studies had no specific immune challenge on the animal. In contrast, Castillo et al, 
(2008) also reported no significant effect on IgG, IgM and IgA serum even with 
temperature stressing the pigs. In addition, Sauerwein et al, (2007) found that pigs fed 
yeast cell wall extracts had higher levels of IgA in their serum without any challenge 
being applied. Therefore, published data is variable and it is difficult to draw 
conclusions from. 
 
It has been seen that butyrate can affect inflammation (Hammer et al., 2008), which 
may mean that butyrate is having an effect on the immune system. This study found that 
the IgG level in birds fed Na But at 21 days was very close to being significantly higher 
than the other diets (P = 0.058). This implies that Na But is causing an increase in the 
activity of the immune system. The increase in IgG also coincided with a decrease in 
performance, indicating that the immune system could have been using more energy, 
and therefore less was available for growth. However, as suggested in chapter 5, this 
may have also been caused by a diet manufacturing issue, as the growth was negatively 
effect to an extent that is very unlikely to be caused by a licenced feed product. White et 
al (2002) found that when feeding a dried yeast product in combination with an organic 
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acid (citric acid), the serum IgG levels increased over the control in pigs but yeast on its 
own did not, suggesting that the organic acid may be having an effect on IgG levels. 
This may help to explain the trend seen in this trial when feeding butyrate. 
 
The supplements in this study showed no effect on levels of immunoglobulins. However, 
the supplements might have changed the specificity of the immunoglobulins, which was 
not measured in this project. Shashidhara et al (2003) found that broiler breeders fed 
MOS have a higher antibody response against infectious bursal disease virus (IBDV), 
Olivera et al (2009) also found this in broilers in the fourth and fifth weeks, as well as 
reporting increased antibody responses against Newcastle disease virus (NDV) at three, 
four and five (P<0.03) weeks of age was higher with MOS. This could suggest that 
MOS products are more effective at stimulating the humoral immune responses against 
specific vaccine viruses, rather than unspecific immunoglobulin levels. 
 
Figures 6.7, 6.8 and 6.9 show the immunoglobulin levels in serum of broiler over time. 
Levels of IgA increased over the birds life. Sauerwein et al (2007) also reported this in 
pigs. By contrast, IgM increased from 7 to 14 days, then decreased at 21 days and then 
at 42 increased to its highest level. IgG decreased from 7 to 14 days, but then increased 
to its highest level at 21 days and slightly decreased at 42 days. A similar pattern in 
serum levels of IgG were seen in pigs where levels decreased and then increased 
(Sauerwein et al., 2007). 
 
6.5.3 Digestive enzymes 
It was seen that feeding NCF, Ca But and Na But either alone or in combination had no 
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significant effect on the broiler digestive enzymes, amylase, chymotrypsin and trypsin 
in either the duodenum or jejunum at any time during the trial period. This suggests that 
NCF, Ca But and Na But does not affect digestibility of the bird though increasing 
activity of these particular enzymes. However this lack of effect  may be due to the 
variability between replicates, which has been reported by other authors (Matur et al., 
2010) This was also reported when feeding saccharomyces cerevisiae extract in broilers 
(Matur et al., 2010). However, in contrast it has been reported that broilers fed MOS 
have increased specific activities of other enzymes (maltase, leucine aminopeptidase 
and alkaline phospatase) in the jejunum (Iji et al., 2001), as well as amylase and 
chymotrypsin activity in the pancreas (Matur et al., 2010).  
 
As the main site of digestion in the bird is the small intestine, most enzyme secretion 
occurs into the proventriculus or duodenum. While it might be anticipated from the 
literature that the  activity of enzymes would be higher in the duodenum than the 
jejunum; it was seen in the current study that amylase, chymotrypsin and trypsin levels 
were higher in the jejunum than the duodenum. This may be due to the selection of 
tissue taken from the duodenum being before the pancreatic ducts, which enter the later 
portion of the ascending branch of the duodenum (Larbier and Leclercq, 1992). This 
may mean that the enzyme activity level measured in the duodenum represented 
residual activity resulting from  anti-peristalsis of the small intestine moving digesta and 
enzyme anteriorly  in the intestinal tract, rather than a true representation of maximum 
enzyme activity in that section of intestine. The increased levels of amylase in the 
jejunum in comparison to the duodenum are consistent with previous reports that most 
carbohydrate digestion occurs in the jejunum (Osman 1982). Another reason trypsin 
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activity may be higher in the jejunum rather than the duodenum is that trypsin is 
produced by the pancreas in an inactive form, such as trypsinogen, which is secreted in 
to the duodenum and then activated by enterkinase in the GI tract. Therefore, higher 
levels in the jejunum may be due to more trypsin being in its active form. It has been 
reported that the trypsin activity increases from hatch to 15 days of age (Leeson and 
Summers 2001). This was also seen in this trial.  
 
6.6 CONCLUSION 
NCF in this project had no profound effect on the digestive enzyme activity or serum 
immunoglobulin level measured in this trial, which demonstrates that NCF is not having 
its effects though these measures, however may be still having an effect on the immune 
system or digestive capabiltys of the bird but through other mechanism not measured in 
this projects. It was seen in this chapter that the mechanism underlying the 
supplementation of NCF may change depending on the inclusion level. 200g/t NCF 
altered immune and metabolism genes, 400g/t NCF altered mostly immune genes, 
whereas 800g/t altered mostly metabolism genes. From the alterations seen in the gene 
expression, when feeding NCF it is indicated that one of NCF main mechanisms is 
through increasing the immune defences of the bird. This emphasizes that performance 
improvements are more likely to be observed with some level of challenge placed on the 
bird. 
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CHAPTER 7: GENERAL DISCUSSION 
7.1 INTRODUCTION 
The recognised risk of antibiotic-resistant bacteria is a global priority (Roe and Pillai, 
2003) and has put increasing pressure on non-EU countries to decrease their use of 
antibiotic growth promoters, and EU countries to reduce their therapeutic antibiotic 
usage in poultry. Therefore there is a requirement for a viable feed supplement, which 
will improve g`ut health, immunity and bird performance, whilst reducing the proposed 
risk to human health. A newly refined natural carbohydrate fraction (NCF) from the cell 
wall of Saccharomyces cerevisiae yeast was produced, with suggested prebiotic 
properties that could improve gut health, immunity and bird performance. The aim of 
this research was to quantify the efficacy of this feed supplement (alone and in 
conjunction with other supplements) in improving gut health, immunity and bird 
performance, as well as to identifying possible modes of action. From these aims, the 
overarching hypothesis of this project is that NCF improves bird performane through 
improving gut health. The first posed mechanism in support of this hypothesis is that 
NCF increases the gut surface area, thereby  increasing digestive capacity. The second 
posed mechanism is that NCF improves immune defence against pathogens by 
decreasing damage from adverse inflammation. The following general discussion 
evaluates the findings from the individual trials presented in chapters 3, 4, 5, and 6 and 
also collectively reviews the observations drawn. The effect of NCF on gut health, 
immunity and bird performance, as well as the potential variability in feed supplements 
and between trial variation are also discussed. 
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7.2 OVERALL BIRD PERFORMANCE 
When evaluating bird performance across the whole project, it was observed that 
feeding NCF to broilers resulted in highly variable performance between trials. When a 
commercial stocking density was implemented in Trial 1, improved FCR in starter and 
grower feeding phases were seen with NCF supplementation but there was no effect on 
performance when stocking density was reduced in subsequent trials. From this, the 
effects of yeast cell wall derived supplements on bird performance are stronger if the 
birds are under some level of challenge, which has also been previously reported in 
broilers and pigs (Nolet, et al., 2007; Castillo, et al. 2008; Che, et al. 2012). It was 
noted that, when comparing body weight performance of control birds in Trial 1 against 
the control birds in Trials 2 and 3, birds were 400g lighter on day 42, which supports the 
suggnestion that birds in trial 1 were under more physiological stress that bird in Trial 2 
and 3.  
The performance data in Trial 1 indicated an inconsistent response to NCF 
supplementation level suggesting more than one mechanism behind the observed 
response to NCF supplementation due to the cubic response at 14 day. Variability with 
supplementation level of NCF in modulation of gene expression relating to immunity 
and metabolism may be a factor in observed performance effects. Another mechanism 
behind the improvement in FCR in the starter and grower phase could be NCF 
supporting improved development of the gut and defence systems, such as 
immunoglobulin and mucin production.  
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7.3 POSSIBLE ROLE OF IMMUNITY AND METABOLISM GENE EXPRESSION 
IN MECHANISMS BEHIND BIRD PERFORMANCE. 
The following two sections relate the improvements in performance observed in Trial 1 
to the detected alterations in gene expression of the immune system and metabolism of 
the birds. Whilst NCF inclusion without doubt affects expression of immune associated 
genes, the specific effects vary with rate of NCF inclusion. Studies of gene expression 
result in large and complex data sets making it difficult to define overall effects. The 
expression of immune and metabolic genes (Table 7.1) provides an overall 
interpretation of the data which is subsequently discussed in more detail.  
 
Table 7.1 Interpreted summary of overall NCF effects on the alteration of gene 
expression. 
Inclusion Immune gene expression Metabolic gene expression 
200g/t NCF Substantial Moderate 
400g/t NCF Substantial None 
800g/t NCF Small Substantial 
 
7.3.1 Immunity 
In Trial 1, the consistent improvement seen in the body weights of birds fed NCF at 
200g/t is partially explained by changes in expression of specific genes relating to 
immune function of  the birds. It was observed that birds fed 200g/t NCF had down 
regulated CPS-I, resulting in a decrease in inflammation in the GI tract (Mueller et al., 
2000). In addition, the up regulation of Act1 decreased numbers of B cells (Qian et al., 
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2004). These suppressions of the immune system decrease the energy requirement of 
the immune system, leading to the improved body weights recorded. In contrast, the 
down regulation of Isopentenyl-diphosphate Delta-isomerase would have increased 
activation of γδ T cells. This increases the readiness of the immune function of birds fed 
200g/t NCF, resulting in the bird being able to overcome the pathogen more quickly. 
When birds are presented with a challenge this readiness reduces loss of growth and 
feed conversion efficiency as the pathogen is overcome before colonisation and 
substantial damage to the gut can occur. This is supported by Trial 1, where the use of 
commercial stocking density placed the birds under a level of challenge and the birds 
fed 200g/t NCF maintained their production level greater than birds fed the control.  
Similarly to birds fed 200g/t NCF, feeding 400g/t NCF to broilers in Trial 1 resulted in 
a mixed alteration of the immune system, with some pathways up regulated and others 
down regulated. However, where 200g/t NCF led to an overall improvement in 
performance, the suppressive and stimulatory effect of 400g/t NCF on differing immune 
pathways appear to have annulled each other. The down regulation of Syk by 400g/t 
NCF decreased B cell development (Turner, et al 1995), and the down regulation of 
Egr-1, PDE7A and SLP-76 would have resulted in the suppression of the immune 
system leading to a decreased energy need for the immune system (Clements et al., 
1998; Yang et al., 2003; Carter et al., 2007). However 400g/t NCF also increased 
immune factors through the down regulation of NF-kB1 and up regulated of TIFA. 
Overall, it was demonstrated that feeding 400g/t NCF had no effect on body weights of 
the birds, as the opposing alterations in the gene expression of the immune system 
resulted no net change in the overall energy required by the immune system.   
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800g/t NCF did not have as profound an effect on the immune system gene expression 
as the lower NCF inclusion rates. In Trial 1, improvements in body weights of birds fed 
NCF at 800g/t were observed but the effects of 800g/t NCF on the alterations in gene 
expression suggest an increase in energy required for the immune system. Based on the 
immune system gene expression findings alone, a decrease in body weight compared 
with the control was anticipated. However, as Trial 1 presented a challenging 
environment this stimulation of the immune system allowed the bird to defend itself 
faster, resulting in a decrease in the loss of production caused by pathogenic challenge. 
The improvements seen in body weights when feeding 800g/t NCF are likely to be due 
to this inclusion level having a greater effect on the alterations of expression of genes 
involved in the metabolism of the birds. 
7.3.2 Metabolism 
Both birds fed 200g/t and 800g/t showed alteration in expression of metabolic genes, 
which correlated with improvements in performance. In contrast, feeding 400g/t to birds 
resulted in neither alteration in metabolic gene expression or performance improvement. 
When investigating the effects of the varying levels of NCF, it was demonstrated that 
200g/t altered expression of genes involved in the metabolism of carbohydrates and 
protein, homeostasis of D-glycogen, the transport of fatty acids and  amino acid 
synthesis and uptake. Feeding 200g/t NCF up regulated HNF-1α and INSR, resulting in 
increased ability of the chicken to take up glucose (Kim et al., 2001). Therefore one 
possible mechanism behind the improved performance may be through increased 
availability of glucose available for growth.  
214 
 
 
 
Trial 1 improvements in body weights were also demonstrated in birds fed NCF at 
800g/t, but not to the same extent as 200g/t. However, 800g/t NCF affected the gene 
expression of more energy related metabolic pathways than 200g/t NCF fed birds. This 
suggests that at commercial stocking densities a balance between up regulation of 
immune and metabolic genes is required for optimum performance. Supplementation at 
800g/t NCF had profound effects on expression of not only the enzyme involved in the 
TCA cycle but also on glyoxylate and dicarboxylate metabolism pathways. This may 
affect the energy produced by the TCA cycle, and therefore the amount of energy 
available for growth. The additional effects of 800g/t NCF on the expression of 
enzymes involved in folate metabolism, linoleic acid metabolism and phospholipid 
digestion and metabolism may have also resulted in the bird being more efficient.  
It is also likely that NCF is having an indirect metabolic effect on performance through 
increased bacterial butyrate production. Butyric acid is produced in the chicken GI tract 
by bifidobacteria (Rolfe, 2000) and used as an energy source by host epithelial cells 
(Lawhon et al., 2002; Guilloteau et al., 2010). There is consensus that MOS increases 
the population of bifidobacteria in the GI tract (Baurhoo et al., 2007; Jung et al., 2008; 
Jacob and Parsons, 2009), therefore NCF is likely to increase levels of butyric acid in 
the GI tract and thus increase energy available to the bird for growth through this 
mechanism.  
Trial 1 demonstrated that supplementing diets with NCF at varying levels affects gene 
expression and performance differently. The best performance was seen when NCF was 
included in the diet at 200g/t, where observed alterations in immune genes were 
substantial and metabolism genes were moderate. Moderate immune and substantial 
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metabolic alterations of genes were also observed alongside improved performance in 
birds fed 800g/t NCF, but performance improvements of 800g/t NCF were not as 
profound as in birds fed 200g/t NCF. From this it can be concluded that alterations in 
gene expression of both the immune system and metabolism are required for optimum 
growth. These alterations were achieved using NCF at the dietary supplementation level 
of 200g/t, suggesting this is the optimum level for commercial application.  
 
7.4 INTESTINAL HEALTH AND RELATED GENE EXPRESSION 
 
Villus height, crypt depth, goblet cells and intestinal weight and lengths were measured 
in this project as indicators of gut health as the main proposed mode of action for this 
feed supplement is to irreversibly bind to pathogenic bacteria in the GI tract, preventing 
them from damaging the gut (Spring, et al., 2000). The mechanism behind this mode of 
action is that, by preventing colonisation of the gut by pathogenic bacteria, they are 
unable to secrete toxins that cause damage to the epithelial cells (Yason et al., 1987). 
Although 200g/t NCF indicated down regulation of CPS-I thereby effecting 
proliferation, differentiation, and migration of intestinal epithelial cells (Wu et al., 
2000), Trials 1, 2 and 3 showed no significant effects of NCF on the gut health of the 
birds through villus height or crypt depth. However there was a cubic response of 
duodenum length to body weight ratio to NCF ROI, which mirrored the response of 
several performance paramenters, suggesting duodenum development might have some 
involvement in the possible mechanistic differences occurring at 200g/t and 800g/t NCF 
inclusion.   
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It was observed that, at a gene expression level, NCF may yet have improved the 
integrity of the gut: birds fed 200g/t and 400g/t NCF had up regulated C-RAF, which 
has been reported to increase level of tight junction proteins and improve barrier 
function of the intestine (Zimmerman et al., 2011). This suggests that NCF may have 
improved intestinal health but through a different mechanism, which was not identified 
by measuring villus height and crypt depth. 
The effect of NCF and other yeast cell wall supplements on parameters representing gut 
health are reported to be variable (Zhang et al., 2005; Sohail et al., 2012). This could be 
due to differences between the environmental conditions of the trial: birds in studies 
with a pathogenic challenge seem to benefit from yeast cell wall products more than 
those without a challenge. An animal with no pathogenic infection of the GI tract, that is 
fed a supplement modifying the microflora population or immune system, will gain 
little benefit from a supplement, because there is no impediment to growth potential 
caused by excessive sloughing of the villi.  
In the first trial the dose response of jejunum goblet cell area was cubic, with 800g/t of 
NCF significantly increased the area of jejunum goblet cells. Whereas the dose response 
of the goblet cell area per 165 μm of villi was linear, with a trend for increasing goblet 
cell area per 165 μm of villi with increasing NCF. This suggesting that an effect on the 
mucin profile of broilers in the jejunum is more likely at high dosage of NCF, however 
there were no mucin specific genes up or down regulated by NCF when looking at the 
gene expression data. Trial 3 showed no significant difference when feeding NCF in 
goblet cell number or area, but whether this is due to the younger bird (one week post 
hatch) or the lower NCF inclusion level (200g/t) cannot be determined from this trial. 
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Published data on goblet cell area is very limited, but Brummer, et al. (2010) also found 
that the area of goblet cells increased with supplementation of MOS. Insight into the 
mechanisms behind this goblet cell response would be highly beneficial to 
understanding the effect of MOS supplementation on gut health. When investigating the 
effects of butyrate salts in the third trial, goblet cells measurements were not 
significantly affected, but there was a trend toward increasing goblet cell area per 
165μm of villi when feeding calcium butyrate. It has been also reported by Nahrling, et 
al. (2010) that butyrate in piglets increased MUC2 expression, which is key in mucin 
production. Therefore the observed trend in Trial 1 towards increased mucin production 
at 800g/t NCF may be due to NCF increasing levels of butyrate in the GI tract by 
increasing the population of butyrate-producing bacteria. However there appear to be no 
published studies on the effects of butyrate salts on goblet cells in broilers, and one 
paper that found that feeding sodium butyrate had no effect on goblet cell number in 
pigs (Manzanilla et al., 2006). 
 
An increase in goblet cell area is thought to show that the storage capacity of the goblet 
cell for mucin has increased (Smirnov, et al., 2005). An increase in mucin storage 
means that the bird is more capable of forming a protective layer on the villi, thereby 
helping protect the intestine from damage caused by enteropathogens if there was a 
challenge from pathogenic bacteria (Smirnov, et al., 2006; Brümmer, et al., 2010). 
Previous studies have suggested that MOS affects mucin production through direct 
crosstalk between beneficial intestinal microbes and goblet cells (Mack, et al., 1999; 
Freitas, et al., 2003; Smirnov, et al., 2005; Uni and Smirnov 2006; Chee, 2008). 
However, the current study suggests an indirect mechanism via MOS or NCF increasing 
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levels of butyrate producing bacteria, which then leads to the butyrate affecting mucin 
production of the bird. 
 
7.5 DIGESTIVE ENZYMES AND RELATED GENE EXPRESSION 
A recently posed mode of action behind the effects of MOS in improving performance 
is through increased digestive enzyme activity (Iji et al. 2001; Matur et al. 2010). 
Therefore activities of three key digestive enzymes, amylase, chymotrypsin and trypsin, 
were measured in Trial 1 and 3. In Trial 1 and 3 it was observed that NCF did not 
significantly affect the activity of these digestive enzymes. Whether this result is a truly 
meaningful contribution is difficult to determine, as published values for activity of 
these enzymes in poultry vary by orders of magnitude (Matur et al. 2010; Kadhim, et al., 
2011), suggesting that producing reliable data from these assays is challenging. 
However the differing values derived from birds of differing ages suggest the assay is 
capable of identifying differences. Whilst amylase activity was not affected by NCF 
supplementation, microarray demonstrated that NCF at 200g/t may have increased the 
uptake of glucose by up regulating the gene encoding the insulin receptor (Kim et al., 
2001). Therefore, the increase in performance seen with 200g/t NCF supplementation 
may be attributed to an increased ability to uptake glucose, rather than an increase in the 
glucose monomers available for absorption through increased digestive enzyme activity. 
 
7.6 NATURAL CARBOHYDRATE FRACTION LEVEL 
In trial two it was shown that NCF has little or no effect on the birds performance or gut 
health. This was initially thought due to the lack of challenge on the birds from the 
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environment, resulting in all birds already performing to their optimum in the trial, 
meaning that NCF could not improve performance or gut health. However when the 
levels of NCF were analysed in the diets the measured levels did not reflect the 
formulated linear increase in NCF. When the assay was repeated, inconsistencies 
between runs and laboratories were revealed, therefore the usefulness of data from this 
trial was very limited. The diets were analysed three times, twice at the Bioscience 
Centre in Dunboyne, Ireland and once at The Bioscience Centre in Lexington, USA. All 
of the assays performed showed unexpected results that were inconsistent. This could be 
due to a number of factors: firstly the assay may not reliable, secondly there is a factor 
in the feed interacting with the NCF or assay, thirdly there was a problem with the 
activity of the NCF and finally the mix of NCF in the feed was not homogenous. Due to 
the variability of measured NCF in the diet between the two laboratories, in 
combination with no clear pattern of effects on performance or gut health in this trial, it 
was decided that no further analysis would be performed on this trial. 
 
7.7 SODIUM AND CALCIUM BUTYRATE 
The main focus of the project was to investigate the mechanisms underlying any effect 
of supplementing broiler diets with NCF, but the final phase of the project (Trial 3) 
investigated any interaction upon feeding NCF in combination with another type of gut 
health supplement; calcium butyrate or sodium butyrate. Overall Trial 3 showed that no 
effects of NCF, butyrate salts or their combination on the performance or gut health of 
young broilers. This supports the hypotheses of Trial 3, that feeding NCF and butyrate 
salts exert their effects on performance via similar modes of action and would therefore  
not show an additive effect when fed in combination. The lack of response to any 
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treatment in Trial 3 is likely to be due to the lack of environmental challenge being 
placed on the birds. Ideally this trial would have included a pathogenic challenge but 
this was not possible due to the lack of Animals (Scientific Procedures) Act 1986 Home 
Office licence (required for this type of trial) at Nottingham Trent University poultry 
facility. In addition, the design of Trial 2 and 3 (weekly sampling days) constantly 
reduced stocking density compared to commercial levels, thereby further decreasing any 
challenge experienced by the birds in these trials. This was due to the requirement to 
cull birds each week for the sample, which allows for the investigation into any 
mechanisms occurring in young birds following NCF supplementation. 
 
7.8 CONCLUSION  
The aim of this project was to investigate and clarify some of the mechanisms behind 
the observed effects of gut health supplements in broilers. This project indicated that 
NCF instigates some of its effects through alteration to the immune and metabolic 
systems of the bird at a gene expression level. Furthermore the project provides 
evidence that some of the immune adaptations are borne out through alteration to mucin 
production by goblet cells in the GI tract. Trial 1 showed that the mechanism underlying 
the effects of NCF supplementation change depending on the inclusion level: 200g/t 
NCF altered immune and metabolism genes, 400g/t NCF altered mostly immune genes, 
whereas 800g/t altered mostly metabolism genes. Histological and enzymatic 
investigations did not provide any clear mechanism for how metabolic alterations at 
gene expression level resulted in the improved performance related to NCF 
supplementation. From the alterations seen in the gene expression and mucin capacity 
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when feeding NCF it is indicated that NCF is increasing immune defences to prevent 
growth impedance, rather than any metabolic, growth promoting effect. This 
emphasises that performance improvements are more likely to be observed with some 
level of challenge placed on the bird.  
This indicates that feed supplements such as prebiotics may be fed as a type of 
insurance policy, as they increase the readiness of the immune system to overcome 
pathogenic challenge. However if there is little risk of pathogenic infection, the cost of 
adding the supplement to the feed, combined with potential decrease in production 
efficiency due to repartitioning of energy from growth to immune readiness, may 
outweigh its benefits. However in modern production systems, it is unlikely that the 
birds will be free from the risk of pathogenic infection. This project demonstrated that 
the effects of the supplementation of NCF are variable, suggesting that the optimum 
level of inclusion of NCF may vary depending on the bird age and environment, as well 
as the activity of NCF. 
 
7.9 FUTURE DIRECTION 
The clearest deduction from this study is that immense complexity lies within the 
mechanisms underlying the effects of successful gut health feed supplements. This 
project has scrutinised a number of possible modes of actions for NCF effects on 
broilers, however a number of avenues remain unexplored. 
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7.9.1 Quantities of mannan and β-glucan within and between different yeast cell 
wall products 
The consistency of a feed supplement is vital for the industry to ensure reproducible 
results can be achieved in similar situation. Investigation in to the variability of mannan 
and β-glucan within and between a yeast cell wall feed supplement, would clarify 
whether the variation between trials using the same or similar products is due to the 
product or the environmental conditions. Presently available yeast cell wall products are 
generally claimed to either contain mannan oligosaccharides, β-glucans or both.  It 
would be interesting to measure levels of both mannan oligosaccharides and β-glucans 
in commercial products to quantify the variability between brands and batches in their 
active contents. 
 
7.9.2 Levels of immune cells within the bird 
Altered expression of genes affecting B and T cell development in the bird was 
consistent throughout all NCF treatment groups. Further investigation in the levels of B 
and T lymphocytes in the blood of birds fed NCF may help to understand the effect of 
NCF on the adaptive immune system. Additionally, such an investigation would 
increase understanding of how NCF may protect the performance of a bird when there is 
a pathogenic challenge.  
 
7.9.3 The effects of sodium butyrate and calcium butyrate on gene expression  
The observed effects of NCF on bird performance and gene expression may be through 
increasing the population of butyrate-producing bacteria in GI tract. Therefore it would 
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be interesting to investigate the effect of feeding a butyrate feed supplement on the gene 
expression of the birds. Comparing alterations of feeding butyrate on gene expression to 
alterations when feeding NCF to birds may expose the underlying mechanism behind 
butyrate and NCF supplementation.  
 
7.9.4 Comparative trials 
There are many types of feed supplements presently used in the poultry industry, which 
are thought to improve intestinal health and performance of broilers. These included 
similar prebiotics, probiotics and organics acids. It would be valuable to investigate 
several other supplements produced from yeast cell walls in a single trial alongside the 
NCF to deepen the understanding of how similar feed supplements affect birds under 
identical environmental conditions.  
 
7.9.5 Implementation of a health challenge on the birds 
When feeding any supplement claiming to improve bird health (whether intestinal 
health, leg health or immunity), the bird needs to be performing sub-optimally to see a 
profound treatment effect. If the bird is in optimum health there will be no apparent 
effect of the supplement on the bird, unless the supplement is delivering growth 
promoting effect rather than health promoting effects. To gain the greatest insight and 
understanding, future trials on health promoting supplements should contain a challenge, 
and therefore be carried out under a Animals (Scientific Procedures) Act 1986 Home 
Office licence. The challenge could be in the form of a dietary, pathogenic or 
environmental challenge. 
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7.9.6 Use of prebiotics after therapeutic antimicrobial treatment 
Although the uses of antimicrobials as growth promoters are banned in the EU, the 
poultry industry still extensively uses antimicrobials as treatment for a disease outbreak. 
Using antimicrobials in broilers decreases the total number of bacteria in the GI tract, 
including beneficial gram positive bacteria (Gunal et al., 2006). Following treatment 
with antibiotics, the entire profile of bacteria in the GI tract alters. Although there is a 
decrease in total numbers of bacteria, the proportion of harmful bacteria increases 
(Apajalahti and Kettunen, 2013). This means that, after treatment with antibiotics, the 
initial bacterial population in the GI tract is potentially harmful. It would therefore be 
interesting to investigate the effects of a prebiotic immediately after using an antibiotic 
in the diet to see the resulting bacteria population growth in the GI tract.  
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APPENDIX 1  
 
Immunoglobulin-A typical standard curves 
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APPENDIX 2:  
 
Immunoglobulin-G typical standard curves 
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APPENDIX 3:  
 
Immunoglobulin-M typical standard curves 
272 
 
 
 
 
273 
 
 
 
APPENDIX 4:  
 
Procedure for measuring levels of IgM, IgA and IgG in serum using an enzyme linked 
immunosorbentassay (ELISA) micro titre plate for the detection of chicken IgM, IgA or 
IgG in serum 
1. Add 100μl of standard or sample to well. - Note: Run each standard or sample in 
duplicate.  
2. Cover plate and incubate at room temperature (20-25 C) for 1 hour.  
3. Wash plate FOUR times.  
4. Add 100 μl of Chicken IgA/G/M Detection Antibody to each well.  
5. Cover plate and incubate at room temperature for 1 hour.  
6. Wash plate FOUR times.  
7. Add 100 μl of HRP Solution A to each well.  
8. Cover plate and incubate at room temperature for 30 minutes.  
9. Wash plate FOUR times.  
10. Add 100 μl of TMB Substrate Solution to each well.  
11. Develop the plate in the dark at room temperature for 30 minutes.  
12. Stop reaction by adding 100 μl of Stop Solution to each well.  
13. Measure absorbance on a plate reader at 450 nm 
 
HRP -strepavidin-conjugated horseradish peroxidase 
TMB - 3,3’,5,5’-tetramethylbenzidine 
 
274 
 
 
 
APPENDIX 5: 
 
APPENDIX 6:  
Proximate Analysis 
 
Attribute
NCF 200g/t NCF 400g/t NCF 800g/t
Starter 338 531 989
Grower 360 487 818
Finisher 316 483 847
Supposed levels
Component % Starter Grower Finisher Starter Grower Finisher Starter Grower
Protien 20.11 18.74 17.89 22.30 22.40 17.60 18.60 16.80
Ether extract 6.23 6.50 6.51 3.90 5.03 3.40 6.93 7.39
Ash 6.69 6.39 5.31 10.70 9.10 10.40 9.20 10.20
Dry matter 87.83 87.30 87.15 86.20 89.20 86.20 88.80 89.10
Trial 1 Trial 2 Trial 3
